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GENERAL INTRODUCTION AND 
OUTLINE OF THIS THESIS
1|
Disruption of one of these structures can lead to loss of support and POP. Depending 
on the location and function of the defect and the organs involved, several types 
of prolapse can occur. The vagina can be separated into three compartments: the 
anterior, apical and posterior compartment. Prolapse of the anterior vaginal wall 
leads to prolapse of the bladder and/or urethra, and is called a (urethro)cystocele. 
Prolapse of the apical compartment is referred to as uterine or cervical descent (if the 
uterus or cervix is still in place) or, after vaginal hysterectomy, vaginal vault prolapse. 
Prolapse of the posterior vaginal wall leads to anterior prolapse of rectum and or small 
bowel referred as a rectocele or enterocele respectively. POP can be present in one 
compartment, but usually more compartments are affected simultaneously. 
POP is one of the most common gynaecological conditions. In a Dutch cross-sectional 
study, 40% of the women over 45 years of age had an anatomical prolapse stage two 
or higher on clinical examination [3]. However, in the vast majority the prolapse was 
asymptomatic, only 12.1% reported a seeing and/or feeling of vaginal bulging. The 
lifetime risk of undergoing surgery for POP or stress urinary incontinence is estimated 
to be 20% by the age of 80 years [4]. As result of the aging of the population, a 
significant increase in both the number of women with POP and those seeking care 
for POP is expected to occur over the next 20-40 years [5]. Consequently, the surgical 
rates for POP and stress urinary incontinence in the United States are estimated to 
increase with 42.7% by 2050 [5]. 
The aetiology of POP is multifactorial. Several risk factors are established, including 
higher parity, vaginal childbirth, advancing age, obesity and previous hysterectomy. 
Potential risk factors include forceps delivery, high infant birth weight (> 4500 g), 
prolonged second stage of labor, age < 25 years at first delivery, pregnancy itself, 
family history of POP, occupations entailing heavy lifting, constipation and connective 
tissue disorders [6].
Although POP is not a life-threatening condition, it significantly affects a woman’s 
quality of life and may influence urinary, gastrointestinal, sexual and psychological 
functioning. In a Dutch cross-sectional study, symptomatic prolapse was found in 11.4% 
of the women aged over 45 years [7]. The correlation between prolapse symptoms 
and the stage of prolapse is weak [8]. However, the one symptom that is consistently 
mentioned by patients with advanced POP is seeing or feeling a vaginal bulge [9]. In 
addition, the hymen seems to be an important threshold for symptoms as women with 
prolapse beyond the hymen have more POP symptoms and are more likely to report a 
vaginal bulge as compared to women with prolapse at or above the hymen [10]. 
PELVIC ORGAN PROLAPSE
Pelvic organ prolapse (POP) is defined as the downward displacement of one of the 
pelvic organs including the uterus and/or different vaginal compartments and their 
neighbouring organs such as bladder, rectum or bowel [1]. POP is part of the group 
of pelvic floor disorders: clinical conditions caused by dysfunction of the pelvic 
floor, which comprises urinary incontinence, lower urinary tract symptoms, faecal 
incontinence, defecatory dysfunction, chronic pain syndromes and sexual dysfunction. 
Pelvic organ support depends on the combination of function of connective tissue 
attachments (endopelvic fascia), tensile strength of the tissues and muscular support 
(levator ani muscle). This support is empirically divided by three levels (figure 1) [2]:
•	 Level I: support of the upper third of the vagina/uterus by the uterosacral and 
cardinal ligaments to the sacrum and the lateral pelvic side wall
•	 Level II: paravaginal attachments of the middle half of the vagina to the arcus 
tendineus  fascia pelvis
•	 Level III: the fusion of the lower third of the vagina to the perineal membrane and 
perineal body
FIGURE 1. Biomechanical models by DeLancey. Level I: proximal suspension, level II: lateral attachment, level 
III: distal fusion. (From DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet 
Gynecol 1992;166:1717). 
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In studies on natural history of POP, only a minimal change over time has been 
documented [12-14]. In a retrospective study with a median follow-up of 16 months, 
63% of the women preferring watchful waiting continued to do so. The main reason to 
ask for an intervention was the occurrence or worsening of prolapse symptoms. Over 
time, 78% of the patients showed no anatomical change in POP-Q examination [12].  
POP can be treated conservatively or surgically. The choice of treatment depends 
on the preference of the woman and the gynaecologist. Clearly defined guidelines 
regarding indications for conservative or surgical treatment of POP are lacking. In 
general, according to the Dutch guideline, it is advised to start with conservative 
interventions; surgical therapy is indicated after failure of conservative treatments. 
However, preference of the woman is leading [15]. 
Conservative treatment is defined as any treatment that does not involve medication or 
surgical treatment, such as life style interventions, physical therapies and/or pessaries [16]. 
Life style interventions include weight loss, reducing activities that strain the pelvic floor 
and treating constipation to avoid further exacerbation of the prolapse by decreasing 
intra-abdominal pressure. There are no studies evaluating the long-term effectiveness 
of life style interventions in the treatment of POP [16]. 
Several studies have demonstrated efficacy of pelvic floor muscle training (PFMT) in the 
treatment of POP, both as a treatment in itself and as an adjunct to surgical therapy. It 
is believed that the effect of PFMT is due to learning women 1) to consciously contract 
their pelvic floor muscles before and during increase in abdominal pressure and 2) to 
improve structural functional support by the performance of pelvic floor exercises 
[17]. PFMT may reduce the symptoms and severity of prolapse and as a result improve 
quality of life [18-20]. The efficacy of PFMT is mainly observed in low stage prolapse 
(stage I or II), studies assessing PFMT in advanced stage prolapse are lacking. 
Pessaries are another non-surgical option for the treatment of POP. Pessaries can be 
categorized in two types: supporting type (e.g. ring pessaries) and space-occupying 
type (e.g. gellhorn pessaries). In general, supporting pessaries are used in patients 
with mild prolapse (stage I or II), whereas space-occupying pessaries are typically 
used in advanced prolapse (stage III or IV) if resistant to the supporting type. There 
is no difference in efficacy between pessary treatment and PFMT in reducing pelvic 
floor symptoms, but specific prolapse-related symptoms seem to improve more 
with pessary treatment. In addition, pessary treatment is more cost-effective [21]. 
However, pessaries fit less good in 43% of women. Predictors of unsuccessful pessary 
EXAMINATION AND CLINICAL QUANTIFICATION
In order to standardize and quantify the degree of POP, the Pelvic Organ Prolapse 
Quantification system (POP-Q) has been developed [11]. During vaginal examination, 
maximum prolapse is demonstrated and identified by asking the patient to cough or 
to perform a Valsalva manoeuvre while each vaginal wall is individually exposed. The 
degree of prolapse of the anterior vaginal wall (point Aa and Ba), the posterior vaginal 
wall (point Ap and Bp) and the cervix (point C and D) are measured in centimetres 
either above/proximal to the hymen (negative number) or beyond/distal to the hymen 
(positive number). The plane of the hymen is defined as zero. Furthermore, the perineal 
body (Pb), the genital hiatus (gh) and the total vaginal length (tvl) are measured. Based 
on these measurements, a stage (0-4) is determined for each compartment whereas 
stage 4 is classified as complete eversion. 
FIGURE 2. POP-Q examination (From Bump RC et al. The standardization of terminology of female pelvic organ 
prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:10)
CONSERVATIVE TREATMENT
Treatment of POP is only indicated if a patient has complaints for which she seeks 
therapy. There are rare cases of advanced prolapse that compromise renal function 
by ureteral obstruction, mandating intervention to maintain renal function, or 
vaginal bleeding due to erosive lesions, but outside of these no absolute indication 
for intervention exists [12]. It is not known if surgery performed at an early or even 
asymptomatic stage is more effective than an intervention after the onset of symptoms 
or worsening of prolapse stage. Therefore, watchful waiting could be a reasonable 
option in women with asymptomatic prolapse or women with mild POP symptoms. 
14 15
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prolapse recurrence [41]. The sacrospinous hysteropexy and the Manchester-Fothergill 
(both vaginal) and abdominal sacrohysteropexy (open abdominal/laparoscopic/
robotic assisted) are the most used uterus preserving techniques. 
Several randomized controlled trials compared anatomical and functional outcome 
after vaginal sacrospinous hysteropexy and vaginal hysterectomy with suspension 
of the uterosacral ligaments in women with uterine descent [42-44]. In general, 
the outcome of both procedures was comparable. However, at five year follow-up, 
significantly less anatomical recurrences of the apical compartment with bothersome 
bulge symptoms or repeat surgery were found after vaginal sacrospinous hysteropexy 
compared to vaginal hysterectomy with uterosacral ligament suspension [44]. 
Another procedure for uterine descent with uterine preservation is laparoscopic 
sacrohysteropexy. The effectiveness of laparoscopic sacrohysteropexy in treatment 
of uterine prolapse was demonstrated in several studies. At short-term follow-up, 
the procedure was successful in 50 out of 51 women, with no objective evidence 
of uterine prolapse on examination [45]. High patient satisfaction with low rates of 
apical prolapse recurrence was found at mean follow-up of 2 years [46]. Furthermore, 
the risk of repeat apical surgery at one year after laparoscopic sacrohysteropexy was 
similar as compared to vaginal hysterectomy, suggesting this procedure is a safe 
surgical alternative to vaginal hysterectomy [47]. 
Vaginal sacrospinous hysteropexy is the most studied surgical technique for uterine 
descent in the Netherlands and the procedure is very popular among Dutch 
gynaecologists. However, there are some comments on this technique. After vaginal 
sacrospinous hysteropexy, the vaginal axis is changed to a more horizontal and 
posterior position [48,49]. Furthermore, the high risk of anterior vaginal wall prolapse 
after this technique is often discussed [50,51]. As for anatomic recurrence after vaginal 
sacrospinous hysteropexy, the cervix generally remains well fixed to the sacrospinous 
ligament, but the weak point is supposed to be the anterior compartment [52].  It 
is hypothesized that the high rates of recurrence in the anterior vaginal wall after 
vaginal sacrospinous hysteropexy may be related to the previously incurred damage 
of muscular supports (e.g. levator ani muscle injury, reduced muscle strength), the 
change in vaginal axis or a combination of these two [50,53]. Abdominal or laparoscopic 
uterine suspension might not have these disadvantages. 
In case of vaginal vault prolapse, abdominal sacrocolpopexy has been shown to have 
a lower rate of recurrent apical prolapse and a lower reoperation rate as compared 
fitting are higher BMl, older patients, shorter transvaginal length (<7.3 cm), previous 
hysterectomy and underactive pelvic floor muscles [22-24]. Furthermore, pessary 
use is associated with more side effects as compared to PFMT (e.g. increased vaginal 
discharge, increase in urinary incontinence and irritation or erosions of the vaginal 
walls on physical examination) [21]. The pessary discontinuation rate varies from 17% 
after 1 year to 24-86% after 5 or more years [25-28]. Side effects occur in more than 
half of women and are the main reason for discontinuation [28,29].  
SURGICAL TREATMENT
The main goals of POP surgery are to restore normal pelvic anatomy, eliminate POP 
symptoms and normalize bowel, bladder and sexual function [6]. Surgery for prolapse 
can be performed by either the vaginal or abdominal route. The latter can be subdivided 
into open abdominal, laparoscopic or robotically assisted surgery. The vaginal route is 
carried out in 80-90% of all procedures [30,31]. Clearly defined guidelines on surgical 
POP repair are lacking. The choice of surgery depends on several factors including site 
and severity of the prolapse, general health of the woman, expertise of the surgeon 
and the preference of both patient and surgeon. 
Unfortunately, surgical prolapse procedures are associated with a high reoperation 
rate. A Danish population-based registry study demonstrated a cumulated incidence 
rate of reoperation for POP in the anterior, apical and posterior compartment of 
12.4%, 7.9% and 12.1% respectively [32]. Overall the reoperation rate was 11.5%. A peak 
was demonstrated in the group of women who had their primary surgery before the 
menopause (18-49 years, 26.9%) as compared to the women between 50-90 years 
(10.1%). 
Surgical treatment of uterine descent
Traditionally, uterine prolapse is treated by vaginal hysterectomy and suspension of 
the vaginal vault, despite the fact that the uterus is not the cause but only a passive 
structure in the development of prolapse [2,33]. While anterior vaginal wall prolapse 
is the most common site of prolapse, loss of apical support is usually present in case 
the prolapse extends beyond the hymen [34,35]. Therefore, adequate support of 
vaginal apex (level I support) is an essential component of a durable surgical repair of 
advanced prolapse. Vaginal hysterectomy alone gives no adequate apical support and 
additional suspension of the vaginal apex after hysterectomy is recommended [36]. 
Uterus preserving techniques are becoming more popular [37-40]. In general, uterine-
preserving surgeries improve operating time and blood loss compared to similar 
procedures with concomitant hysterectomy without significant change in short-term 
16 17
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OUTLINE OF THIS THESIS
This thesis studies different treatment methods for uterine prolapse. Emphasis is 
placed on the comparison of vaginal and laparoscopic hysteropexy. The following 
objectives are addressed: 
•	 How do doctors in the Netherlands treat uterine prolapse? And more specific, 
how do Dutch gynaecologists perform laparoscopic sacrohysteropexy and 
sacrocolpopexy? 
•	 What treatment do women in the Netherlands prefer (uterus preservation or 
removal) when surgical management for uterine descent is indicated? 
•	 How should women with uterine prolapse be treated and is there a difference in 
outcomes between laparoscopic and vaginal hysteropexy?
•	 Is there a difference in pelvic mobility after sacrospinous hysteropexy as compared 
to other treatments for uterine prolapse? 
The availability of many treatment modalities for POP can lead to variation in care 
between physicians and hospitals, referred to as practice pattern variation. In CHAPTER 
2 we describe the practice pattern variation for treating POP patients in Dutch hospitals.
A surgical technique of a specific procedure might vary between gynaecologists 
as well. CHAPTER 3 describes variation between Dutch gynaecologists in surgical 
technique of the laparoscopic sacrohysteropexy and laparoscopic sacrocolpopexy.  
It is believed that uterine preservation is becoming more popular because women 
want to retain their uterus more often [37,38]. However, evidence to support this 
statement is lacking. In CHAPTER 4 women’s attitude towards hysterectomy and 
uterus preservation in surgical management of uterine prolapse is described. 
CHAPTER 5 provides a study protocol of a randomized controlled clinical trial to 
investigate outcomes after laparoscopic sacrohysteropexy and vaginal sacrospinous 
hysteropexy.
CHAPTER 6 presents the results of that randomized study comparing laparoscopic 
sacrohysteropexy and vaginal sacrospinous hysteropexy in the treatment of uterine 
prolapse (LAVA trial). Surgical failure, functional outcome and quality of life were 
evaluated after 12 months follow-up.
to vaginal sacrospinous fixation of the vaginal vault [35]. When compared to vaginal 
POP surgery of the vaginal vault in general (vaginal sacrospinous fixation of the 
vault, uterosacral suspension of the vault and transvaginal mesh), sacrocolpopexy is 
associated with lower risk of any recurrent prolapse on examination, repeat surgery 
for prolapse, postoperative stress urinary incontinence and dyspareunia [35]. With 
the advantages of sacrocolpopexy of the vaginal vault, laparoscopic hysteropexy 
is a promising surgical technique. Consequently, this procedure seems to become 
increasingly popular [38,54]. However, laparoscopic sacrohysteropexy has not been 
compared directly in a randomised trial against vaginal sacrospinous hysteropexy. 
As a result, it is unclear whether or not these uterine suspension procedures have 
comparable anatomical and functional outcomes. 
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PRACTICE PATTERN VARIATION IN SURGICAL 
MANAGEMENT OF PELVIC ORGAN PROLAPSE AND 
URINARY INCONTINENCE IN THE NETHERLANDS
M.N. van IJsselmuiden
R.J. Detollenaere
M.Y. Kampen
M.K. Engberts
H.W.F. van Eijndhoven
INTRODUCTION
The choice for surgical treatment for pelvic organ prolapse (POP) in women mainly 
depends on the prolapse severity, symptoms, the general health of the woman, and 
the preference and capabilities of the surgeon [1]. Although there are many surgical 
techniques available, well-executed, randomized controlled trials to evaluate these 
different techniques are limited. Like POP, various treatment modalities for urinary 
incontinence (UI) have been described. In clinical practice, it is a convention 
that nonsurgical therapies, e.g., physiotherapy, mechanical devices, drugs, or 
neuromodulation, are applied first, because they usually carry a smaller risk of harm 
[2]. Therefore, surgery for treating UI is usually considered an option after failure of 
conservative therapy. 
The availability of many treatment modalities can lead to variation in care between 
physicians and hospitals, the so called practice pattern variation (PPV). PPV is defined 
as the difference in care that cannot be explained by the underlying medical condition 
[3]. It can be caused by noncompliance to evidence-based practice standards, lack 
of evidence for optimal treatment, or by a difference in skills and resources. If patient 
characteristics, surgical capabilities, and indication for surgical interventions are 
equally spread among hospitals, there should be minimal PPV. PPV is considered to be 
a great problem in controlling medical costs [4]. 
In the literature, PPV has been reported in several medical conditions. Decades ago, 
regional PPV was already observed. In 1936, it was reported that tonsillectomy rates in 
Britain varied substantially between the different school districts [5]. In South Florida, 
USA, rates for surgery to treat degenerative diseases of hip, knee, and spine are highly 
variable among different hospital referral regions [6]. Furthermore, rates of coronary 
bypass surgery, prostatectomy, and many other major procedures varied at least 
four- to fivefold across different hospital referral regions [7]. In addition, PPV has been 
reported in gynecology. Recently, geographical variation in hysterectomy rates and 
surgical routes for hysterectomy (vaginal/abdominal) for benign diseases was reported 
in The Netherlands [8]. Little is known about PPV in POP and UI. However, variable 
surgical policy for treating uterine descent [9] and the wide range in types of surgery 
[10] might contribute to PPV.
The Netherlands is a small, developed country. With almost 17 million inhabitants, the 
country is densely populated. In 2010, the country contained a total of 92 hospitals 
and private clinics, with 958 practicing gynecologists. Due to its small size and good 
ABSTRACT
INTRODUCTION
Practice pattern variation (PPV) is the difference in care that cannot be explained by 
the underlying medical condition. The aim of this study was to describe PPV among 
Dutch gynecologists regarding treatment of pelvic organ prolapse (POP) and urinary 
incontinence (UI).
MATERIALS AND METHODS
PPV was calculated from data of healthcare declaration codes of 2010. Data were 
provided by Vektis and Kiwa Carity. PPV for POP and UI in general was calculated 
per hospital and per region. Furthermore, PPV for transvaginal mesh and surgical 
treatment of uterine descent was assessed.
RESULTS
PPV of surgical treatment for POP and UI in general was assessed for 91 hospitals. 
PPV for surgical treatment of uterine descent and transvaginal mesh placement was 
calculated for 88 hospitals. A high PPV per hospital and per region was found. In some 
hospitals, a hysterectomy was performed in all cases of uterovaginal prolapse, while in 
other hospitals, uterus-preserving techniques were mostly performed. A high PPV of 
transvaginal mesh placement was observed.
CONCLUSION
In the small country of The Netherlands, we found a high PPV in surgical management 
of POP and UI with respect to the choice for surgical treatment and the type of surgery. 
This finding might be due to the absence of clearly defined guidelines. Studies with 
respect to conservative versus surgical treatment and the type of surgery are of need 
to establish evidence-based guidelines.
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Practice variation was defined as the number of patients who underwent POP or UI 
surgery per 100,000 women. Based on 2010 data, the practice variation was calculated 
both per region and per hospital. Furthermore, hospital and regional practice variations 
were pooled, and the ratio between conservative versus surgical treatment of POP and 
UI was assessed. Hospitals were divided into the categories of university, teaching, 
and nonteaching hospitals. All declaration codes with respect to POP and UI (G25) 
were used. One private clinic was excluded because < 20 surgical procedures were 
performed.
FIGURE 1. Creating hospital service area: assigning patients to a hospital
KIWA CARITY
Kiwa Carity (www.kiwacarity.nl) analyzes declaration codes to determine the quality 
and costs of healthcare, commissioned by the Dutch government and the healthcare 
branch. Since this company analyzes at the procedure level, it is possible to distinguish 
between different types of surgery for a specific condition. However, Kiwa Carity does 
not have access to data with respect to the total number of women with healthcare 
insurance and their demographic characteristics. Therefore, Kiwa Carity is not able 
to correct for age and social economic status. Data are based on the declaration of 
information system (DIS), where all declaration codes and medical procedures of the 
hospitals are recorded. Based on these data, we calculated the PPV of transvaginal 
mesh by dividing the total number of transvaginal mesh placements in 2010 per hospital 
by the total number of POP procedures. Furthermore, the ratio of uteruspreserving 
surgery versus vaginal hysterectomy for treating uterine descent was calculated. 
registration, The Netherlands is a very eligible country in which to explore practice 
patterns. Because of its size and the limited number of gynecologists (who are all 
member of the Dutch gynecologic society and are well organized in different working 
parties), PPV should be theoretically low. 
The aim of this study was to identify and describe PPV among Dutch gynecologists 
regarding POP and UI treatment.
MATERIALS AND METHODS
In The Netherlands, health insurance is mandatory. All procedures performed by 
hospitals are invoiced from the health insurance companies using declaration codes. 
Each medical condition has a specific declaration code; POP and UI have a common 
code (G25). Furthermore, the type of treatment (conservative/surgical) must be stated 
in this declaration code. For various medical conditions, the companies Vektis and Kiwa 
Carity collect these declaration codes. In addition, Vektis analyzes these codes and 
calculates PPV. To assess PPV for POP and UI, we used data and calculations obtained 
from these organizations. The year 2010 was chosen because more recent data from 
both data sets (Kiwa Carity and Vektis) were not available when this study started.
VEKTIS
Vektis (www.vektis.nl) collects data from all healthcare insurance companies in The 
Netherlands. This independent organization analyses these data with respect to costs 
and quality of healthcare and calculates practice variation using the declaration codes. 
Data we obtained were corrected for age and social economic status. Information 
about social economic status was received from the Dutch Institute for Social Research, 
a government agency. Vektis did not distinguish between the different POP and UI 
procedures because they have a common code. Therefore, all surgical procedures for 
POP and UI were combine.
Data analysis was performed in two ways: per region and per hospital service area. The 
Netherlands is divided into 39 regions. A region is defined as a geographical district 
with the same zip/postal code. These data reflect the treatment of patients living in 
that region, regardless of where the care was actually delivered. A hospital service 
area is determined by assigning all patients to a hospital according to the decision 
tree shown in in Fig. 1. These data are hospital specific and reflect patients treated per 
hospital regardless of the region in which the patient lives.
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Figure 3 shows the total number of patients who underwent POP and UI surgery per 
100,000 women per region. This represents the practice variation per region and varies 
between 55 and 363 surgical procedures per 100,000 women (median 179). The figure 
implies a mixed pattern: the northeastern and western regions seem to have a higher 
surgical rates compared with central, southern, and eastern Netherlands.
FIGURE 2. Practice variation per hospital: total number of patients that underwent pelvic organ prolapse (POP) 
or urinary incontinence (UI) surgery per 100.000 women per hospital service area in 2010
FIGURE 3. Practice variation per region: total number of patients that underwent pelvic organ prolaose (POP) or 
urinary incontinence (UI) surgery per 100.000 women per region in 2010. The minimum number of procedures 
per region was 55 per 100.000 women and the maximum number 363 per 100.000 women 
For both data sets, it was not possible to register more than one procedure per patient 
per year. In case of another surgical procedure for POP and/or UI in the same year, the 
same declaration code was used.
STATISTICAL ANALYSIS
Statistical analysis was performed with the Statistical Package for the Social Science 
22.0 for Windows (IBM SPSS Statistics). Differences between hospital types were 
compared using one-way analysis of variance (ANOVA) for parametric variables, and 
Kruskal–Wallis test for nonparametric variables. An additional post hoc Bonferroni 
test was performed to assess the significance of each variable. A p value <0.05 was 
considered to be statistically significant.
RESULTS
PPV in general was assessed for 91 hospitals and for 88 hospitals with respect to treating 
uterine descent and the use of transvaginal mesh specifically. In 2010, more than 40,000 
women were referred to a hospital because of POP and/or UI, and just over 15,000 
surgical procedures were performed (Table 1). The number of patients per hospital varies 
depending on the size of the hospital service area. Differences in surgical rate between 
the different hospital types were not statistically significant (p=0.11).
Table 1. Total number of initial patients and procedures per practice type in 2010
Number of initial G25-
patients (range)
Number of POP and UI 
procedures (range)
Mean surgical rate 
(%) (procedures/G25)
University hospital (n=8)
Non-university teaching hospital 
(n=28)
Non-teaching hospital (n=54)
TOTAL
2.190    (112 - 540)
18.419  (361 - 1.222)
22.248  (127 – 1.151)
42.857
737     (36  - 185)
5.888  (100 – 437)
8.443 (27 - 486)
15.068
34
32
38
G25 = declaration code for POP and incontinence; POP = pelvic organ prolapse; UI = urinary incontinence
Figure 2 demonstrates the total number of patients who underwent POP and UI 
surgery per 100,000 women per hospital in 2010. This represents the PPV per hospital 
service area and varies between 75 and 412 procedures per 100,000 women (median 
171). University hospitals seem to have a very high or very low surgical rate compared 
with other hospital types,. and nonteaching hospitals have a higher surgical rate than 
teaching hospitals.
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but patients in that hospital will less often receive conservative treatment as well. 
Figure 6 demonstrates the percentage of vaginal hysterectomy and uterus-preserving 
surgery for treating uterine descent. Uterus-preserving surgery is defined as vaginal 
sacrospinous hysteropexies and Manchester–Fothergill procedures. There is a high 
practice variation in treating uterine descent.
In some hospitals, a hysterectomy was performed in all cases of uterovaginal prolapse, 
while in others, patients were mainly treated with uterus-preserving surgery. This 
variation was observed in all types of hospitals. Nonteaching hospitals performed 
significantly more hysterectomies in relation to uterus-preserving techniques 
compared with teaching (p=0.002) and university (p=0.014) hospitals.
When looking at the practice variation with respect to transvaginal mesh placement, a 
high variation was observed (Fig. 7). In some hospitals, a transvaginal mesh was placed 
in 1:100 POP patients, while in other hospitals, it was placed in 44:100 POP patients. 
In 21 hospitals, it was not used at all. Hospitals with the highest number of transvaginal 
mesh placements per 100 POP patients were nonteaching hospitals. The differences in 
transvaginal mesh placement between hospital types were not statistically significant 
(p=0.91).
FIGURE 5. Conservative versus surgical treatment for pelvic organ prolapse (POP) and urinary incontinence (UI) 
per hospital in 2010 (the hospitals are listed in the same order as figure 2 and 4).
 
Figure 4 combines practice variation per hospital (see Fig. 2) with practice variation per 
region (see Fig. 3). It demonstrates surgical rate per hospital (displayed by the total length 
of the bar) and distinguishes the type of regions patients come from (displayed by the 
different colors of the bar). This figure indicates whether or not the hospital contributes 
to a high or low surgical rate in its region. If all patients who underwent POP or UI 
surgery in that hospital came from a region with a high surgical rate, it is likely that this 
hospital contributes to the high surgical rate in that region. In other words, when looking 
at a mostly dark-colored bar on the right side of the figure, it is plausible that this hospital 
might contribute to a high surgical rate in that particular region, while a mostly light-
colored bar at the left side might contribute to a low surgical rate in the region. 
FIGURE 4. Practice variation for pelvic organ prolapse (POP) and urinary incontinence (UI) surgery per hospital 
combined with practice variation per region in 2010. The figure indicates whether the hospital contributes to 
a high or low surgical rate in that region. A mostly dark colored bar at the right side might contribute to the 
high surgical rate in a region, since all patient who underwent POP or UI surgery in that hospital come from a 
region with a high surgical rate. On the other hand, a mostly light colored bar a the left side might contribute 
to a low surgical rate in that region.
Figure 5 shows the ratio between conservative and surgical treatment for POP and UI 
per hospital. Again, hospitals are listed in the same order as in Figs. 2 and 4. Unlike the 
previous figures, in which POP and UI procedures were plotted against 100,000 women 
(the total population), this figure focuses on women with declaration code G25 who 
were referred to the hospital. It also shows that hospitals with a high surgical rate (right 
side of the figure) not only have a high surgical rate compared with the total population, 
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our hypothesis that due to good cooperation and registration and the small size of The 
Netherlands, PPV should be low. We found a high PPV between regions. Because of 
the small size of the country, most regions include both rural and urban areas, and the 
different types of hospitals are equally spread throughout the country. Therefore, we 
believe that the regional differences cannot be explained by differences in population 
or hospital distribution. The surgical rate per region appears to be dominated by 
the treatment policy of specific hospitals in that specific region. Hospitals with a 
low surgical rate are actually responsible for the low surgical rate in their region. In 
addition, hospitals with a high surgical rate are responsible for the high surgical rate in 
their region. These hospitals seem to be mainly nonteaching hospitals (Figs. 2 and 4). 
In other words, the surgical rate per region appears to be caused by specific hospitals 
rather than being a mean of several hospitals. 
The high PPV might imply over- and undertreatment. In case of overtreatment, the 
patient is exposed to the unnecessary risks of surgery. In case of undertreatment, 
the patient might not receive adequate treatment for the specific medical condition. 
However, since a gold standard for treating POP is still a matter of debate, it is difficult 
to conclude whether or not we observed over- or undertreatment. 
The ratio between conservative and surgical POP and UI treatment varies per hospital. 
With regard to UI, guidelines state that nonsurgical therapies are tried first [2, 11, 12]. In case 
of failure, surgical therapy is considered. A lack of adherence to the current guidelines 
for UI might contribute to the PPV. Contrary to UI, there is no consensus or guideline 
for treating POP conservatively or surgically. As a result, treatment depends mostly 
on the opinion of the gynecologist. Therefore, one can assume that the observed 
variation is mainly caused by variation in treating POP but not UI. However, because 
data were pooled, we were unable to differentiate between disorders. 
Our results demonstrate a high PPV in the surgical treatment of uterine descent. 
Nonteaching hospitals perform significantly more hysterectomies in relation to uterus-
preserving techniques compared with teaching and university hospitals. Worldwide, 
vaginal hysterectomy is the most frequently used treatment for patients with 
symptomatic uterovaginal prolapse [13, 14]. However, uterus-preserving procedures are 
gaining interest, and many techniques have been described. Because well-executed 
randomized trials are limited, there is no consensus for either uterus-preserving 
surgery or vaginal hysterectomy. Therefore, our results seem to be a reflection of the 
ongoing discussion about the value of uterus-preserving techniques in case of uterine 
descent.
FIGURE 6. Practice variation in treatment of uterine descent: percentage of vaginal hysterectomy (VH) and 
uterine preserving surgery (sacrospinous hysteropexy and Manchester-Fothergill procedure) for treatment of 
uterovaginal prolapse per hospital.
Figure 7. Practice variation of transvaginal mesh placement per hospital in 2010: number of transvaginal mesh 
placements per 100 patients referred to that hospital for pelvic organ prolapse (POP)
DISCUSSION
We assessed PPV for POP and UI surgery in The Netherlands. Our results demonstrate 
a high PPV with respect to treating POP and UI. These findings are inconsistent with 
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overtreatment, medical costs will be very high compared with undertreatment. Such 
variation is unfair, because people who live in a region with a low surgical rate (or are 
referred to a hospital with a low surgical rate) subsidize the care of those in high-
cost regions [3]. In the USA, the difference in lifetime Medicare (federal social health 
insurance) spending for a typical 65-year-old in Miami, FL, and in Minneapolis, MN, is 
> $50,000 [4].
A strength of this study is the completeness of the data sets. In The Netherlands, 
hospitals are required to use declaration codes to receive funding from healthcare 
insurance companies. Without a declaration code, it is not possible for insurance 
companies to invoice the procedure. Since the declaration code is compulsory, we 
obtained complete data sets. Another strength of this study is the correction for age 
and social economic status in case of PPV in general, making data more valid. Vektis 
determined whether age and social economic status were relevant in the total number 
of patients with UI and POP. For instance, if in a specific region live more older people 
compared with another region, differences in surgical rate are more likely explained 
by the differences in population statistics than by PPV. In their analysis, age and social 
economic status influenced the surgical rate, and therefore, data were corrected by 
Vektis for age and social economic status.
The study reported here has some limitations: Since UI and POP have the same 
declaration code, it is not possible to differentiate between these two conditions with 
respect to PPV in general. It is unknown whether the practice variation is caused by UI, 
POP, or both. Since clearly defined guidelines for UI are available in The Netherlands, and 
clear consensus on treating POP is lacking, we assume that the PPV is mostly caused 
by POP. In addition, a clearly defined diagnosis of POP (e.g., the compartment involved) 
cannot be obtained from the Vektis data set. However, since most types of prolapse can 
be treated surgically or conservatively, we believe that the PPV we found is applicable 
to treating POP in general. Furthermore, data derived from Vektis are based on 91 
hospitals, and Kiwa Carity provided data obtained from only 88 hospitals. This difference 
is explained by the fact that Kiwa Carity did not include data from private clinics (n=1), 
and two hospitals did not consent to Kiwa Carity using their data. With respect to the 
practice variation of uterine descent (Fig. 6), data of one university hospital is missing. 
Ideally, PPV is very low, and the surgical rate for POP and UI does not differ between 
hospitals. However, in the small country of The Netherlands, we observed a high PPV 
in the surgical management of POP and UI. Furthermore, we observed a high variation 
in treating uterine descent and the placement of transvaginal mesh for POP. A patient’s 
There is a high PPV with respect to transvaginal mesh placement. In recent years, 
transvaginal mesh has become matter of debate. In October 2008, the US Food and 
Drug Administration (FDA) issued a public health notification informing clinicians and 
patients of adverse events related to urogynecologic use of surgical mesh [15]. After this 
publication, the use of transvaginal mesh in the USA decreased from 32.1 % in 2006 to 
27.5 % in 2010 [16]. In The Netherlands, the debate over safety and efficacy of vaginal 
mesh is ongoing. An important issue in this debate is the number of meshes placed per 
gynecologist. The high PPV and therefore limited experience of some gynecologists 
is one reason that recently formulated guidelines state that vaginal mesh placement is 
allowed only when a minimum of 20 procedures a year are performed. 
In the literature, several factors contributing to PPV in general have been described. 
First, variations in patient characteristics and demand for surgery might contribute to 
PPV. Some regions might have a higher rate of surgical procedures because of greater 
demand for surgery. This correlation is more obvious in clinical disorders for which 
surgery is strongly recommended or needed, e.g., hip fracture. In the USA, regional rates 
of hip-fracture surgery in elderly people are almost linearly correlated with the regional 
incidence of hip fracture [7]. Second, the preference of the patient can contribute to 
PPV. For some clinical conditions, the decision to intervene should depend as much 
on patient preferences as on scientific evidence. The value of a surgical intervention 
depends on the tradeoff between risks and benefits of that intervention. In case of a 
large imbalance, the decision to intervene is distinct, and there might be some PPV. 
However, PPV becomes more pronounced when the tradeoff is a close call, and the 
patient’s preference can become decisive [7]. Shared decision making is a collaborative 
process that allows patients and physicians to make healthcare decisions together, 
taking into account the best scientific evidence available as well as patient preference. 
Third, scientific uncertainty contributes to PPV [6]. In the absence of a professional 
consensus and guideline-based on outcomes, individual or small groups of clinicians 
can hold on to their own clinical rules of defining which patient needs surgery. This 
might result in the “surgical signature” of a region: rates for specific surgical procedures 
that are peculiar to a region sometimes differ substantially between surrounding regions 
[4, 6]. Finally, surgical innovations and new technologies, such as vaginal mesh, can 
pronounce PPV by increasing the number of therapeutic alternatives available to 
clinicians. This variation can arise because of differences in clinicians’ opinions as to 
whether the new intervention should replace the existing procedures and change the 
indications for surgery [7].
PPV is considered to be a great problem in controlling medical costs. In case of 
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odds of undergoing surgery for POP and UI seems to depend more on where the 
patient lives and to which hospital she is referred than on clinical circumstances. The 
choice of treatment seems to depend mainly on the preference of the gynecologists. 
The absence of clearly defined guidelines regarding indications for conservative and 
surgical treatment of POP and the use of different types of surgical technique might 
contribute to the high PPV. With respect to UI, there might be a lack of adherence to 
the current guidelines for UI, which contributes to the PPV as well. To reduce PPV and 
prevent over- and undertreatment, studies with respect to conservative versus surgical 
treatment, and randomized controlled trials between different types of surgery, are 
necessary to establish such evidence-based guidelines.
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INTRODUCTION
Pelvic organ prolapse (POP) is a common health problem. As life expectancy increases, 
more women will suffer from POP and will require surgery. The lifetime risk of surgery 
for POP by the age of 85 years is estimated to be 19% [1].   
Traditionally, POP surgery has been performed via vaginal or abdominal approach. 
In an effort to improve outcomes in transvaginal reconstructive prolapse surgery, 
biologic and synthetic mesh devices have been introduced to complement, reinforce 
or replace native tissues. Subsequently, the use of mesh in prolapse surgery in the USA 
has increased from 7.9% in 2000 to a peak of 32.1% in 2006 [2]. 
Together with the growing use of transvaginal mesh, the number of reported adverse 
events has also increased. In October 2008, the Food and Drug Administration (FDA) 
issued a Public Health Notification to inform clinicians and patients of adverse events 
related to urogynecologic use of surgical mesh [3]. Following this notification, the 
FDA continued to monitor the outcomes of the use of surgical mesh. From 2008 to 
2010, the most frequent complications reported to the FDA included vaginal mesh 
erosion, pain (including dyspareunia), infection, urinary problems, bleeding, and organ 
perforation [3]. After the publication of these safety advisories, the use of transvaginal 
mesh in the USA decreased slightly from 32.1% in 2006 to 27.5% in 2010 [2]. In the 
Netherlands, however, the use of vaginal mesh diminished dramatically after negative 
publicity in the media in 2012. 
The use of abdominal mesh appears to result in lower rates of complications 
compared to transvaginal POP surgery with vaginal mesh [4].  Two common types 
of abdominal prolapse repair are the sacrohysteropexy (in case of uterine descent) 
and the sacrocolpopexy of the vaginal vault after hysterectomy. In these procedures, 
uterus or vaginal vault is elevated by attaching the cervix or vaginal vault to the sacral 
promontory using a mesh [5,6]. Although the open abdominal procedures have been 
performed for many years, the laparoscopic approach of these procedures is relatively 
new [7,8]. In studies comparing abdominal sacrocolpopexy with the laparoscopic 
approach, these procedures have shown clinical equivalence [9], but laparoscopic 
sacrocolpopexy seems to be related to less procedure-related morbidity concerning 
blood loss, hospital stay and severe complications [10].  
Although the laparoscopic approach is associated with good outcome and minimal 
morbidity, the use of rigid laparoscopic instruments can constraint suturing in and 
ABSTRACT 
INTRODUCTION AND HYPOTHESIS
Laparoscopic techniques for pelvic organ prolapse surgery using mesh are 
gaining interest. A standard approach or published guideline for the laparoscopic 
sacrohysteropexy (LSH) or laparoscopic sacrocolpopexy (LSC) is lacking.  The purpose 
of this study is to assess the variation between Dutch gynecologists in executing LSH 
and LSC.
METHODS
A questionnaire was developed to evaluate the technique of LSH and LSC. All members 
of the Dutch Society for Gynecological Endoscopy and Minimally Invasive Surgery and 
the Dutch Society for Urogynecology were invited by email to participate in a web-
based survey.
RESULTS
With 357 respondents, the response rate was 71%. Of the respondents, a total of 49 
gynecologists (13.7%) perform LSH and/or LSC. Gynecologists who perform both 
procedures, use the same surgical technique for LSH and LSC. There are variations 
among gynecologists on several key points such as the level of dissection along the 
anterior and posterior walls of the vagina, the type of mesh used, the type of sutures 
used, the tension of the implanted mesh and reperitonealization of the mesh.
CONCLUSIONS
There is a high practice variation in LSH and LSC performed by a selected group 
of Dutch gynecologists.  Different methods have been described in the literature 
and there is no consensus on how to perform these procedures. A well-designed 
prospective study or randomized controlled trial with regard to the specific parts of 
these procedures is needed to provide evidence for the best surgical technique. The 
outcomes of these studies will help to establish evidence-based guidelines. 
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In case of ordinal variables, proportions were calculated. 
RESULTS
The questionnaire was sent to the 503 members of Dutch Society for Gynecological 
Endoscopy and Minimally Invasive Surgery and the Dutch Society for Urogynecology. 
With 357 respondents, the response rate was 71%. Of the respondents, a total of 49 
gynecologists (13.7%) reported that they perform LSH and/or LSC. The characteristics 
of these gynecologists are shown in table 1. 
TABLE 1. Characteristics of the respondents performing laparoscopic sacrohysteropexy and/or 
laparoscopic sacrocolpopexy
Characteristic n (%), N = 49
Practice type
Academic hospital
Non-academic teaching hospital
Non-teaching hospital
7 (14)
34 (69)
8 (16)
Experience in laparoscopic procedures (years)
2 – 5
5 – 10
> 10
5 (10)
11 (22)
33 (67)
Performing laparoscopic sacrohysteropexy
Yes
No
39 (80)
10 (20)
Number of sacrohysteropexies performed in the past 12 months 
as first surgeon
<10
10-30
31-50
as second surgeon
<10
10-30
23 (59)
15 (38)
1 (3)
30 (77)
9 (23)
Change in number of sacrohysteropexies compared with 12 months ago
Increased
Decreased
No difference
20 (51)
4 (10)
15 (38)
Performing laparoscopic sacrocolpopexy
Yes
No
45 (92)
4 (8)
Number of sacrocolpopexies performed in the past 12 months 
as first surgeon
<10
10-30
31-50
as second surgeon
<10
10-30
22 (49)
22 (49)
1 (2)
29 (64)
16 (36)
accessing to the deep pelvis. Because of the steep learning curve, laparoscopic 
prolapse repair is generally reserved for expert laparoscopists [11]. In literature, 
different surgical methods for laparoscopic sacrohysteropexy (LSH) and laparoscopic 
sacrocolpopexy (LSC) have been described and there is no consensus how to perform 
these laparoscopic procedures [7,9,12,13]. 
Because of the negative publicity surrounding transvaginal mesh and advantages of 
laparoscopic surgery, we expect that the numbers of laparoscopic POP surgery will 
increase. In the Netherlands, a standard approach or published guideline for LSH or 
LSC is lacking.  In addition, a standard laparoscopic mesh kit, as known in transvaginal 
mesh procedures, is not available. Therefore, analysis of the different laparoscopic POP 
procedures will be of utmost importance to be able to evaluate outcomes of these 
procedures.  The purpose of this study is to assess the variation among gynecologists 
in executing laparoscopic POP procedures. The knowledge of these practice variation 
will help to design future protocols for these procedures. 
MATERIALS AND METHODS
We conducted a cross-sectional study in the Netherlands, consisting of a questionnaire. 
In January 2014, all members of the Dutch Society for Gynecological Endoscopy and 
Minimally Invasive Surgery and the Dutch Society for Urogynecology (n=503) were 
invited by email to participate in a web-based survey. A total of 52.5% of all practicing 
gynecologists in the Netherlands, is member of one or both of these Societies. A 
reminder email was sent 2 weeks after the initial survey invitation, and after 5 weeks 
the identical questionnaire was sent by post to the non-responders. 
QUESTIONNAIRE
The questionnaire addressed the following topics: characteristics of the hospital and 
the gynecologist, laparoscopic characteristics, preoperative treatment of patients 
and specifications of the procedure. The survey was self-developed. Prior to the 
start of the study, we performed a pilot study among 5 gynecologists. Based on 
the recommendations of the pilot participants, the questionnaire was revised. All 
questionnaires were treated anonymously. No financial compensation was given. 
STATISTICS
Descriptive statistics were performed using SPSS 22.0 (SPSS Statistics UK, SPSS Inc, 
Chicago, IL, USA). Results were expressed as mean and range for continuous variables. 
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Table 3 shows the specific characteristics for LSH and LSC. The mean number of 
trocars inserted is the same for both procedures and depends on the use of a robot: 
in case of a robot-assisted approach all gynecologists insert 5 trocars; when the robot 
is not used the mean number of trocars inserted is 4 (LSH range 3-6; LSC range 3-5). 
Mostly, trocars are placed umbilical, suprapubic and symmetric left and right in the 
iliac region. 
DISSECTION
Of the respondents, the majority starts the surgery with dissection of the peritoneum 
and the promontory (LSH n=29 (59%); LSC n=32 (71%)). The depth of the anterior 
and posterior dissection of the cervix or vaginal vault differs (table 3). In contrast to 
posterior dissection, anterior dissection of the cervix or vaginal vault is not routinely 
performed by all gynecologists: the mesh is only attached to the posterior cervix or 
vaginal vault in 18% (LSH) and 4% (LSC). One respondent mentioned  another extent 
for dissection of the posterior site: until the musculus levator ani on the right site and 
until the rectal fold on the left site. With respect to the anterior site, dissection until 
the balloon of the urinary catheter or until 3-4 cm of the anterior vaginal wall were 
mentioned as other extents for dissection. 
MESH CHARACTERISTICS AND ATTACHMENT
Most gynecologists use polypropylene meshes (table 3). In addition, the majority of the 
respondents use Y-shaped meshes (prefabricated or prepared during surgery). Most 
respondents attach the mesh both anterior and posterior of the cervix or vaginal vault 
(double mesh). None of the gynecologists attach the mesh only to the anterior site. 
The mean number of sutures for attaching the mesh to the anterior cervix or vaginal 
vault is 5 (LSH range 1 - >5; LSC range 3 - >5). To attach the mesh to the posterior 
cervix or vaginal vault, a mean of 5 sutures are used (LSH range 1- >5; LSC range 3 - 
>5). Different types of sutures for attaching the mesh to the cervix or vaginal vault are 
used, with a preference for the non-absorbable multifilament (LSH 46%, LSC 49%). 
In addition, the material for attachment of the mesh to the promontory varies: mean 
number of sutures/tackers/staples used is 3 (LSH range 1-5; LSC range 3-5). The mesh 
is attached to the promontory with slight tension or tension free. To assess the tension, 
several techniques are used: visually, vaginal examination and/or vaginal manipulator. 
TABLE 1. (continued)
Characteristic n (%), N = 49
Change in number of sacrocolpopexies compared with 12 months ago
Increased
Decreased
No difference
23 (51)
3 (7)
19 (42)
Preference of gynecologist to perform laparoscopic supracervical hysterectomy prior 
to sacrocolpopexy 
Yes
No, only sacrocolpopexy in case of posthysterectomy vaginal vault 
prolapse
18 (40)
27 (60)
PREOPERATIVE CHARACTERISTICS
Table 2 shows the results of the questions related to laparoscopic surgery in general. 
The composition of the surgery team differs, depending on experience training and 
the usage of a robot. Bowel preparation prior to surgery is not a standard procedure. 
Methods used for bowel preparation are emptying the rectum by flushing with a 
syringe filled with water or povidone, moviprep, enemata and bisacodyl drops. Of the 
respondents, 90% routinely administer antibiotic prophylaxis. Antibiotics are given 30 
minutes prior to the procedure (n=28, 64%) or during administration of anesthesia 
(n=16, 36%). Cefazolin in combination with metronidazole is the most used prophylaxis 
(n=21, 43%), followed by cefuroxime and metronidazole (n=9, 18%), amoxicillin/
clavulanic acid (n=6, 12%) and cefazoline alone (n=5, 13%). One respondent stated to 
administer intravenous amoxicillin/clavulanic acid for 3 days postoperative, after an 
initial administration of cefazolin/metronidazole perioperatively. 
TABLE 2. General characteristics of laparoscopy
Laparoscopic surgery (general) n (%), N = 49
Team composition
One gynecologist, one instrument nurse and one scrub nurse
Two gynecologists and one instrument nurse
One gynecologist, one general surgeon and one instrument nurse
One gynecologist, one resident and one instrument nurse
Other (e.g. with robot)
4 (8)
19 (39)
3 (6)
9 (18)
14 (29)
Robot-assisted approach
Yes
No
10 (20)
39 (80)
Pre-operative bowel preparation
Yes
No
5 (10)
44 (90)
Routine administration of antibiotics peri-operatively
Yes
No
44 (90)
5 (10)
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TABLE 3. (continued)
Characteristics LSH
(%), N=39
LSC
(%), N=45
Attachment of mesh to promontory*
Sutures
Non-absorbable monofilament
Absorbable multifilament
Non-absorbable multifilament
Tackers
Staples
9 (23)
3 (8)
1 (3)
5 (13)
23 (59)
10 (26)
9 (20)
2 (4)
1 (2)
6 (13)
28 (62)
13 (29)
How much tension is used to attach mesh to promontory
Tension free
Slight tension
Tension is not important
22 (56)
16 (41)
1 (3)
20 (44)
24 (53)
1 (2)
Assessment of tension
Visually
Vaginal examination
Vaginal manipulator (uterus / vaginal manipulator) 
Other (combination of above)
10 (26)
12 (31)
14 (36)
3 (8)
13 (29)
13 (29)
15 (33)
4 (9)
Routinely performance of cystoscopy afterwards
Yes
No
1 (3)
38 (97)
0 (0)
45 (100)
Performance of concomitant colporrhaphy
Yes
Prior to laparoscopy
After laparoscopy
Other
No
10 (26)
3 (8)
5 (13)
2 (5)
29 (74)
7 (16)
1 (2)
5 (11)
1 (2)
38 (84)
* more answers possible
LSH = laparoscopic sacrohysteropexy, LSC = laparoscopic sacrocolpopexy
REPERITONEALIZATION AND CONCOMITANT COLPORRHAPHY
The majority of the respondents close the peritoneum over the mesh (LSH 92%, LSC 
91%) using absorbable sutures, Quill/V-lock or staples. Cystoscopy after the surgery 
is not routinely performed: only one gynecologist performs a cystoscopy after 
a LSH. Furthermore, concomitant colporrhaphy in case of prolapse of the anterior 
and/or posterior vaginal wall is not standard and is performed by the minority of the 
respondents (LSH 26%, LSC 15%).  
DISCUSSION
We performed a nationwide survey to assess practice variation of LSH and LSC. To our 
knowledge, this is the first study that focuses on differences in surgical techniques of 
LSC and LSH in POP surgery. Our results demonstrate a high practice variation of these 
procedures.
TABLE 3. Characteristics of laparoscopic sacrohysteropexy and laparoscopic sacrocolpopexy
Characteristics LSH
(%), N=39
LSC
(%), N=45
Placement of trocars
Umbilical, suprapubic, left and right (symmetrically)
Umbilical, two left, one right
Umbilical, two right, one left
Other 
27 (69)
2 (5)
1 (3)
9 (23)
30 (67)
3 (7)
2 (4)
10 (22)
Fixation of colon with temporary sutures through appendices epiploicae
Yes, always
No, never
Only in case of poor visibility
11 (28)
11 (28)
17 (44)
12 (27)
13 (29)
20 (44)
Dissection
Technique of dissection of peritoneum
Entire peritoneum (from promontory to pouch of Douglas)
Tunneling of caudal peritoneum
31 (79)
8 (21)
34 (76)
11 (24)
Extension of posterior dissection of cervix/vaginal vault 
Up to the level of the cervix/vault and maximum the upper part of the 
posterior vaginal wall 
Up to halfway the posterior vaginal wall
Dissection of musculus levator ani on both sides
Other
Depending on the situation
Other
11 (28)
11 (28)
14 (36)
3 (8)
2 (5)
1 (3)
8 (18)
13 (29)
20 (44)
4 (9)
3 (7)
1 (2)
Extension of the anterior dissection of cervix/vaginal vault 
Up to the level of the cervix/vault and maximum 1-2 cm of anterior 
vaginal wall 
Up to 1-2 cm under the bladder
As deep down as possible
Other 
Depending on the situation
Not performed
Other
12 (31)
10 (26)
10 (26)
7 (18)
2 (5)
3 (8)
2 (5) 
9 (20)
18 (40)
11 (24)
7 (15) 
3 (7)
0 (0)
4 (9)
Introduction mesh and attachment
Mesh
Attachment
Only posterior
Both anterior and posterior
Other 
Depending on the situation
Other
Characteristics*
Polypropylene mesh
Mersilene graft
Y-shaped mesh prepared during surgery (two parts attached 
during surgery)
Prefabricated Y-shaped mesh
Single leaf
Individually cut to fit/adjusted
7 (18)
27 (69)
5 (13)
3 (8)
2 (5)
38 (97)
1 (3)
3 (8)
13 (33)
9 (23)
19 (49)
2 (4)
37 (82)
6 (13)
3 (7)
3 (7)
44 (98)
1 (2)
3 (7)
25 (56)
3 (7)
20 (44)
Type of sutures for attaching mesh to cervix/vault
Absorbable monofilament
Non-absorbable monofilament
Absorbable multifilament
Non-absorbable multifilament
3 (8)
13 (33)
5 (13)
18 (46)
4 (9)
12 (27)
7 (16)
22 (49)
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of the three compartments of the pelvis (anterior, apical and posterior) [18]. A double 
mesh is associated with a reduction in anatomical recurrence, the posterior mesh 
demonstrated to have a high effectiveness in correcting and preventing a posterior 
compartment prolapse [18]. However, systematic placement of a posterior mesh is 
responsible for specific complications, like rectal injury, postoperative constipation and 
postoperative perianal pain [18]. Therefore, literature suggests to reserve the posterior 
mesh (or double mesh) for cure of enterocele or rectocele. In cases without prolapse 
of the posterior vaginal wall, an anterior mesh only would be sufficient. However, 
these conclusions are based on retrospective data. A well-designed prospective study 
or randomized controlled trial with respect to this item is of need to provide evidence 
for the best technique for mesh attachment.
Since a standard laparoscopic mesh kit does not exist, our results demonstrate practice 
variation in the type and shape of the mesh. The majority of the gynecologists (97%) 
use a mesh made of polypropylene, some gynecologists use a prefabricated Y-shaped 
mesh, while others prefer to prepare a Y-shaped mesh during surgery. Mostly, non-
absorbable sutures are used to attach the mesh to the cervix/vault and tackers to 
attach the mesh to the promontory. In literature, we found no studies concerning 
surgical outcome and the material for attaching the mesh to the cervix or vaginal vault 
in case of sacrocolpopexy and sacrohysteropexy (open or laparoscopic). One study 
compares non-absorbable sutures with tackers to attach the mesh to the prevertebral 
ligament of the promontory. The main advantage of the use of staplers is the ease. 
Spondylodiscitis is a rare complication, the risk is enhanced by the deeper infiltration 
of the staples in the intervertebral discs. Fixation of the mesh to the promontory by 
using sutures is much stronger than by staples [19]. 
One of the most critical steps of these procedures is to determine the appropriate 
amount of tension to suspend the uterus or vaginal vault sufficiently without causing 
pain, de novo stress incontinence or de novo dyspareunia [20]. In Dutch practice, the 
mesh is usually attached tension free or with slight tension. In the literature, several 
studies reported to attach the mesh tension free [12] or even with moderate tension 
[13]. However, there is no standard with respect to the amount of tension and the best 
way to assess this. 
After the uterus or vault is suspended, most respondents cover the mesh with 
peritoneum in an attempt to avoid bowel entrapment and internal hernia [20]. 
However, in a study of 128 women undergoing sacrocolpopexy without burial of mesh 
by peritoneal closure, no bowel complications were reported [21]. Nevertheless, after 
Only 13.7% (n=49) of the responding Dutch gynecologists perform LSH and/or LSC. 
This small number can probably be explained by the complexity and the long learning 
curve of these procedures. Therefore, laparoscopic prolapse repair is generally 
supposed to be the domain of expert laparoscopists [11].  Despite the small number 
of gynecologists performing this type of surgery, 51% of the respondents observed an 
increase in the number of LSH and LSC in the last 12 months. This might be explained 
by the diminished use of transvaginal mesh after the publication of safety advisories 
and the negative publicity [2], which possibly led to a growing interest in laparoscopic 
POP surgery. Gynecologists who perform both procedures, use the same surgical 
technique for LSH and LSC. However, we found variation in surgical technique among 
gynecologists.   
Most gynecologists do not administer bowel preparation. If bowel preparation is 
performed, different methods are used. In the literature, there is no evidence regarding 
bowel preparation in laparoscopic prolapse surgery. In gynecological laparoscopy 
in general, bowel preparation improves surgical view and bowel handling, but the 
benefit is thought to be small [14]. One randomized controlled trial demonstrated that 
mechanical bowel preparation is well–tolerated, but it does not influence the surgical 
field visualization for laparoscopic hysterectomy [15]. 
Most Dutch gynecologists routinely administer perioperative antibiotics, which is in line 
with most large series describing laparoscopic prolapse surgery [9,16]. There are no 
specific studies on the use of antibiotic prophylaxis at the time of mesh reconstructive 
surgery for prolapse [17]. As a consequence, there is no evidence if, and if so, which 
antibiotics should be given to prevent postoperative infection.  
The majority of the respondents prefer to dissect the entire peritoneum (from 
promontory to pouch of Douglas), while some gynecologists create a tunnel under 
the caudal peritoneum to avoid later suturing. Again, there is no evidence in literature 
which technique is better.
In contrast to posterior dissection, an anterior dissection of the cervix or vaginal vault 
is not routinely performed by the respondents. As related to the dissection of cervix 
or vaginal vault, the mesh is mostly attached to the anterior and posterior site of the 
cervix or vaginal vault (double mesh). None of the respondents attach the mesh to 
the anterior site only. However, in a minority the mesh is attached to the posterior 
site only. In a few large series of LSC reported in literature, the majority of authors 
systematically place a double mesh, which is in line with the systematical treatment 
33
52 53
VARIATION IN PRACTICE OF LAPAROSCOPIC SACROHYSTEROPEXY AND SACROCOLPOPEXYCHAPTER 3
The strength of this study is the high response rate to this questionnaire (71%). There are 
also some limitations of the study protocol. A questionnaire is always a simplification 
of the reality. It is impossible to question all minor details of the surgical technique, 
which will be influenced by various details of the surgical anatomy and expertise of 
the surgeon. Furthermore, the questionnaire is anonymous and we did not ask for the 
hospital where the respondent is currently working. Therefore, it might be possible 
that a part of respondents work in the same hospital using the same local protocol. 
These factors might influence the data and its interpretation. Another limitation of 
this study is the small number of respondents who perform LSH and LSC (n = 49). 
Membership of the Dutch Society of Obstetrics & Gynecology (NVOG) is compulsory 
for all Dutch practicing gynecologists. The NVOG has several subdivisions including 
the Dutch Society for Gynecological Endoscopy and Minimally Invasive Surgery or 
the Dutch Society for Urogynecology. All gynecologists who perform laparoscopic 
prolapse surgery are most likely member of one or both societies. Therefore, we are 
quite certain that we have reached all the relevant gynecologists. Because laparoscopic 
prolapse repair is reserved for expert gynecologists, this procedure is only performed 
by the minority of Dutch gynecologists. That might explain that, in a small country 
as the Netherlands with a total of 958 gynecologists, there will be a small number of 
gynecologists who perform LSH and LSC. However, despite this small group, we were 
able to demonstrate great variations in the practice of these techniques. 
Laparoscopic POP surgery seems to be on the increase, probably because of the 
long-term complications of the vaginal mesh [3]. However, a standard protocol 
for laparoscopic prolapse repair is lacking. While laparoscopic application of 
these procedures might be relatively new, the abdominal approach has been 
performed for many years. Surgical techniques for this open procedure have been 
described in literature [5,6,9,10]. Several studies have compared the open abdominal 
sacrocolpopexy to the laparoscopic sacrocolpopexy. In these studies, the technique 
for open procedure is identical to the laparoscopic procedure on several key points 
[9,10]. Despite the experience in abdominal sacrohysteropexy and sacrocolpopexy, 
our study demonstrates that gynecologists differ in performing LSH and LSC on 
several key points like level of dissection along the anterior and posterior wall of the 
vagina, type of mesh used, type of sutures used, tension of the implanted mesh and 
reperitonealization of the mesh. To monitor outcome and long-term complications of 
laparoscopic prolapse repair, consensus of how to perform these  procedures seems 
mandatory. It might not be possible to achieve complete standardization, since some 
points depend on the preference of the gynecologist. In addition, it can be discussed if 
standardization of the whole procedure would be relevant, as some variables probably 
partial closure of the peritoneum over the mesh, adhesions between the mesh and 
loops of small bowel were noticed at subsequent laparoscopies [13]. 
Only one gynecologist routinely performs a cystoscopy after LSH. Intraoperative 
cystoscopy can be performed to detect bladder injury. The exact incidence of mesh 
misplacement in the bladder or sutures penetrating the bladder are unknown. In 
literature, the removal of intravesical mesh following LSC has been described in several 
case studies [22,23]. However, diagnosis was made months after the initial surgery. 
Therefore, it is unknown if these mesh protrusions were due to cystotomies during 
the initial surgery or to erosion or migration [23]. Furthermore, cystoscopy can detect 
ureteral injury by assessing urine efflux from the ureteral orifices [24]. The overall 
incidence of ureteral injury is estimated to be <1-2% in gynecological laparoscopy 
[24]. Potential disadvantages of performing universal intraoperative cystoscopy are 
increased operative time, procedure costs and incidence of minor complications such 
as urinary tract infection and bladder trauma. Furthermore, cystoscopy will not detect 
all injuries, particularly those caused by thermal damage, which may take several weeks 
to develop [25]. Cystoscopy could lead to overdiagnosis and unnecessary intervention, 
since some urinary tract injuries are asymptomatic and resolve spontaneously [25]. 
Because the potential disadvantages of intraoperative cystoscopy and the possibility 
to identify the ureter during laparoscopy, literature suggests to perform intraoperative 
cystoscopy only when urinary tract injury is suspected during gynecologic laparoscopy 
[24,25]. However, no recommendations for intraoperative cystoscopy with respect to 
POP surgery with abdominal mesh could be found in literature.
Concomitant colporrhaphy in case of prolapse of the anterior or posterior vaginal wall 
after LSH and LSC is only performed by a minority of the gynecologists. The majority 
of these respondents prefer to perform anterior or posterior colporrhaphy after the 
laparoscopy. In literature, it is thought that elevating the vaginal vault or cervix may 
correct anterior and posterior vaginal wall prolapse. Furthermore, deep attachment 
of the anterior and posterior mesh can repair anterior and posterior vaginal wall 
prolapses as well [26]. However, there is a risk of enterotomy or cystotomy [20]. In a 
retrospective cohort study comparing outcomes after abdominal sacrocolpopexy with 
and without concomitant paravaginal anterior wall repair, no statistical differences in 
recurrence rates of cystoceles were detected [27]. With respect to the posterior wall, 
abdominal sacrocolpopexy without concomitant posterior repair sufficiently restores 
posterior vaginal wall support in most women at one year follow up [28]. Furthermore, 
concomitant posterior repair after robotic sacrocolpopexy did not significantly affect 
bowel symptoms [29].  
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INTRODUCTION
Different surgical techniques are available to treat pelvic organ prolapse (POP). 
Whether or not the uterus should be preserved in case of uterine prolapse is still a 
matter of debate. Well-executed randomized controlled trials to evaluate these 
therapies are limited and based on current literature no clear superiority in favour of 
uterus preserving surgery or hysterectomy is known [1-3].
In the Netherlands, a trend towards uterus preserving surgery was found during the 
last decade [4].  A similar change was observed in Taiwan and the US [5,6]. A possible 
explanation for this phenomenon could be that gynaecologists have become more 
familiar with the different operative uterus sparing techniques. Also women’s belief 
and opinion about the treatment of uterine prolapse may have changed. In literature 
it is often stated that more women want to preserve the uterus in case of surgical 
management of uterine prolapse. However, little is known on women’s attitude, 
preference and belief with respect to uterus preservation or hysterectomy in surgical 
management. 
The aim of this study was to explore attitude towards hysterectomy and uterus 
preservation in Dutch women referred with POP complaints. Patient’s perception 
and belief on the impact of uterus preservation and hysterectomy on body image 
and sexual function were also studied. Furthermore we studied the importance of 
treatment success, risk of urinary incontinence after surgery, complication risk, 
recovery time, length of hospital stay, costs and the risk of developing endometrial 
cancer when choosing one of the treatment options. 
MATERIALS AND METHODS 
Women’s attitude towards hysterectomy or preservation was assessed by a structured 
preference questionnaire in a cross-sectional study during one year. The study took 
place in a large teaching hospital (Isala Zwolle) and a university hospital (Radboud 
University Nijmegen Medical Centre) in The Netherlands from December 2013 to 
November 2014. Both hospitals obtained approval for this study from the central 
medical ethical committee of the Isala (March 8, 2012, registration number 12.0326)
All women aged 18 years or older, referred with POP complaints by their general 
practitioner (GP), without previous prolapse surgery or hysterectomy, could participate 
ABSTRACT
OBJECTIVE
To investigate Dutch women’s attitudes and preferences towards hysterectomy or 
uterus preservation in surgical treatment of pelvic organ prolapse. 
STUDY DESIGN
Women’s attitude was assessed by a structured questionnaire in one university hospital 
and one non-university teaching hospital in the Netherlands. Between December 
2013 and November 2014, 102 women referred with prolapse complaints, without 
previous prolapse surgery, responded to the questionnaire received by mail prior to 
gynaecological consultation. Main outcome was the preference for uterus preserving 
surgery versus hysterectomy. Furthermore we studied the impact of uterus preservation 
and hysterectomy on body image and sexual function and the importance of treatment 
success, risk of urinary incontinence after surgery, complication risk, recovery time, 
length of hospital stay, costs and the risk of developing endometrial cancer.
RESULTS
Assuming that functional and anatomical outcomes after hysterectomy and uterus 
preserving surgery were equal, more women expressed preference for uterus 
preservation (43%, 44 out of 102 women) compared to hysterectomy (27%, 27 out 
of 102 women). The majority of women expected a similar improvement in sexuality 
and body image after the two treatment modalities. Treatment success, risk for urinary 
incontinence after surgery and complication risk were the most important factors. 
Taken the future risk of endometrial cancer into account, 18% of the women preferred 
hysterectomy because of this risk.
CONCLUSIONS
This study demonstrated that women referred with prolapse complaints have a 
preference for uterus preservation in case outcomes after both interventions are 
expected to be equal. The majority of women expected that body image and sexual 
function would equally improve after both interventions 
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following factors when choosing surgery: 1. treatment success, 2. risk of urinary 
incontinence after surgery, 3. post-operative recovery, 4. costs, 5. length of hospital 
stay, 6. complications, and 7. sexual functioning after surgery. Finally, patients were 
explained that with uterus preservation there is a small risk of getting endometrial 
cancer. Information was given that in The Netherlands every year approximately 1900 
women develop endometrial cancer and this type of cancer is usually discovered at 
an early stage due to blood loss. The 5-year overall survival of this early stage disease 
is 95%.  Women were asked whether the risk of endometrial cancer influenced their 
preferred treatment. 
A pilot study was performed among 15 women referred with POP complaints. These 
women completed the preference questionnaire under supervision of one of the study 
investigators (RJD) and several modifications were made to increase the readability 
and to clarify some questions. The results of this pilot study were not used in the 
final analysis. The POP-Q score and UDI questionnaire scores were collected from the 
medical record to describe baseline characteristics. 
All statistical analyses were performed in SPSS for Windows version 22.0.0.1 (SPSS 
Inc., Chicago, IL, USA). Patient characteristics were summarized using descriptive 
statistics for continuous variables presented with medians, means, range and standard 
deviations as appropriate. Differences were compared using one-way analysis of 
variance (ANOVA). 
RESULTS
During one year, a total of 200 women were asked to participate of which 102 women 
(52%) actually responded and filled out the questionnaire.  In 30 women (29%) UDI scores 
were missing. Table 1 shows the baseline characteristics. Of the participating women, 36 
(35%) were aged 18 to 50 years and 66 (65%) over 50 years of age. Furthermore, 32 (33%) 
appeared to have a uterine prolapse POP-Q stage two or higher assessed by POP-Q 
examination. Anterior vaginal wall prolapse stage two or higher was found in 68% of the 
women and 24% had posterior vaginal wall prolapse stage two or higher.
Outcomes on preference for hysterectomy or uterus preservation assuming 
equivalence are shown in table 2. In case of equal outcome 43% (44 out of 102) 
preferred uterus preservation, 27% (27 out of 102) preferred hysterectomy and 30% (31 
out of 102) had no preference. 
in the study. Eligible patients were identified and selected based on the referral 
letters by the investigators (MvIJ, MG and KK). Prior to the scheduled gynaecological 
consultation, eligible patients received written and oral study information and were 
asked to participate. Written informed consent was obtained from all participants. 
Demographic data were collected and prior to the consultation all patients were 
requested to complete two questionnaires: 1) a self-developed questionnaire and 2) a 
standardized validated quality of life and disease-specific questionnaire as recommend 
by the Dutch Urogynaecological Society including the Urogenital Distress Inventory 
(UDI) [7-9]. 
Primary objective of the study was to assess women’s attitudes towards uterus 
preservation versus vaginal hysterectomy in surgical treatment of uterine prolapse. 
Secondary objectives were women’s perception and opinion on:  1. Impact of 
uterus preserving surgery and vaginal hysterectomy on body image and sexuality, 
2. Importance of treatment success, risk of urinary incontinence after surgery, 
complication risk, recovery time, length of hospital stay, costs and sexual functioning 
after surgery in choosing a surgical POP procedure and 3. Influence of future risk to 
develop endometrial cancer on the preferred treatment. 
In the self-developed questionnaire the aim of the study was explained and information 
on POP and surgical treatment was given. First, women were questioned whether they 
preferred uterus preserving surgery or vaginal hysterectomy assuming equivalence. 
Furthermore we counselled women based on what was known from literature at that 
time based on the latest reviews regarding this subject: 1. Complication risk during 
and short after surgery (bleeding, infection, damage to the bladder or bowel and 
problems with micturition) appears to be equal after both interventions [10]; 2. Some 
women need repeat surgery because of recurrent prolapse. It is not clear whether this 
is more frequent after uterus preservation or hysterectomy [1,2,10]; 3. It is possible 
that surgery relieves symptoms but also other complaints can occur. A small number 
of women will suffer from urinary incontinence after surgery for POP. Removal of the 
uterus is possibly more often associated with urinary incontinence in comparison to 
uterus preservation, but this need further investigation [11]; 4. Some uterus preserving 
procedures are associated with a shorter hospital stay (about a day shorter) and a faster 
recovery after surgery [10,12,13]. Women were asked whether this information affected 
their preferred surgical approach. Subsequently, there were specific questions about 
the influence of the type of surgical approach on the expected change in improvement 
of body image and sexual functioning after surgery. Furthermore, women rated on a 
5-point Likert scale (1 = not important, 5 = very important) the importance of the 
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In table 4 the results of counselling are demonstrated. Statistically significant more 
women preferred uterus preservation (65%) compared to hysterectomy (13%, 
p=0.001). Of women who preferred uterus preservation 96% opted for the same 
treatment after counselling. However, of the women who preferred hysterectomy, 
50% changed their mind after counselling and preferred uterus preservation instead. 
Among the women who had no preference, 45% preferred uterus preservation after 
written counselling. 
Several reasons were given to sustain the choice of treatment. Most common reasons 
to choose for hysterectomy were: to avoid problems in the future (43%), menstrual 
disorders (17%) and the feeling that the uterus has become unnecessary (13%). Most 
frequently mentioned reasons for uterus preservation were: less invasive procedure 
(22%), the wish to stay as complete as possible (22%), not unnecessarily remove a 
healthy organ (22%). Only one woman had preference for uterus preservation because 
of future childbearing. 
TABLE 4. Preference for hysterectomy or uterus-preserving surgery assuming equal outcome 
and crossover of the preference after counselling. 
Q1. Preference in case of equal outcome 
Uterus preservation Hysterectomy* No preference Total
Q2. Preference after counselling**
Uterus preservation 42 (96%) 10 (36%) 14 (45%) 66 (65%)
Hysterectomy 0 (0%) 13 (50%) 0 (0%) 13 (13%)
No preference 2 (4%) 3 (12%) 17 (55%) 22 (22%)
Data are presented as number (percentage). 
* Preference after counselling in one patient was missing with preference for hysterectomy in case of equal 
outcome
**  I. Similar complication risk, II. difference in anatomical outcome between both procedures unclear, III. 
Removal of the uterus is possibly more often associated with occurrence of urinary incontinence, IV. uterus 
preserving procedures are associated with shorter hospital stay and faster post-operative recovery [1,2,9-12].
Table 5 shows outcomes on the improvement of body image and sexuality. The 
majority of women (77%) expected that the improvement in body image would be 
the same after both interventions. Regarding sexuality, also 79% expected that both 
interventions would equally improve sexuality.
On a 5-point Likert scale, treatment success (4.5 ± 0.7), risk of urinary incontinence 
after surgery  (4.5 ± 0.8), complication risk (4.4 ± 0.7) and postoperative recovery (4.0 
± 1.0) were the most important factors for the preference of a surgical intervention. 
TABLE 1. Baseline and anatomical characteristics 
Characteristics n= 102
Age, years 56.2 (12.7)
Parity 2.6 (1.2)
Body mass index, kg/m2 27.0 (4.1)
Postmenopausal 65 (63.7%)
Highest educational level:
    Primary  / secondary school 19 (26.8%)
    High school 38 (53.5%)
    Bachelor, master or academic degree 14 (19.7%)
VAS general health (0-100) 70.9 (15.6)
UDI subscale prolapse* 35.0 (31.2)
Overall POP-Q stage prolapse ** 2 (0.8)
Data are presented as mean (SD) or number (percentage) as appropriate. Percentages were calculated using 
non-missing data. UDI: Urogenital Distress inventory; VAS: visual analogue scale score; 
* UDI: 0=no symptoms or not bothersome and 100=most bothersome symptoms.
** Evaluated by Pelvic Organ Prolapse Quantification (POP-Q) examination. 
TABLE 2. Preference for hysterectomy or uterus-preserving surgery assuming equal outcome 
Number of women (%) 
Uterus preservation 44 (43%)
Hysterectomy 27 (27%)
No preference 31 (30%)
Table 3 demonstrates the relation between the women’s preference and their 
characteristics. In the hysterectomy preference group, the percentage of 
postmenopausal women is higher as compared to the uterus preservation preference 
group (not significant). No significant differences in preoperative bladder and prolapse 
symptoms were found between the preference groups. 
TABLE 3. Characteristics by treatment preference 
Uterus preservation 
(n = 44)
Hysterectomy
(n = 27)
No preference 
(n = 31)
Postmenopausal status 24 (55%) 17 (63%) 24 (77%)
Bladder and prolapse symptoms (UDI)*
Obstructive micturition 29.2 (26.7) n = 28 33.3 (24.7) n = 21 18.8 (23.7) n = 23
Overactive bladder 25.5 (23.0) n = 27 23.2 (21.1) n = 22 25.9 (24.1) n = 24
Urinary incontinence 23.2 (24.1) n = 28 30.8 (27.7) n = 20 32.6 (28.0) n = 24
Discomfort/pain 30.3 (24.9) n = 28 38.3 (24.8) n = 20 25.4 (20.0) n = 23
Genital prolapse 40.1 (33.7) n = 27 25.4 (29.6) n = 21 37.5 (29.2) n = 24
Data are presented as mean (SD) as appropriate. Percentage were calculated using non-missing data. UDI = 
Urogenital Distress Inventory. 
* UDI: 0 = no symptoms or no bothersome, 100 = most bothersome symptoms.
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In the US, a preference assessment in women with POP symptoms reported that a 
higher proportion of women with prolapse symptoms preferred uterine preservation, 
instead of hysterectomy [14]. Assuming outcomes were equal between hysterectomy 
and uterine preservation, 36% of the women preferred uterine preservation; 20% of 
the women preferred hysterectomy, and 44% of the women had no clear preference. 
Overall, this is in line with our findings.  Geographic region, education level, and belief 
that the uterus is important ‘for a sense of self’ were predictors of preference for uterine 
preservation.  Another study with respect to patients’ attitude toward the uterus and its 
role in surgery found that women had relatively neutral attitudes on the uterus being 
beneficial to sexuality or femininity [15]. The majority of respondents disagreed that 
the uterus was important for body image and sexuality. This is in line with our results; 
since approximately 80% of the women reported that the effect of uterus preservation 
and hysterectomy would be the same on sexuality and body image.  A study among 
predominately Hispanic women concluded that 32% would choose to preserve their 
uterus at the time of prolapse repair [16].
In our study women completed the questionnaire before gynaecological consultation 
and examination. Therefore our results could not be influenced by the preference of 
the gynaecologist, or information on their actual prolapse. On the other hand, the 
fact that women did not really know whether or not they had an uterine prolapse 
or indication for surgery may have introduced bias into the study as their prolapse 
complaints could also be caused by anterior and/or posterior vaginal wall prolapse. 
Only one third of the respondents had an uterine prolapse POP-Q stage two or higher 
assessed by POP-Q examination. It is known that pelvic floor symptoms and prolapse 
complaints have a weak correlation with prolapse in a specific compartment or severity 
of the prolapse [17]. Therefore, we believe that this population was representative for 
this study. Another limitation was the relatively low response rate, with only half of the 
patients giving approval. The most important reason to decline participating was the 
bother to fill out the questionnaire. One could argue that the counselling statements 
encouraged women to choose for uterus preservation. The study would have been 
more complete if we had also used counter-factual statements providing advantages 
for hysterectomy over uterine preservation. The lack of providing such statements 
might be regarded as a limitation. The statements used for counselling were based 
on the best available evidence at the moment of project development. Furthermore, 
we did not ask the participants if their family was complete or if there was still a wish 
for childbearing. However, only one woman preferred uterus preservation because 
of future childbearing. Therefore, we assume that most participants had complete 
families. 
In addition, sexual functioning after surgery was also regarded to be important (3.8 
± 1.1). Length of hospital stay (2.9 ± 1.1) and costs (3.0 ± 1.1) were found to be less 
important. 
TABLE 5. Improvement in body image and sexuality
No of women (%)
Body image
Equally improvement in body image 79 (77%)
Uterus preservation more improves body image 18 (18%)
Hysterectomy more improves body image 4 (4%)
Missing 1 (1%)
Sexuality
Equally improvement sexuality 81 (79%)
Uterus preservation more improves sexuality 13 (13%)
Hysterectomy more improves sexuality 4 (4%)
Missing 4 (4%)
Data are presented as number (percentage).
With respect to the future risk of endometrial cancer, 18% answered they preferred 
hysterectomy because of this risk, 52% would not necessarily choose hysterectomy 
and 30% did not know. Excluding women without a specific preference and taking 
age into account, more women aged under 50 years (47.8%) preferred hysterectomy 
because of the future risk of endometrial cancer compared to women aged above 50 
years  (14.6%, p=0.003). 
COMMENT
This study analysed women’s attitude towards hysterectomy and uterus preserving 
surgery in treatment of POP. In case of equal outcomes after these procedures, more 
women preferred uterus preservation (43%) compared to hysterectomy (27%). After 
counselling based on current knowledge from literature, the percentage of women 
preferring uterus preservation increased to 65%.  Our findings suggest that preoperative 
bladder and prolapse symptoms do not influence the preference. In the hysterectomy 
preference group, the percentage postmenopausal women is higher as compared to 
the uterus preservation preference group suggesting that having a menstrual cycle or 
having bleeding disorders does not influence the choice for hysterectomy over uterus 
preservation. 
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CONCLUSIONS
This study demonstrated that women referred with prolapse complaints have a 
preference for uterus preservation in case the outcomes after both interventions are 
equal. The majority of women expected that body image and sexual function would 
equally improve after both interventions. 
We have used a written, non-validated questionnaire, which was send to women 
prior to gynaecological consultation. Advantage of this type of survey is that it allows 
women to fill it out at their own convenience. Furthermore it is relatively inexpensive 
and little time consuming to health care providers, which makes it possible to send it 
to a large number of women with the possibility to analyse the results more objectively 
than other types of preference survey. Disadvantages of non-validated written 
questionnaires are low response rates and a level of subjectivity in the answers since 
people may read differently into each question and therefore reply based on their own 
interpretation. We tried to avoid this issue by piloting the questionnaire among women 
before the trial started. 
In a previous study we found a trend toward more uterus preservation among 
gynaecologists in the Netherlands with large variation in treatment of uterine 
prolapse [4]. Better understanding of women’s thoughts and preference on surgical 
treatment of uterine prolapse makes that more specific information can be given prior 
to surgery. This is valuable in the shared-decision making process prior to surgery. 
Women appointed treatment success, risk on urinary incontinence, complication 
risk and recovery time as important factors in the choice of a surgical procedure. In 
addition it seems that counselling had a significant effect on the preferred treatment. 
Caregivers must be aware of these points and evidence based information should be 
given prior to surgery. However, shared decision making is a delicate process. Not only 
the characteristics of the procedure should be discussed with the patient, but also the 
risk of future malignancy. 
Data from randomised trials on the outcomes of different prolapse operations are 
sparse. Recently, we published the results from the SAVE U trial, comparing uterus 
preserving sacrospinous hysteropexy with vaginal hysterectomy with suspension of the 
uterosacral ligaments [3]. This RCT demonstrated that both anatomical and functional 
outcome were equal for these operative techniques. Although vaginal hysterectomy 
used to be the most performed operation in case of uterine prolapse [4,18,19], these 
results provide us an alternative comparable treatment. Better understanding of 
women’s preferences on uterus preservation makes it possible to come to a process 
of shared-decision making with respect for women’s attitudes in case of POP surgery.
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BACKGROUND
Pelvic organ prolapse (POP) is defined as the descent of one or more of the pelvic organs. 
POP is a common health problem.  As life expectancy increases, a significantly greater 
number of women will present with POP requiring surgery. Given a life expectancy of 
85 years, the lifetime risk of women undergoing a surgery for POP is 19% [1]. POP has 
significant negative effects on a woman’s quality of life, ranging from physical discomfort, 
psychological and sexual complaints to occupational and social limitations.
The etiology of POP is multifactorial: vaginal childbirth, advancing age and increasing 
body-mass index are the most consistent risk factors [2,3].  
Women can present with prolapse of one or more compartments. Symptoms are 
commonly attributed to the anatomical compartments that are involved. Anterior 
vaginal wall prolapse concerns the urethra and/or the bladder (uretrocele, cystocele). 
Apical prolapse entails either the uterus or vaginal cuff after hysterectomy. Posterior 
vaginal wall prolapse involves the rectum (rectocele) but can also include the small 
intestines (enterocele). This study will focus on the treatment of uterine prolapse. 
Worldwide, vaginal hysterectomy is the most frequently used treatment method for 
patients with symptomatic uterovaginal prolapse: it appeared to be the procedure 
of choice in the United Kingdom (82%) [4] and in Australia and New Zealand (79%) 
[5]. Although the literature is inconclusive, it has been suggested that hysterectomy 
may cause nerve supply damage and disrupt supportive structures of the pelvic floor, 
subsequently increasing the risk of future vaginal vault prolapse [6]. Furthermore, 
hysterectomy alone fails to address the underlying deficiencies in pelvic support causing 
uterine prolapse. Up to 11.6% of women undergoing hysterectomy subsequently 
present with vaginal vault prolapse [7] and the frequency of posthysterectomy vault 
prolapse requiring surgical repair is estimated between 6 and 8% [8].  
Many other techniques for the treatment of uterine descent have been described, 
including vaginal, abdominal and laparoscopic procedures.  
One procedure for uterine descent with uterine preservation is vaginal sacrospinous 
hysteropexy. In this procedure, the uterus is suspended to the sacrospinous ligaments 
with permanent sutures. In several studies, this technique was demonstrated to be 
a safe procedure for the primary treatment of uterine descent [9-11]. In a prospective 
observational study of 72 women with uterine descent, sacrospinous hysteropexy 
ABSTRACT
BACKGROUND
Pelvic organ prolapse is a common health problem: the lifetime risk of undergoing 
surgery for pelvic organ prolapse by the age of 85 years is 19%. Pelvic organ prolapse has 
significant negative effects on a woman’s quality of life. Worldwide, vaginal hysterectomy 
is the leading treatment method for patients with symptomatic uterovaginal prolapse. 
Several studies have shown that vaginal sacrospinous hysteropexy and laparoscopic 
sacrohysteropexy are safe and effective alternatives in treating uterine descent. To 
date, it is unclear which of these techniques leads to the best operative result and the 
highest patient satisfaction.  Therefore, we conducted the LAVA trial. 
METHODS
The LAVA trial is a randomized controlled multicenter non-inferiority trial. The study 
compares laparoscopic sacrohysteropexy with vaginal sacrospinous hysteropexy in 
women with uterine prolapse stage 2 or higher. The primary outcome of this study 
is surgical success of the apical compartment at 1 and 5 years follow-up. Secondary 
outcomes are subjective improvement on urogenital symptoms and quality of life 
(assessed by disease-specific and general quality of life questionnaires), complications 
following surgery, hospital stay, post-operative recovery, sexual functioning and 
costs-effectiveness. Evaluation will take place pre-operatively, and 6 weeks, 6 months, 
12 months and annually till 60 months after surgery. Validated questionnaires will be 
used. 
Analysis will be performed according to the intention to treat principle. Based on 
comparable recurrence rates of 3% and a non-inferiority margin of 10%, 62 patients 
are needed in each arm to prove the hypothesis with a 95% confidence interval. 
DISCUSSION
The LAVA trial is a randomized controlled multicenter non-inferiority trial that will 
provide evidence whether the efficacy of laparoscopic sacrohysteropexy is non-
inferior to vaginal sacrospinous hysteropexy in women with symptomatic uterine 
prolapse stage 2 or higher. 
TRIAL REGISTRATION
Netherlands Trial Register (NTR): NTR4029
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controlled trial to determine whether the efficacy of laparoscopic sacrohysteropexy 
is similar to vaginal sacrospinous hysteropexy in women with symptomatic uterine 
prolapse POP-Q stage 2 or higher.  
METHODS/DESIGN
STUDY OBJECTIVES
The objective of this study is to determine whether laparoscopic sacrohysteropexy in 
women with uterine descent stage 2 or higher improves outcome in terms of recurrence 
of prolapse, quality of life, complications, hospital stay, post-operative recovery, sexual 
functioning and costs-effectiveness compared to vaginal sacrospinous hysteropexy. 
HYPOTHESIS
Based on the literature, we hypothesize that there is no difference in surgical success 
rate of the apical compartment between laparoscopic sacrohysteropexy and vaginal 
sacrospinous hysteropexy in symptomatic women with uterine descent POP-Q stage 
2 or higher. Possibly, laparoscopic sacrohysteropexy might be associated with quicker 
post-operative recovery, less dyspareunia post-operatively and lower recurrence rates 
with respect to the anterior vaginal wall.
STUDY DESIGN
The LAVA-trial is a prospective, randomized controlled non-blinded clinical trial 
conducted with the aim to determine non-inferiority of the primary endpoint (surgical 
success of the apical compartment) between laparoscopic sacrohysteropexy and vaginal 
sacrospinous hysteropexy. The study will be an open label study, as it is impossible to 
blind the participating patients and the health care workers for the surgical procedure 
to which the woman is allocated. However, follow-up at six months, one and five 
years will be done by a physician not involved in the surgery. Post-operative follow-
up will take place after 6 weeks, 6 months, 12 months and annually thereafter until 5 
years. Patients will undergo a standard gynecological examination (including a POP-Q 
examination) and fill in questionnaires. The study design is presented in figure 1. 
PRIMARY AND SECONDARY OUTCOMES
Surgical success of the middle compartment at 1 and 5 years follow-up in both study 
groups will be considered as the primary outcome. Success is defined as position 
of the cervix at or above the mid-vagina (C<-TVL/2), no symptoms (defined as no 
symptoms of vaginal bulging and protrusion on the validated questionnaire) and no 
significantly reduced all urogenital and several defecatory symptoms and significantly 
improved quality of life. It also cured the uterine descent in 93.1% of women [12]. 
The procedure is associated with a few serious complications. The most common 
complication is buttock pain on the side where the sacrospinous sutures have been 
passed, this occurs in approximately 10-15% of the women, but resolves typically in 
days to months. One prospective study and one retrospective study comparing vaginal 
hysterectomy to vaginal sacrospinous hysteropexy demonstrated no significant 
difference in anatomical outcome, while hospital stay was shorter, less pain was 
experienced and recovery was quicker in the latter group [13-15]. These studies 
conclude that vaginal sacrospinous hysteropexy is associated with a faster complete 
recovery compared to vaginal hysterectomy. In both groups high recurrence rates of 
anterior vaginal wall prolapse were demonstrated (50% in hysterectomy group vs. 65% 
in sacrospinous hysteropexy group) [15]. It is believed that the change in axis of the 
vagina after a sacrospinous hysteropexy predisposes to an increased risk of prolapse 
of the anterior compartment [16].  
Another procedure for uterine descent with uterine preservation is laparoscopic 
sacrohysteropexy. In this procedure, the uterus is elevated by attaching the cervix 
to the sacral promontory using a mesh. One prospective study suggests that 
sacrohysteropexy is a safe and effective procedure. One out of 13 women (7.7%) had 
a recurrence of uterine prolapse (mean follow-up 15.6 months) [17]. However, in this 
study the sacrohysteropexy was performed by laparotomy. 
Another prospective study in which laparoscopic sacrohysteropexy was performed 
in 51 women showed no objective recurrence of uterine prolapse during a 10 weeks 
follow-up [18]. Laparoscopic sacrohysteropexy may have some complications. 
Typically, the use of a synthetic mesh  implies a theoretical risk of erosion into an 
adjacent structure, or adhesion of bowel to the mesh, with subsequent development 
of symptoms and eventually signs of acute or chronic obstruction. Current experience 
anticipates a mesh related complication in less than 1% using a polypropylene mesh in 
abdominal correction of pelvic organ prolapse [19].  
Based on literature, it seems that uterus suspension in case of uterine descent 
could be an effective procedure and avoid the limitations of hysterectomy. To our 
knowledge, a study comparing vaginal sacrospinous hysteropexy with laparoscopic 
sacrohysteropexy for the treatment of uterine descent has not been performed yet. It 
is unclear which of these treatment modalities results in the best anatomic correction 
and the highest patient satisfaction.  Herein, we report on a multicenter randomized 
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abnormal ultrasound findings of uterus or ovaries which cause symptoms and/
or require treatment, abnormal uterine bleeding that requires surgical treatment, 
postmenopausal bleeding in the past year and women who are unwilling to return for 
follow-up are excluded from this study. Inclusion of women with cervical elongation 
will be left to the discretion of the enrolling surgeon. In case the surgeon believes that 
surgical shortening of the cervix or even vaginal hysterectomy is more appropriate 
because of a distinct elongation the patient should not be enrolled. Assessment for 
eligibility is performed by a gynecologist of the participating hospital. Patients eligible 
for this study are counseled about the long duration of follow-up required for this study. 
Subsequently, written patient information is provided, which contains information on 
the objectives, design, methods, possible advantages and disadvantages of the study 
treatments, and information that non-co-operation with the study or withdrawal will 
not have consequences for their treatment. An interval of at least one week between 
the primary visit and the next appointment allows sufficient time for women to think 
about participation. Before randomization, written informed consent is obtained. 
PARTICIPATING HOSPITALS
One university hospital in Belgium and five Dutch general hospitals will participate in 
this trial and enroll patients. 
RANDOMIZATION
After patients have consented for participating in this study, randomization will be 
performed by the coordinating researcher centrally through a website using a 
computer-generated randomization table. The subjects are assigned in a 1:1 ratio 
to either vaginal sacrospinous hysteropexy or laparoscopic sacrohysteropexy. The 
randomization will be stratified according to the center and severity of prolapse 
(POP-Q stage 2, 3 or 4). The order of outcomes is unknown to the investigators or 
to the participating gynecologists. Data will be kept anonymous. The subjects will be 
informed about the allocated operative procedure shortly after the randomization. 
Subjects that withdraw after randomization will be treated according to the preference 
of the gynecologist. 
DATA COLLECTION
All patients will undergo routine gynecological examination, which is part of the 
standard procedure before surgery. This examination includes pelvic ultrasound to 
exclude uterine or ovarian disease, routine PAP-smear and vaginal inspection in 45° 
semi-upright position for staging uterovaginal prolapse by a POP-Q examination. 
Maximum prolapse is demonstrated and identified by asking the patient to cough and 
reoperation or pessary use for recurrent apical prolapse [20].  Failure in one of these 
areas will constitute a failure. Secondary outcomes of this study include prolapse of 
the anterior and posterior compartment, subjective outcome and improvement in 
general and disease-specific quality of life, complications, hospital stay, postoperative 
recovery, sexual functioning, cost-effectiveness and uterine issues (e.g. abnormal 
bleeding, cervical dysplasia) and the need for subsequent hysterectomy. 
Women with symptomatic uterine prolapse POP-Q 
stage ≥ 2 requiring surgical treatment
Follow-up visits at 6 weeks, 6 and 12 months and 
annually thereafter until the end of the study 
(5 years)
Checking eligibility
Baseline examination
Informed consent
Randomization (n = 124)
Laparoscopic
sacrohysteropexy
(n = 62)
 - Gynecological examination including 
POP-Q, ultrasound and PAP-smear 
 - Questionnaires
 - Gynecological examination including 
POP-Q 
 - Questionnaires
Vaginal sacrospinous 
hysteropexy
(n = 62)
FIGURE 1. Study design.
STUDY POPULATION AND RECRUITMENT
All women seeking treatment for symptomatic pelvic organ prolapse with uterine 
descent POP-Q stage 2 or higher are eligible for inclusion in the LAVA trial. A total 
of 124 women will participate in this trial. Patients with co-existing anterior/posterior 
defects or concomitant incontinence surgery can be included. 
Women with previous pelvic floor or prolapse surgery, known malignancy of the 
cervix or cervical dysplasia, language barriers, a wish to preserve fertility, presence 
of immunological or hematological disorders interfering with recovery after surgery, 
contraindications for laparoscopic surgery (e.g. ileus, risk of severe adhesions), 
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has been developed for both surgical procedures. All procedures are performed 
according to this standardized protocol and also all participating hospitals use the 
same materials for the procedures (e.g. sutures, mesh). At least twenty procedures 
must have been performed by participating gynecologists to eliminate a learning 
curve effect. It is allowed for participating gynecologists to partner with a colleague 
gynecologist: one gynecologist can perform the laparoscopic sacrohysteropexy and 
the other gynecologist can perform the vaginal sacrospinous hysteropexy. 
LAPAROSCOPIC SACROHYSTEROPEXY
The patient is placed in lithotomy position. An uterine manipulator (Clearview, Clinical 
Innovations LLC, Murray, UT, USA) is placed to provide visualization of the surgical site. 
Four laparoscopic ports (umbilical, suprapubic, two lateral ports) will be placed and 
a pneumoperitoneum will be created. The colon sigmoid can be removed from the 
operating field by attaching it to the abdominal wall by a suture through some plica 
epiploica. The peritoneum over the sacral promontory will be incised; the right ureter 
will be identified. Each broad ligament at the level of the cervico-uterine junction will 
be opened. The vesico-uterine peritoneum will be incised and the bladder will be 
dissected distally for 2-3 cm. A bifurcated polypropylene flat mesh (Gynemesh, Ethicon 
Inc, Sommerville, NJ, USA) will be used. The arms of the mesh will be introduced 
bilaterally through windows created in the broad ligaments. Permanent sutures 
(Mersilene 2.0, Ethicon, Sommerville, NJ, USA) will be placed through the arms of the 
mesh and the anterior cervix (2-3 sutures) and the posterior cervix (4 sutures). The 
surgeon is allowed to place the mesh further down the anterior and posterior vaginal 
wall to treat compartment specific prolapses.  The mesh will be tacked to the sacral 
promontory using 5.3 x 3.7 mm titanium staples (Endoscopic Multifeed Stapler-20, 
Ethicon Inc, Sommerville, NJ, USA) to elevate the uterus (3 staples). The peritoneum 
will be closed with 5.3 x 3.7 mm titanium staples (Endoscopic Multifeed Stapler-20, 
Ethicon, Sommerville, NJ, USA) covering the promontory part of the mesh and a 
running suture (Vicryl 2.0, Ethicon Inc, Sommerville, NJ, USA) covering the cervical 
part of the mesh. The laparoscopic ports will be removed and the wounds will be 
closed. Vaginal examination after the laparoscopic hysteropexy is part of the protocol 
and additional anterior and/or posterior colporrhaphy or incontinence surgery can be 
performed if necessary, according to the standard procedures of the hospital. 
VAGINAL SACROSPINOUS HYSTEROPEXY
The patient is placed in lithotomy position. Access to the sacrospinous ligament is 
obtained through the pararectal space. The posterior vaginal wall will be incised and 
separated from the rectum. The right ischial spine will be localized digitally and after 
to perform a Valsalva maneuver while each vaginal wall is individually exposed. 
To obtain baseline characteristics of both patients groups all patients are asked to fill 
in standardized questionnaires at inclusion. These questionnaires are validated quality 
of life questionnaires (RAND 36, Euroqol 5D, Urogenital Distress Inventory, Defecatory 
Distress Inventory, Incontinence Impact questionnaire) and two questionnaires 
regarding sexual functioning (Pelvic Organ Prolapse/Urinary Incontinence Sexual 
Questionnaire and selected items from the “Vragenlijst Seksuele Disfuncties”) [21-
29]. Preoperative urodynamic evaluation is only performed in women with bladder 
dysfunction. 
During hospitalization and in the first 6 weeks after surgery patients are asked to keep 
a diary which contains the following items: postoperative pain measured by Visual 
Analogue Score (VAS), used pain medication and the RI-10 recovery questionnaire. 
The RI-10 recovery questionnaire is a validated quality of life questionnaire measuring 
subjective postoperative recovery [30]. To prevent a recall bias as much as possible, 
patients will be phoned two and four weeks after surgery as a reminder to fill in the 
diary. After surgery, patients will visit the hospital at 6 weeks (routine post-operative 
consultation), 6 months, 12 months and yearly thereafter. The total duration of the 
follow-up is 5 years. Each check-up includes a standardized written questionnaire 
regarding quality of life and sexual functioning (similar to the questionnaires at 
baseline) and a clinical examination (including POP-Q)
The validated questionnaires will be administered by the participating hospitals 
(baseline and 6 weeks postoperative) and by the coordinating hospital (6 months 
postoperative and yearly thereafter). 
INTERVENTIONS
Eligible women will be randomly allocated to receive either a laparoscopic 
sacrohysteropexy or a vaginal sacrospinous hysteropexy. The vaginal procedure can be 
performed under general or spinal anesthesia, according to the preference of patient 
and anesthesiologist. The laparoscopic procedure will be performed under general 
anesthesia. All women receive peri-operative antibiotics and thrombosis prophylaxis. 
Post-operatively a bladder catheter is placed and removed after one day. Patients will 
receive analgesics if necessary in accordance with local hospital protocol. All patients 
are advised to abstain from heavy physical work for a minimal period of 6 weeks. 
In order to standardize both procedures and prevent variation in procedures, a protocol 
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hysteropexy will be concluded if the 95% confidence interval (CI) does not exceed the 
non-inferiority margin of 10% (figure 2, scenario B). If the whole 95% CI exceeds the 
non-inferiority margin of 10%, the laparoscopic sacrohysteropexy will be considered 
to be inferior (scenario C). If the 95% CI for the difference in surgical success rates lies 
left from zero, it can be concluded that there is evidence of superiority of laparoscopic 
sacrohysteropexy over vaginal sacrospinous hysteropexy (scenario A) [31,32].   
Ethics
The study is conducted in accordance with the principles of the Declaration of Helsinki. 
The LAVA trial has been approved by the Medical Ethical Committee of the Isala 
Klinieken Zwolle (METC 13/0320) and the local Ethical Committees of the participating 
centers. Prior to randomization, informed consent will be obtained. 
FIGURE 2. Interpreting results of non-inferiority trials. Interpreting results of non-inferiority trials: Δ stands 
for the non-inferiority margin. The results of a non-inferiority trial can conclude superiority (A) as the 95% 
confidence interval (CI) lies left from zero (A), non-inferiority as the 95% CI does not exceed Δ (B) and inferiority 
as the 95% exceed Δ (C). If the 95% CI included Δ, the results are inconclusive (D).
retractor positioning, the ligament is made visible through blunt dissection. Two 
permanent sutures (Prolene 1.0, Ethicon Inc, Sommerville, NJ, USA) will be placed under 
direct vision through the right sacrospinous ligament at least 2 cm from the ischial 
spine. Hereafter, an additional anterior and/or posterior colporrhaphy or incontinence 
surgery can be performed, according to the standard procedures of the hospital. The 
permanent sutures will be placed through the posterior side of the cervix and two 
thirds of the posterior vaginal wall will be closed with absorbable sutures (Vicryl 2.0, 
Ethicon Inc, Sommerville, NJ, USA). The permanent sutures will be tightened and the 
cervix will be redressed. The remainder of the vaginal wall will be closed. 
STATISTICAL ANALYSIS
Sample size and power calculations
Sample size calculation was performed using Sample Power 2.0 (SPSS inc. Chicago, 
IL, USA). The aim of the study is to clarify whether laparoscopic sacrohysteropexy and 
vaginal sacrospinous hysteropexy do not differ significantly in surgical success rates of 
the apical compartment. We aim to demonstrate non-inferiority of the laparoscopic 
sacrohysteropexy at both 1 and 5 year (i.e. two tests on the primary endpoint will be 
performed). Two groups of 55 patients will be included to yield a 80% power for a 
non-inferiority margin of 10% assuming a recurrence rate of prolapse at the apical 
compartment of 3%. Taking into account 10% attrition, a number of 62 patients will 
be included in each study arm. This dropout can be expected when patients, after 
randomization, are unhappy with their allocated treatment and choose to end their 
participation in the study or due to incomplete or lost data. A total number of 124 
women will be included in this study. 
 
Data analysis
The analysis will be performed by intention to treat, and stratified for center and severity 
of prolapse. Patient characteristics will be summarized using descriptive statistics for 
continuous variables (mean ± standard deviation, minimum, maximum and sample 
size) and frequency tables for categorical variables (numbers and percentages).
Statistical analysis of the data will be conducted at 12 and 60 months follow-up. 
Surgical success of the apical compartment at 1 and 5 years follow-up in both study 
groups will be considered as the primary outcome. Success is defined as position of the 
cervix at or above the mid-vagina (C<-TVL/2), no symptoms (defined as no symptoms 
of vaginal bulging and protrusion on the validated questionnaire) and no reoperation 
or pessary use for recurrent apical prolapse. Failure in one of these areas will constitute 
a failure. Non-inferiority of laparoscopic sacrohysteropexy to vaginal sacrospinous 
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INTRODUCTION
Pelvic organ prolapse (POP) is a common health problem and associated with a 
significant impairment in quality of life [1]. The lifetime risk of undergoing surgery for 
POP or urinary incontinence is 20% by the age of 80 years [2]. As result of an aging 
population, a significant increase in both the number of women with POP and those 
seeking care for POP is expected to occur over the next 20-40 years [3]. Consequently, 
surgical rates for POP and urinary incontinence in the United States are estimated to 
increase with 42.7% by 2050 [3].
Traditionally, uterine prolapse is treated by vaginal hysterectomy and suspension of the 
vaginal vault, despite the fact that the uterus is not the cause but only a passive structure 
in the development of prolapse [4,5]. However, uterus preservation techniques are 
gaining interest and more of these operations are being done in recent years [6-9]. In 
concert with this, more women express a preference for uterine preservation [10-12]. 
Women may want to avoid hysterectomy because they feel the uterus is important for 
a sense of self-esteem and plays a role in sexual satisfaction, the added surgical risk of 
hysterectomy, and/or a desire to preserve fertility [10,12,13]. In addition, data  showing 
an added value of hysterectomy over uterus preservation are lacking.
Several studies have demonstrated that uterine suspension is as effective and safe 
as prolapse surgery including vaginal hysterectomy [13-16]. Laparoscopic, robotic, 
abdominal and vaginal procedures have been described to suspend the uterus. To 
date, no randomised controlled trials (RCTs) are available comparing these different 
routes [13]. Surgical access route and method of uterus suspension mostly depends 
on the preference of the surgeon. Whether or not these operations have comparable 
anatomical and functional outcomes remains unclear. 
ABSTRACT
OBJECTIVE
To investigate whether laparoscopic sacrohysteropexy (LSH) is non-inferior to vaginal 
sacrospinous hysteropexy (SSHP) in the surgical treatment of uterine prolapse.
DESIGN
Multicentre randomised controlled non-blinded non-inferiority trial. 
SETTING
5 non-university teaching hospitals in the Netherlands, one university hospital in 
Belgium. 
POPULATION
126 women with uterine prolapse stage 2 or higher undergoing surgery without 
previous pelvic floor surgery. 
METHODS
Randomisation in a 1:1 ratio to LSH or SSHP, stratified per centre and severity of the 
uterine prolapse.  The predefined inferiority margin was an increase in surgical failure 
rate of 10%. 
MAIN OUTCOME MEASURES
Primary outcome was surgical failure, defined as reoccurrence of uterine prolapse 
(POP-Q ≥ 2) with bothersome bulging/protrusion symptoms and/or repeat surgery or 
pessary at 12 months postoperative.  Secondary outcomes were anatomical recurrence 
(any compartment), functional outcome and quality of life. 
RESULTS
LSH was non-inferior for surgical failure (n=1, 1.6%) compared with SSHP (n=2, 3.3%, 
difference -1.7%, 95% CI -7.1 to 3.7) 12 months postoperatively. Overall anatomical 
recurrences and quality of life did not differ. More bothersome symptoms of overactive 
bladder (OAB) and faecal incontinence were reported after LSH. Dyspareunia was 
more frequently reported after SSHP.
CONCLUSION
LSH was non-inferior to SSHP for surgical failure of the apical compartment at 12 
months’ follow-up. Following LSH, bothersome OAB and faecal incontinence were 
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Written information was provided to eligible women and informed consent was 
obtained. Participants were then randomly assigned in a 1:1 ratio to either SSHP or LSH 
using a web-based computer application with generated computer randomisation 
tables in blocks of four. Randomisation was stratified per centre and severity of the 
uterine prolapse (POP-Q stage 2, 3 or 4). Surgeons and women were not blinded to 
the allocated surgical procedure. A physician trained in urogynaecology who was not 
involved in the management of patients performed the follow-up at 12 months. 
PRIMARY AND SECONDARY OUTCOMES
The primary outcome was a composite outcome of surgical failure of the apical 
compartment at 12 months’ follow-up, defined as reoccurrence of uterine prolapse 
(POP-Q ≥ stage 2) with bothersome bulging/protrusion symptoms and/or requiring 
therapy, whether it was repeat surgery or pessary [21]. Additional outcomes were 
anatomical failure in any compartment (POP-Q ≥ stage 2 in any compartment); 
surgical success defined as no prolapse beyond the hymen, neither bothersome bulge 
symptoms, and no therapy for recurrent prolapse within 12 months; and overall surgical 
failure, which was defined as POP-Q ≥ stage 2, pessary use, or repeat surgery for 
recurrent prolapse in any compartment within 12 months. Other secondary outcomes 
were functional outcome, quality of life and sexual functioning. 
DATA COLLECTION
POP measurements using the POP-Q system were performed at baseline, at six 
weeks, six months and 12 months after surgery. At those visits, women completed 
questionnaires regarding health-related and disease-specific quality of life (short 
form-365, Euroqol 5D, urogenital distress inventory, defecatory distress inventory and 
incontinence impact questionnaire) [22-25]. We defined the presence of bothersome 
bulge symptoms after surgery as any positive answer to any of the following two 
questions from the urogenital distress inventory: “Do you experience a sensation 
of bulging or protrusion from the vagina” and “Do you have a bulge or something 
protruding that you can see in the vagina?” in combination with a response “somewhat 
bothered” to “very much bothered” to the question “how much does this bother you?”. 
To assess sexual functioning, the 12-item pelvic organ prolapse/urinary incontinence 
sexual questionnaire was used [26]. Data were entered and registered using a web-
based application facilitated by the Isala.  
INTERVENTIONS
Women received perioperative antibiotics, thrombosis prophylaxis, a bladder catheter 
and postoperative analgesia according to local hospital protocols. LSH was performed 
Vaginal sacrospinous hysteropexy (SSHP) is the most studied technique for uterus 
suspension, its efficacy has been demonstrated in several RCTs [15-17]. However, 
laparoscopic sacrohysteropexy (LSH) has not been compared directly in a randomised 
trial against SSHP, although it seems to become increasingly popular [7,18]. Therefore, 
we tested the hypothesis that LSH is non-inferior to SSHP regarding surgical failure at 
12 months’ follow-up.
METHODS
STUDY DESIGN
The trial protocol of this study was previously published [19]. The study was approved by 
the ethics committee of the Isala Hospital (file number NL43801.075.13) and all additional 
centres, and was registered in the Dutch Trial Register (NTR4029). Briefly, all women 
with uterine prolapse at stage 2 or higher (uterine prolapse 1 cm above the hymen and 
beyond) and opting for surgical treatment were invited to participate. Women with 
coexisting anterior and/or posterior vaginal wall prolapse or concomitant incontinence 
surgery were also eligible. Exclusion criteria were previous pelvic floor or prolapse 
surgery, known cervical dysplasia/malignancy, language barriers, the wish to preserve 
fertility, presence of immunological or haematological disorders potentially interfering 
with postoperative recovery, contraindications for laparoscopic surgery (e.g. ileus, risk 
of severe adhesions), suspect findings of  uterus and/or ovaries on ultrasound causing 
symptoms and/or requiring surgical treatment, abnormal uterine bleeding requiring 
surgical treatment, postmenopausal bleeding in the past year and unwillingness to 
return for follow-up. Participants were randomly assigned to LSH or SSHP. 
Before enrolment, gynaecological examination was performed including pelvic 
ultrasound to exclude uterine or ovarian disease, a cervical smear test and vaginal 
inspection in 45o semi-upright position for staging uterovaginal prolapse using the 
pelvic organ prolapse quantification system (POP-Q) [20].
Five non-university teaching hospitals in the Netherlands and one university hospital in 
Belgium participated in this study. In order to standardize surgery, a detailed protocol 
was developed for both operations during a specific study masterclass in which all 
centres participated. All procedures were performed according to this standardized 
protocol using the same materials (e.g. sutures, mesh). To eliminate a learning curve 
effect, each surgeon should have performed at least 20 procedures of each prior to 
the recruitment of the first patient for this study. 
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recurrence risk of 3% in both groups and a two-sided α risk of 0.05, with two groups of 
55 women each, the trial had 80% power with a prespecified non-inferiority margin of 
10%. Considering a 10% loss to follow-up, we required 124 women, hence 62 in each 
study arm. 
Data were analysed primarily according an intention to treat (ITT) principle. However, 
a per protocol (PP) analysis was done as well. In case of missing data on anatomical 
outcome at 12 months, this was reported, and we applied the last observation carried 
forward (LOCF) strategy with data at the six-month follow-up if available. If these data 
were not available, data of 6 weeks follow-up was used. In case the six-week follow-
up was missing, we left the women out of the ITT-LOCF analysis. In case of missing 
questionnaires, we obtained information on the presence or absence of bothersome 
bulge symptoms from the 12-month follow-up visit. As sensitivity analysis we applied 
conservative imputation (worst-case scenario, failure) in which all patient lost to 
follow-up at the 12 months’ visit were regarded as having experienced a recurrence. 
The PP-analysis was performed on the primary and secondary outcomes for anatomical 
and surgical failure. This analysis included women who completed the entire treatment 
protocol as originally planned, with availability of the POP-Q scores at 12 months and 
absence of major deviations from the protocol. 
For exploratory purposes of the results, chi-square or Fisher’s exact test was used to 
compare proportions and a Mann-Whitney U test was used to compare continuous 
variables between the groups. A p-value of less than 0.05 was considered to be 
significant. In case of statistical significance, linear regression was used to assess 
confounding with baseline values. 
All statistical analyses were performed using SPSS for Windows (version 22.0.0.1). 
under general anaesthesia. For SSHP, patients received general or spinal anaesthesia, 
according to patient or physician’s preference. Participants were advised to abstain 
from heavy physical duties for six weeks. 
Vaginal SSHP – The posterior vaginal wall was incised and separated from the 
rectum. The right ischial spine was localized digitally. After retractor positioning, the 
sacrospinous ligament was exposed through blunt dissection. Under direct vision, 
two permanent sutures (Prolene 1/0, Ethicon Inc., Sommerville, NJ, USA) were placed 
through the right sacrospinous ligament at least 2 cm from the ischial spine. After 
placing the polypropylene sutures through the posterior aspect of the cervix, these 
were tightened to redress the uterus. Finally, the posterior vaginal wall was closed 
using absorbable sutures. Concomitant anterior or posterior colporrhaphy and anti-
incontinence surgery were performed if indicated. 
LSH – First a uterine manipulator (Clearview, Clinical Innovations LLC, Murray, UT, USA) 
was placed. After placing four laparoscopic ports (umbilical, suprapubic, two lateral 
ports) and creating a pneumoperitoneum, the peritoneum over the sacral promontory 
was incised. The broad ligament at the level of the cervico-uterine junction was 
opened. The vesico-uterine peritoneum was incised and the bladder dissected distally 
for 2-3 cm. The arms of a bifurcated polypropylene flat mesh (Gynemesh, Ethicon 
Inc., Sommerville, NJ, USA) were introduced bilaterally through windows created in 
the broad ligaments. Non-absorbable sutures were placed through the arms of the 
mesh and the anterior (2-3 sutures) and posterior (4 sutures) aspect of the cervix, 
respectively. The mesh was attached to the sacral promontory using three 5.3x3.7 
mm titanium staples (Endoscopic Multifeed Stapler-20, Ethicon Inc., Sommerville, NJ, 
USA). The peritoneum was then closed using a resorbable running suture (Vicryl 2.0, 
Ethicon Inc., Sommerville, NJ, USA). After removing the laparoscopic ports, the wounds 
were closed. If indicated, anterior and/or posterior vaginal wall repair was performed 
laparoscopically (by extended dissection) or vaginally afterwards (anterior and/or 
posterior colporrhaphy). Furthermore, anti-incontinence surgery was performed if 
necessary. 
    
STATISTICAL ANALYSIS
Sample size calculation was based on the primary outcome. We assumed a failure 
rate of 3% based on outcomes of SSHP in a previous prospective study [17]. The non-
inferiority margin was set at 10%. This means that when the upper limit of the 95% 
confidence interval (CI) for the estimated difference in recurrence rate after LSH versus 
SSHP exceeded 10%, LSH would be regarded as inferior to SSHP. Assuming an absolute 
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it was impossible to attach the mesh to the promontory due to extremely hard tissue. 
Consequently, a Manchester Fothergill procedure was performed. Finally, in one 
woman an endometrial polyp was removed during LSH. Histopathologic examination 
demonstrated endometrial carcinoma. Two months after surgery, a total laparoscopic 
hysterectomy was performed. Baseline characteristics and prolapse staging were 
comparable between groups (table 1).
In the SSHP group, there were significantly more additional anterior (SSHP: n=61, 98.4%; 
LSH: n=55, 85.9%, p 0.010), but not posterior vaginal wall repairs (SSHP: n=14, 22.6%; 
LSH: n=13, 20.3%).  In the SSHP group, all anterior vaginal wall repair was performed 
by anterior colporrhaphy, while in the LSH group the majority of the anterior repair 
was performed laparoscopically (n=44, 80%; vaginally n=11, 20%). When looking at 
posterior repair, women in the SSHP group underwent posterior colporrhaphy (n=12, 
86%) or perineorrhaphy (n=2, 14%).  In the LSH group, posterior repair was performed 
laparoscopically (n=5, 38%), by posterior colporraphy (n=5, 38%) or by perineorraphy 
(n=3, 23%). Three associated tension-free vaginal tapes were placed, two after LSH 
(3.1%) and one (1.6%) after SSHP . 
Table 2 presents the results on the primary outcome and the additional definitions of 
surgical failure. Regarding the primary outcome, LSH was non-inferior to SSHP: LSH 
1.6% (n=1) versus SSHP 3.3% (n=2), difference -1.7% (95% CI -7.1 to 3.7) for the ITT-LOCF 
approach. Non-inferiority of the LSH was also shown in the ITT- analysis with complete 
cases and the PP-analysis. The worst-case scenario did not lead to different conclusions. 
No difference was found in overall surgical failure, composite outcome of success and 
anatomical failure. Most anatomical failures occurred in the anterior compartment. 
Table 3 provides details on the functional outcomes. After LSH, significantly more 
bothersome symptoms of overactive bladder (OAB) were reported (UDI-score LSH: 11 
(interquartile range (IQR) 0-22); SSHP 0 (IQR 0-11), p=0.012). De novo OAB occurred 
in 2 women (4.0%) after LSH. However, 28% (14/50) of women after LSH who suffered 
already of OAB before surgery reported persistent OAB symptoms after surgery as 
compared to 13.5% (7/52) of women after SSHP. 
Significantly more bothersome symptoms of faecal incontinence following LSH were 
reported (DDI-score LSH: 0 (IQR 0-17); SSHP: 0 (IQR 0-0), p=0.017). Persistent faecal 
incontinence was reported in 3.4% (2/58) of women after SSHP, as compared to 10.2% 
(6/59) of women after LSH. De novo faecal incontinence was reported in 5 women 
(8.5%) after LSH compared to 4 women (6.9%) after SSHP. 
Randomized (n = 126)
Allocated to LSH (n = 64 )
  Received allocated intervention (n = 58)
  Did not receive allocated intervention (n = 6)
Received SSHP due to technical difficulties 
n = 5)
Received Manchester Fothergill due to 
technical difficulties (n = 1)
Lost to follow-up at 12 months (n = 11)
  Missing POP-Q score (n = 10)
  Missing questionnaires (n = 5)
Analysed  at baseline (n = 64)
Analysed for primary outcome intention to treat 
with complete cases (n = 53)*
Analysed for primary outcome intention to treat 
with last observation carried forward  (n = 64)
Analysed for primary outcome per protocol  
(n = 47) ‡
Allocated to SSHP (n = 62)
  Received allocated intervention (n = 62)
Lost to follow-up at 12 months (n = 4)
  Missing POP-Q score (n = 4)
  Missing questionnaires (n = 4)
Analysed at baseline (n = 62)
Analysed for primary outcome intention to treat 
with complete cases (n = 58)*
Analysed for primary outcome intention to treat 
with last observation carried forward (n = 61) †
Analysed for primary outcome per protocol  
(n = 58) ‡
ALLOCATION
FOLLOW-UP
ANALYSIS
FIGURE 1. Flow of women through the study. 
* Intention to treat complete cases: only patients with complete follow-up (e.g. POP-Q and questionnaire) 
were analyzed according to allocation.  Six patients allocated to LSH received a vaginal procedure and were 
analyzed in the laparoscopic group. 
† Intention to treat with last observation carried forward: missing data was imputed with data at the six months 
follow-up visit if available (n = 12) or, in case these data is also missing, data of 6 weeks follow-up visit (n = 2). 
In one patient allocated to the SSHP, no follow-up data was available.  
‡ Per protocol analysis: 6 patients did not received intended treatment. Excluded per protocol analysis: lost to 
follow-up at 12 months (n = 15) and major protocol deviations (n = 7). 
RESULTS
In total, 126 women were randomly assigned to LSH (n = 64) or SSHP (n = 62) between 
August 2013 and September 2016. Figure 1 displays the flowchart of this study. Seven 
protocol deviations occurred. Five women received SSHP instead of LSH (crossovers). 
Reasons for crossover were intra-abdominal adhesions making mesh placement 
difficult (n=2), excessive intra-abdominal fat tissue with impaired visualization of 
the promontory (n=1), an enlarged uterus reaching up to the promontory (n=1) and 
perforation of the vaginal wall during dissection (n=1). In one woman allocated to LSH, 
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Table 2. Outcomes for pelvic organ prolapse at 12 month follow-up. Values are numbers 
(percentages) of women unless states otherwise. 
Outcomes 
Laparoscopic 
sacrohysteropexy 
Vaginal sacrospinous 
hysteropexy Difference (95% CI) 
Primary outcome surgical failure*
ITT analysis with complete cases 1/54 (1.9%) 2/58 (3.4%) -1.6 (-7.5 to 4.3)
ITT analysis with LOCF 1/64 (1.6%) 2/61 (3.3%) -1.7 (-7.1 to 3.7)
Per protocol analysis 1/47 (2.1%) 2/58 (3.4%) -1.3 (-7.6 to 4.9)
Overall surgical failure†
ITT analysis with complete cases 39/57 (68.4%) 37/58 (63.8%) 4.6 (-12.7 to 21.9)
ITT analysis with LOCF 42/64 (65.6%) 38/61 (62.3%) 3.3 (-13.5 to 20.2)
Per protocol analysis 35/50 (70%) 37/58 (63.8%) 6.2 (-11.5 to 23.9)
Composite outcome success‡
ITT analysis with complete cases 44/55 (80.0%) 48/58 (82.8%) -2.8 (-17.1 to 11.6)
ITT analysis with LOCF 53/64 (82.8%) 51/61 (83.6%) -0.8 (-13.9 to 12.3)
Per protocol analysis 38/49 (77.6%) 48/58 (82.8%) -5.2 (-20.4 to 10.0)
Anatomical failure §
Overall anatomical failure 35/55 (63.6%) 36/58 (62.1%) 1.6 (-16.3 to 19.4)
Apical compartment 2/55 (3.6%) 2/58 (3.4%) 0.2 (-6.6 to 7.0)
Anterior compartment 28/55 (50.9%) 33/58 (56.9%) -6.0 (-24.3 to 12.4)
Posterior compartment 10/55 (18.2%) 4/58 (6.9%) 11.3 (-0.8 to 23.4)
Prolapse beyond hymen¶
Apical (POP-Q C >  0) 0/64 (0%) 1/61 (1.6%) -1.6 (-4.8 to 1.5)
Anterior (POP-Q Ba > 0) 6/64 (9.4%) 5/61 (8.2%) 1.2 (-8.7 to 11.1)
Posterior (POP-Q Bp > 0) 0/64 (0%) 0/61 (0%) n.a.
Repeat surgery¶
Overall repeat surgery 2/64 (3.1%) 3/61 (4.9%) -1.8 (-8.7 to 5.1)
Apical compartment 0/64 (0%) 2/61 (3.3%) -3.3 (-7.7 to 1.2)
Anterior compartment 2/64 (3.1%) 1/61 (1.6%) 1.5 (-3.1 to 1.6)
Posterior compartment 0/64 (0%) 0/61 (0%) n.a.
Primary surgery different site ** 0/64 (0%) 0/61 (0%) n.a.
Surgery for non-prolapsed conditions¶
Anti-incontinence 4/64 (6.3%) 2/61 (3.3%) 3.0 (-4.5 to 10.4)
Hysterectomy 1/64 (1.6%) 0/61 (0%) n.a. 
ITT = intention to treat; LOCF = last observation carried forward; POP-Q = pelvic organ prolapse quantification. 
Percentages were calculated using non-missing data. 
* Recurrent apical prolapse POP-Q ≥2 with bothersome symptoms or repeat surgery or pessary for 
apical prolapse
† Prolapse POP-Q stage ≥2 (any compartment) or repeat surgery or pessary use
‡ No prolapse beyond hymen (any compartment), absence of bothersome bulge symptoms, and no repeat 
surgery or pessary use
§ Prolapse POP-Q stage ≥  2
¶ ITT with LOCF
** Reoperation for pelvic organ prolapse in non-operated compartment
Table 1. Baseline characteristics and pelvic measurements of women. Values are numbers 
(percentages) unless stated otherwise.
Characteristics
Laparoscopic 
sacrohysteropexy (n = 64)
Vaginal sacrospinous 
hysteropexy (n = 62)
Mean (SD) age (years) 61.08 (9.8) 60.76 (10.7)
Mean (SD) body mass index (kg/m2) 26.6 (3.4) 26.6 (2.9)
Comorbidity: 
Cardiovascular disease 29 (45.3) 19 (30.6)
Respiratory disease 4 (6.3) 4 (6.5)
Diabetes Mellitus 3 (4.7) 4 (6.5)
Current smoker (self-reported) 5 (7.8) 7 (11.3)
Median (range) number of vaginal deliveries 2 (1-10) 2 (1-5)
Median (range) number of caesarean deliveries 0 (0-1) 0 (0-1)
POP-Q stage uterine prolapse (point C)*:
2 45 (70.3) 39 (62.9)
3 18 (28.1) 19 (30.6)
4 1 (1.6) 4 (6.5)
POP-Q stage 2-4:
Anterior prolapse (Ba ≥ -1) 59 (92.2) 56 (90.3)
Posterior  prolapse (Ba ≥ -1) 14 (22) 16 (25.8)
Prolapse beyond hymen: 
Apical (POP-Q C > 0) 30 (46.6) 28 (45.2)
Anterior (POP-Q Aa or Ba > 0) 51 (81) 45 (72.6)
Posterior (POP-Q Ap or Bp > 0) 2 (3.2) 3 (4.8)
Vaginal bulge symptoms:
Any 56/62 (90.3) 56/59 (94.9)
Bothersome 54/62 (87.1)† 56/59 (94.9)
POP-Q = pelvic organ prolapse quantification 
Percentages were calculated using non-missing data. All patients were analyzed as allocated. 
* System involves quantitative measurements of various points of vaginal wall with hymen as reference point. 
Degree of prolapse of anterior vaginal wall (Aa and Ba), posterior vaginal wall (Ap and Bp) and uterus (C) is 
measured in centimeters above or proximal to hymen (negative number) of beyond or distal to the hymen 
(positive number), with plane of hymen defined as zero. Point A represents the descent of a measurement point 3 
cm proximal to the hymen on the anterior (Aa) and posterior (Ap) vaginal wall. B is the most descended edge on 
the anterior (Ba) and posterior (Bp) vaginal wall. 
POP-Q stage 2: most distal prolapse is between 1 cm above and 1 cm beyond hymen;
POP-Q stage 3: most distal prolapse is > 1 cm beyond hymen, but no further than 2 cm less than total vaginal 
length;
POP-Q stage 4: total prolapse. 
† Not all women reported bothersome prolapse symptoms at baseline. The questionnaire was provided after 
women consented to participate, therefore amount of bother as reported at outpatient clinic could differ.
Quality of life and sexual functioning were not different. In the laparoscopic group, 
84% (42/50) of the women were sexually active as compared to 75.5% (40/53) in 
the vaginal group. Of the sexually active women, 13 out of 39 women (33.3%) of the 
SSHP group reported dyspareunia, which is almost three times as often compared 
to the laparoscopic group (5/37, 13.5%, p=0.042). De novo dyspareunia was found in 
respectively 5 women (13.2%, SSHP) and 3 women (8.1%, LSH, not significant).
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DISCUSSION
MAIN FINDINGS
LSH was non-inferior to SSHP for surgical failure in the middle compartment one 
year after surgery, both following ITT- and PP-analysis. There was no difference in 
anatomical and surgical failure in other compartments, neither in quality of life or 
sexual function. There were however more bothersome symptoms of OAB after 
LSH, which seems mostly due to persistence of preoperative OAB symptoms. These 
findings implicate that OAB symptoms seem to improve more after SSHP. Several 
studies suggest that OAB might be caused by the presence of a prolapse due to the 
loss of normal support of the bladder, which could interfere with bladder emptying 
and sensory urgency [27,28]. However, in this subgroup, we found no difference in 
anterior vaginal wall prolapse at 12 months’ follow-up. De novo OAB occurred solely 
after LSH, though in only 2 women. After laparoscopic sacrocolpopexy, de novo 
OAB seems to occur more often, with incidences varying between 2.5-11.3% [27,29]. 
The polypropylene-mesh implantation is associated with de novo OAB [30]. Mesh-
shortening (retraction) is thought to play a role. In our study, determination of mesh 
shortening was not evaluated. 
More bothersome faecal incontinence was reported after LSH compared to SSHP. 
It is suggested that extensive dissection between the posterior vagina and the 
rectum exacerbates or causes defecatory dysfunction due to damage of the inferior 
hypogastric nerve [31,32]. Furthermore, one of the causes of faecal incontinence is 
posterior compartment prolapse [33]. However, in this subgroup posterior vaginal wall 
prolapse was not observed. 
Dyspareunia was reported almost three times as often after SSHP compared to LSH. 
The vaginal surgical route might contribute to the high rate of dyspareunia after SSHP. 
Vaginal POP surgery may be accompanied by vaginal narrowing and scarring as well 
as damage of the vascularization and innervation of the vaginal wall, which can lead to 
sexual dysfunction including dyspareunia [34].
Anatomical failure of the anterior compartment was found in half of the women after 
both LSH and SSHP. This finding is in line with other studies regarding SSHP with 
incidences of anatomical failure in this compartment of 47% and 51% [15,17]. The risk 
for recurrent prolapse of the anterior vaginal wall after SSHP is thought to be related to 
the change in vaginal axis to a more posterior and horizontal position [35]. In our study 
however no difference in anatomical recurrence of anterior vaginal wall prolapse was 
One year after surgery, 86.2% (n=50) of the women were satisfied with the results 
of LSH, which is comparable with the satisfaction after SSHP (89.7%, n=52). In both 
groups, a large majority would recommend the surgery to someone else (LSH: n=50, 
87.7%; SSHP: n=52, 89.7%).
Table 3. Functional outcome and quality of life after laparoscopic sacrohysteropexy versus vaginal 
sacrospinous hysteropexy at 12 month follow-up. Values are medians (interquartile ranges) of 
domain scores unless stated otherwise
Before surgery 12 months after surgery
Domains LSH (n = 62) SSHP (n =  59) LSH (n = 59 ) SSHP (n = 58 ) P value* 
Urogenital distress inventory†: 
Overactive bladder 22 (6-44) 22 (11-47) 11 (0-22) 0 (0-11) 0.012
Urinary incontinence 25 (0-33) 17 (0-33) 17 (0-33) 0 (0-17) 0.057
Obstructive micturition 16 (0- 33) 33 (0-50) 0 (0-17) 0 (0-0) 0.188
Genital prolapse 58 (33-67) 67 (33-67) 0 (0-0) 0 (0-0) 0.251
Pain 17 (0-33) 33 (0-50) 0 (0-17) 0 (0-17) 0.691
Defecatory distress inventory†: 
Obstipation 0 (0-17) 0 (0-17) 0 (0-0) 0 (0-0) 0.779
Obstructive defecation 0 (0-17) 0 (0-8) 0 (0-8) 0 (0-8) 0.758
Pain 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0.123
Incontinence 0 (0-17) 0 (0-0) 0 (0-17) 0 (0-0) 0.017
Flatus 33(0-67) 33(0-33) 33 (0-33) 0 (0-33) 0.144
Incontinence impact questionnaire‡: 
Mobility 22 (6-39) 22 (0-44) 0 (0-17) 0 (0-11) 0.616
Physical 33 (0-33) 33 (0-33) 0 (0-0) 0 (0-0) 0.746
Social 0 (0-17) 0 (0-22) 0 (0-0) 0 (0-0) 0.740
Embarrassment 16(0-17) 0 (0-33) 0 (0-0) 0 (0-0) 0.862
Emotion 11(0-33) 11(0-33) 0 (0-11) 0 (0-0) 0.298
Short form-36 §: 
Physical functioning 70 (55-85) 70 (50- 85) 90 (78-95) 90(79-95) 0.434
Social functioning 88 (75-100) 88 (63-100) 100 (88-100) 100 (88-100) 0.512
Role limitations physical 75 (29-100) 75 (0-100) 100 (100-100) 100 (75-100) 0.776
Role limitations emotional 100 (83-100) 100 (92-100) 100 (100- 100) 100 (100-100) 0.857
Mental health 84 (68 - 88) 80 (68-92) 88 (76-92) 87 (76-96) 0.809
Vitality 65 (54-78) 70 (50-80) 75 (60 -80) 80 (69-90) 0.097
Bodily pain 78 (57-90) 78 (45-90) 90 (78-100) 100 (78-100) 0.629
General health perception 70 (60-80) 70 (54-81) 75 (60-90) 78 (64-90) 0.928
Health change 50 (25- 50) 50 (25-50) 75 (50-100) 75 (50-100) 0.693
PISQ-12¶ 35 (32-39) 35 (32-40) 39 (37-42) 39 (34-42) 0.252
LSH = laparoscopic sacrohysteropexy; VSH = vaginal sacrospinous hysteropexy
All patients were analyzed as allocated. 
* p value for exploratory purposes: Mann Whitney U test of LSH versus VSH
† 0 = no symptoms or not bothersome to 100 = most bothersome symptoms 
‡ 0 = best quality of life to 100 = worst quality of life
§ 0 =  worst quality of life to 100 = best quality of life 
¶ 0 = poorest sexual functioning, 48 = best sexual function
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versus 6%). Differences in sample size (37 versus 59) and subtle differences in surgical 
protocol might explain this finding. 
STRENGTHS AND LIMITATIONS 
Strengths of this study are the randomised multicentre design and the large sample size. 
Also, prior to first enrolment, all study centres participated in a masterclass, where both 
surgeries were discussed in detail and a standardized approach was demonstrated. The 
primary outcome was defined as prolapse of the apical compartment in combination 
with bothersome bulge symptoms or repeat surgery or pessary use for recurrent 
prolapse. It is known that treatment success varies widely depending on the definition 
of surgical success. However, definitions of treatment success that require patient 
reported outcome are more clinically relevant and meaningful to the patient than 
those that include anatomical criteria only [21].
We acknowledge some limitations. First, our findings are based on a short-term follow-
up. However, a recent cohort study demonstrated that the highest risk for undergoing 
repeat surgery for POP is within the first year [41]. Another limitation is the relatively 
high loss to follow-up in the laparoscopic group, with an eventual number of women 
with data available lower than what was required (<55 women).  Two women withdrew 
the informed consent due to intercurrent illness, and nine did not report at 12 months, 
hence observations at 6 months were used. At that time, no anatomical recurrence of 
the apical compartment was observed. 
INTERPRETATION
This study provides evidence that on the short-term LSH is as effective as SSHP for the 
treatment of uterine prolapse. The subtle differences in secondary outcomes may help 
in the process of shared-decision making and choose the optimal surgical route for 
a specific patient. Symptoms of OAB seem to improve more after SSHP as compared 
to LSH. Furthermore, persistent faecal incontinence was reported more frequent after 
LSH compared to SSHP. Since treatment options are limited and associated with side-
effects, faecal incontinence is a devastating outcome [42,43]. Dyspareunia occurred 
more frequently after SSHP.
There is a wide variation in LSH techniques on several key points such as level of 
dissection, mesh type and tension of the mesh [44]. This variation could play a role in 
both anatomical and functional results. Well-designed trials regarding the procedure 
are needed to provide evidence for the best surgical technique. 
found between SSHP and LSH. 
We found a relatively high crossover rate from LSH to SSHP. Nevertheless, all 
gynaecologists participated in this trial were fully trained in advanced laparoscopic 
urogynaecology procedures and performed LSH at a regular base prior to the start of 
this study. Reasons for crossover were adhesions, excessive intra-abdominal tissue, an 
enlarged uterus and perforation of the vaginal wall during dissection. 
Due to different definitions of the primary outcome and the usage of different 
questionnaires to analyse functional outcome and quality of life, it is difficult to make 
a comparison with other studies [21]. In addition, studies on the outcome of LSH are 
limited, typically pooling data with outcomes after the sacrocolpopexy (either for 
vault prolapse or concomitant (subtotal) hysterectomy), making it hard to separate 
outcomes.
There are however several RCTs that compare SSHP with vaginal hysterectomy [15,17]. 
In these, SSHP is as effective as vaginal hysterectomy for the treatment of uterine 
prolapse. Our findings are in line with those studies though we observed a higher 
overall surgical failure after SSHP at one-year follow-up (62.3% versus 51%) [15]. This 
might be caused by a higher incidence of prolapse of the anterior compartment 
in our study group (56.9% versus 47%), whereas the rates of concomitant anterior 
colporrhaphy were comparable (98.4% and 97%). This may be attributed to the large 
variation in surgical technique of anterior colporrhaphy, though other factors may 
play a role as well [36]. Compared to the RCT of Dietz et al. we found less anatomical 
recurrences of the apical compartment (3.4% versus 21%) after SSHP [17]. The latter 
number is rather high for SSHP [15,16,37]. In the RCT of Dietz et al, performed between 
2001 and 2005, SSHP was perhaps a relatively novel technique for those surgeons. The 
differences between anatomical recurrence might be explained by more experience 
nowadays. 
In a prospective study by Price et al, one surgical failure (2%) of the apical compartment 
was observed at 10-week follow-up, compared to 1.9% in our study [38]. In a 
prospective observational study 3 women (2%) required reoperation for apical support 
for symptomatic prolapse at a mean follow-up of 2.1 years [39]. In our study, no 
reoperation of the apical compartment was observed at a follow-up of 12 months, 
probably due to the shorter follow-up. Furthermore, our findings are mainly in line 
with a randomised study comparing LSH to vaginal hysterectomy [40]. However, we 
found lower reoperation rates of the apical compartment at one-year follow-up (0% 
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INTRODUCTION
Worldwide, vaginal hysterectomy (VH) with uterosacral suspension of the vaginal vault 
is the most important treatment for symptomatic uterovaginal prolapse [1]. However, a 
high proportion of women with prolapse symptoms prefer uterine preservation instead 
of hysterectomy [2,3].  As a consequence, these preserving procedures are becoming 
more popular [4,5]. Recent studies have demonstrated that suspension of the cervix to 
the sacrospinous ligament, the so called vaginal sacrospinous hysteropexy (SSHP), is 
as effective as the VH [6,7].
The risk for recurrent prolapse of the anterior vaginal wall after SSHP is often discussed 
with incidences ranging from 5.8 to 21.3% [8,9]. A recent randomized controlled trial 
comparing SSHP to VH demonstrated more anterior vaginal wall recurrences after 
SSHP (40% vs 36%), but more posterior vaginal wall recurrences after VH (18% vs 5%) 
[6]. As for anatomic recurrence after SSHP, the cervix generally remains well fixed to the 
sacrospinous ligament, but the weak point is supposed to be the anterior compartment 
[10].  It is hypothesized that the high rates of recurrence in the anterior vaginal wall 
after SSHP may be related to the previously incurred damage of muscular supports 
(e.g. levator ani muscle injury, reduced muscle strength), the change in vaginal axis to 
a more posterior and horizontal position or a combination of these two [9,11].
Imaging has become an important complementary tool in the assessment of pelvic 
floor disorders. Magnetic resonance imaging (MRI) can simultaneously evaluate all 
the compartments of the pelvic floor, and provide information about muscles and 
ligaments. Furthermore, dynamic MRI of the pelvic floor allows detailed functional 
evaluation of the pelvic floor [12].
Pelvic organ mobility is defined as the displacement of pelvic organs between rest and 
maximal straining. Studying pelvic organ mobility after surgery for uterine prolapse is 
of interest, because it can provide more insight in the cause of recurrence of anterior 
vaginal wall prolapse after SSHP. It is unknown how mechanical forces after pelvic 
organ prolapse (POP) surgery change and whether or not they contribute to this 
recurrence. Numerical simulation methods have been developed to analyse pelvic 
organ mobility and to evaluate the role of support structure on mobility in general 
and in case of POP, or it can be used to simulate surgery [13-15]. These methods 
might also help to reveal the distribution of mechanic forces on pelvic structures after 
surgery and compare these forces between surgical procedures. With patient-specific 
analysis and simulations the process of decision making in case of surgical intervention 
ABSTRACT 
INTRODUCTION
Pelvic organ mobility is defined as the displacement of pelvic organs between rest 
and maximal straining. We hypothesized that pelvic organ mobility after vaginal 
sacrospinous hysteropexy (SSHP) is increased as compared to other surgeries for 
uterine descent, which might contribute to the high occurrence of postoperative 
cystocele after this surgery. Pelvic organ mobility and the vaginal axes after SSHP are 
compared with other surgical procedures for uterine descent: vaginal hysterectomy 
with uterosacral suspension (VH) and laparoscopic sacrohysteropexy (LSH). 
METHODS
In this prospective pilot study, 15 women were included (5 of each procedure). Six 
months postoperative, POP-Q examination and dynamic MRI were performed and 
questionnaires were filled out regarding prolapse complaints. Pelvic organ mobility 
on MRI was defined as vertical displacement of pelvic organs at rest and maximal 
straining. The displacements and angles were measured using an image registration 
method. Furthermore, the angle of displacement of cervix/vaginal vault and vaginal 
axes were assessed. 
RESULTS
No anatomical recurrences of pelvic organ prolapse were found. No difference in 
pelvic organ mobility was demonstrated . After VH, a more posterior position of the 
upper vagina was found compared to SSHP and LSH. 
CONCLUSION
Based on these data, the higher recurrence risk in the anterior compartment after 
SSHP cannot be explained. Larger sample sizes, studying women with recurrence or 
de novo cystocele after SSHP or using an upright MRI scanner would be of interest 
to further assess the relation between pelvic organ mobility and the occurrence of 
anterior vaginal wall prolapse. 
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the sacral promontory was incised and the broad ligament at the level of the cervico-
uterine junction was opened bilaterally. The arms of a bifurcated polypropylene mesh 
were introduced in these windows of the broad ligament, the mesh was attached 
to the anterior and posterior side of the cervix using permanent sutures. Afterwards, 
the mesh was attached to the sacral promontory using titanium staples. Afterwards, 
additional anterior and/or posterior colporrhaphy was performed if indicated. 
Regarding VH, the vaginal wall around the cervix was circumcised and, after bowel 
and bladder dissection, the anterior and posterior peritoneum were opened. The 
uterosacral ligaments were ligated and transected. Next, the uterus was released in 
several steps using clamps and sutures. After removing the uterus, the peritoneum was 
closed with absorbable sutures. Vault suspension was performed by suspension of the 
uterosacral ligaments. Such suspension involves the attachment of the uterosacral 
ligaments to the vaginal vault, thereby restoring normal support to the apical 
compartment. Concomitant anterior or posterior vaginal wall repair were performed 
afterwards if indicated.
GYNECOLOGICAL EXAMINATION
All women underwent gynecological examination, which includes vaginal inspection 
in 45o semi-upright position for staging prolapse of the anterior, apical and posterior 
compartment using the Pelvic Organ Prolapse Quantification system (POP-Q) 
[16]. Maximum prolapse was demonstrated and identified by performing a Valsalva 
maneuver while each vaginal wall is individually exposed. 
QUESTIONNAIRES
To assess the presence and discomfort of prolapse symptoms, women were asked to fill 
out a validated questionnaire. This questionnaire covers quality of life (Short Form-36, 
EQ-5D), urogenital and defecation symptoms (UDI, DDI, IIQ) and sexual dysfunction 
(PISQ-12) [17-21]. Furthermore, the questionnaire contained several questions with 
respect to parity, mode of delivery and BMI. 
DYNAMIC MRI
All women underwent MRI in the supine position using a 1.5T MR scanner (Ingenia, 
Philips Healthcare, Best, the Netherlands) with an anterior coil centered low on the 
pelvis for better signal reception. Women were asked not to void their bladder one hour 
before examination, to ensure a moderate filled bladder. No intravenously administered 
contrast was used. Prior to the MRI, the rectum was filled with an aqueous gel (200 ml) 
with the patient in left lateral decubitus position, using a rectal catheter. Furthermore, 
could be improved. However, all these numerical methods have not been validated by 
quantitative measurements especially after POP surgery.
We hypothesized that, after SSHP, pelvic organ mobility of the cervix is decreased 
due to fixation of the cervix. Therefore, more pressure on the anterior vaginal wall 
occurs, resulting in an increase in pelvic organ mobility of the anterior vaginal wall. 
This might contribute to the occurrence of postoperative cystocele. In addition, 
vaginal axis and its change between rest and maximal straining is assessed, because 
this might contribute to the recurrence of anterior vaginal wall prolapse as well. 
In this study, the mobility of pelvic organs and the vaginal axis after vaginal SSHP are 
compared with VH with uterosacral suspension of the vaginal vault and laparoscopic 
sacrohysteropexy (LSH). 
MATERIALS AND METHODS
This prospective observational pilot study was performed in the Isala hospital (Zwolle, 
the Netherlands) from November 2014 to May 2017. After approval from the medical 
ethics committee, eligible women were asked to participate in this study. Three 
different surgical procedures for uterine descent were analyzed: vaginal sacrospinous 
hysteropexy (SSHP), laparoscopic sacrohysteropexy (LSH) and vaginal hysterectomy 
(VH). All women who recently underwent one of those procedures as a primary 
treatment for uterine descent were eligible to participate in this study. Exclusion criteria 
were factors that precludes MRI interpretation (e.g. prosthetic hip), contraindications 
for MRI (e.g. claustrophobia), patients with neurological disease affecting the pelvic 
floor or with previous pelvic floor surgery and patients who were not able to maintain 
Valsalva maneuver for at least 10 seconds (e.g. due to pulmonary problems). A total 
of 15 women were enrolled in this study (5 of each procedure). All women gave 
written informed consent. Six months after surgery, women underwent gynecological 
examination and dynamic MRI, and filled out validated questionnaires. 
 
SURGICAL TECHNIQUES
SSHP was carried out by fixing the posterior side of the cervix to the sacrospinous 
ligament using two permanent sutures (Prolene 1/0, Ethicon Inc, Sommerville, NJ, 
USA). The sutures were placed unilaterally to the right sacrospinous ligament at least 
2 cm from the ischial spine using a needle driver under direct visualization. Additional 
anterior or posterior vaginal wall repair was performed if indicated.LSH was performed 
using 4 laparoscopic ports (umbilical, suprapubic, 2 lateral ports). The peritoneum over 
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FIGURE 1. Assessing pelvic organ mobility using MRI. The white contours demonstrate the pelvic organs at rest. 
The blue contours illustrate the position of these organs during straining. Pelvic organ mobility is the difference 
between the position at rest and during straining (in mm) of these organs.
Three areas of the vagina were more particularly analyzed to compare mobility of each 
surgical procedures: anterior vagina (AV), posterior vagina (PV) and cervix/vaginal vault 
(figure 2). On each area, the mean vertical displacement was quantified in pixel (and 
converted in millimeters (mm)) by calculating the difference in position of these points 
in rest and during straining. Furthermore, the angle of displacement of the cervix/
vaginal vault was also assessed. 
       
FIGURE 2.  a) Areas to quantify pelvic organ mobility in sagittal plane. Anterior vaginal wall (AV), posterior vaginal 
wall (PV) and cervix/vaginal vault were assessed. b) Angle of displacement of cervix/vaginal vault in sagittal 
plane.
the vagina was filled with 30 ml aqueous gel.
Static MRI for anatomical reference was based on the acquisition of a multishot turbo 
spin echo (TSE) T2-weighted sequence in axial and sagittal planes [field-of-view (FOV) 
350×350 mm2, slice thickness 4 mm, slices 35, slice gap 0.4 mm, TR/TE 1846/100 ms, 
in plane resolution of 1.0× 1.0 mm2]. 
Dynamic MRI of the pelvis was performed using a single-shot balanced fast field echo 
sequence in the midsagittal and axial plane with a temporal resolution of 1.5 s (FOV 
230x230 mm2 and 325x252mm2), slice thickness 4 and 6 mm, TR/TE 4.8/2.3 ms, 66 
dynamics, in-plane resolution of 1.6×1.5 mm2 and 1.5x1.2 mm2). 
Images were obtained at rest and during maximal straining. Instructions were given by 
the technologist prior to each separate series. Average scanning time was 20 minutes, 
the total duration of the MRI examination was 35 minutes. 
ANALYSIS OF MR IMAGES
All MR images of the dynamic sequence were analyzed by one experienced researcher; 
measurements were done in a midsagittal plane. The researcher was not blinded to 
the surgical procedure. However, the researcher is a physician/engineer who was not 
involved in the subject-matter of this study and, as a result, could not influence the 
outcomes. 
Pelvic organ mobility was defined as the displacement of pelvic organs between rest 
and maximal straining. Displacement field was calculated by comparison of initial image 
at rest and images of the dynamic sequence during straining by an image registration 
method using Elastix Software. In medical applications, the Image Registration 
technique is commonly used to modify one image to correspond to another taken at 
a different time or in different conditions [22]. This technique consists in finding the 
spatial relation between position of pixels of the initial image (at rest) and the position 
of pixels in images taken during straining.  A detailed version of the protocol used for 
analyzing has been published previously [23]. This protocol was used to determine the 
displacement field on the contour of bladder, vagina and rectum as shown in figure 1. 
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FIGURE 3. Vertical displacement field in mm on contour of pelvic organs at different percentage of maximum 
straining (25%, 50%, 75% and 100%).
RESULTS
Baseline characteristics were similar between the groups (table 1) with a median time 
between surgery and MR imaging of 31 weeks (LSH and VH group) and 33 weeks (SSHP 
group). Furthermore, concomitant surgeries were comparable between the three groups. 
The number of sexually active women was higher in the LSH and VH group (n=4, 80%) 
as compared to the SSHP group (n=1, 33.3%). However, only three out of five women of 
the SSHP group filled out the questionnaire regarding sexual functioning. In all groups, 
no anatomical recurrences of pelvic organ prolapse were found. Postoperative POP-Q 
assessment was comparable between the groups (table 1).
Moreover, each patient is applying loading more or less progressively, to compare 
mobility at same time or level of straining, a progress of the straining has been defined 
as a percentage calculated in time of straining:
tmax – t0
t – t0%of strain =
Where % of strain is the percentage of progress of the loading time t before the 
maximum strain, t
0
 is the time of the beginning of the straining and t
max
 the time at 
maximum straining of the dynamic sequence. Figure 3 provides an example of the 
determination of pelvic organ mobility. In this sagittal plane, the organs are contoured 
at rest (in white) and during straining, the color bar corresponding to the displacement 
intensity on the contour of organs at 4 levels of straining. 
VAGINAL AXES
To compare vaginal axes at rest, the vagina was separated into three distinct regions: 
upper, middle and lower vagina [24,25]. The upper region was defined as a straight line 
drawn from the anterior to the posterior fornix or from the anterior to the posterior 
aspect of the vaginal cuff in case of hysterectomy. The anterior vaginal wall (from 
introitus to anterior vaginal fornix or vaginal cuff) was divided in half, the proximal 
portion was defined as middle vaginal region, the distal portion was defined as lower 
vaginal region. Straight lines were drawn to fit both of these regions. 
To correct for variations in pelvic inclination and to allow standardize measurements 
within the pelvis, the vaginal axis was measured as the angle between the vaginal axis 
and the pelvic inclination correction system (PICS line) [26]. This line is obtained by 
rotating a line from the inferior point of the pubic symphysis to the junction between 
the fifth lumbar vertebra and first sacral coccygeal bone (sacro-coccygeal inferior 
pubic point (SCIPP) line) by 34 degrees in a clockwise direction. For each vaginal 
region, vaginal axis was measured using this PICS line. 
STATISTICS
All statistical analyses were performed with SPSS for Windows (version 24.0.0.1). 
Because the small number of participants in each group, data was assumed not being 
normally distributed. Consequently, medians and interquartile ranges were used as 
measures of central tendency and dispersion, respectively. Comparisons of continuous 
variables between the three surgeries were calculated using Kruskal Wallis tests, or, 
in case of two groups, Mann Whitney-U tests. Categorical variables were compared 
using Chi-square tests. P-values below 0.05 were considered to be significant. 
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Table 2. Postoperative functional outcome and quality of life. Values are medians (interquartile 
range) unless stated otherwise.
Domains SSHP (n=5) LSH  (n=5) VH (n=5) p-value*
Urogenital distress inventory †: 
Overactive bladder 22 (0 – 44) 0 (0 – 17) 0 (0 – 22) 0.481
Urinary incontinence 33 (0 – 83) 0 (0 – 25) 17 (8 – 25) 0.449
Obstructive micturition 0 (0 – 17) 0 (0 – 0) 0 (0 – 33) 0.317
Genital prolapse 0 (0 – 8) 0 (0 – 8) 0 (0 – 8) 1.000
Pain 0 (0 – 17) 33 (8 – 50) 0 (0 – 8) 0.066
Defecatory distress inventory †: 
Obstipation 0 (0 – 25) 0 (0 – 0) 0 (0 – 25) 0.289
Obstructive defecation 0 (0 – 0) 0 (0 – 4) 0 (0 – 8) 0.311
Pain 0 (0 – 0) 17 (0 – 25) 0 (0 – 0) 0.031
Incontinence 0 (0 – 0) 0 (0 – 8) 0 (0 – 0) 0.368
Incontinence impact questionnaire ‡: 
Mobility 11 (0 – 33) 0 (0 – 22) 0 (0 – 28) 0.758
Physical 0 (0 – 33) 0 (0 – 0) 0 (0 – 8) 0.265
Social 0 (0 – 17) 0 (0 – 6) 0 (0 – 0) 0.581
Embarrassment 17 (0 – 33) 0 (0 – 0) 0 (0 – 0) 0.031
Emotion 0 (0 – 22) 0 (0 – 0) 0 (0 – 11) 0.311
Short form-36§: 
Physical functioning 95 (83 – 98) 90 (80 – 93) 85 (70 – 93) 0.392
Social functioning 100 (69 – 100) 100 (94 – 100) 100 (81 – 100) 0.677
Role limitations physical 100 (63 – 100) 100 (100 – 100) 100 (63 – 100) 0.362
Role limitations emotional 100 (50 – 100) 100 (100 – 100) 100 (50 – 100) 0.584
Mental health 88 (62 – 88) 92 (82 – 92) 84 (72 – 92) 0.560
Vitality 75 (55 – 90) 80 (75 – 83) 70 (33 – 75) 0.204
Bodily pain 100 (72 – 100) 90 (68 – 95) 90 (56 – 100) 0.746
General health perception 85 (70 – 88) 80 (48 – 88) 65 (60 – 83) 0.571
Health change 100 (38 – 100) 75 (50 – 88) 50 (50 – 100) 0.903
* p value using Kruskal-Wallis 
SSHP = vaginal sacrospinous hysteropexy, LSH  = laparoscopic sacrohysteropexy, VH = vaginal hysterectomy
† 0 = no symptoms or not bothersome to 100 = most bothersome symptoms
‡ 0 = best quality of life to 100 = worst quality of life
§ 0 = worst quality of life to 100 = best quality of life
Table 3 demonstrates the mean displacement of the anterior vaginal wall, the posterior 
vaginal wall and the cervix/vaginal vault during straining for each surgical procedure. 
Furthermore, the angle of displacement of the cervix/vaginal vault during straining is 
displayed in this table. Pelvic organ mobility was not significantly different between the 
three groups. In addition, no difference was found in the angle of displacement of the 
cervix/vaginal vault during straining between the three groups. Figure 4 illustrates the 
range of the pelvic organ mobility between groups. The largest dispersion was found 
in the VH group. 
Table 1. Characteristics of women. Values are numbers (percentages) unless stated otherwise.
Characteristics SSHP (n=5) LSH (n=5) VH (n=5) p-value*
Median  (IQR) age (years) 62 (57-68) 68 (48-70) 57 (50-68) 0.690
Median (IQR) body mass index 25.7 (23.5-27.5) 24.5 (21.4-27.7) 25.5 (24.3-28.8) 0.482
Median (IQR) parity 3 (2-6) 3 (2-6) 3 (2-4) 0.815
Concomitant surgery
Anterior colporrhaphy 4 (80) 3 (60) 5 (100) 0.287
Posterior colporrhaphy 1 (20) 1 (20) 2 (40) 0.711
Median time (IQR) between surgery 
and MRI (weeks)
33 (31-39) 31 (27-44) 31 (28-34) 0.606
Sexual active 1 (33.3) 4 (80) 4 (80) 0.307
Preoperative POP-Q assessment (mean (SD))
Aa 0.8 (2.4) -0.2 (0.4) -0.2 (0.8)
Ba 1.0 (2.3) 1.2 (1.3) 1.4 (0.9)
C -0.4 (3.4) 0.6 (0.5) 0.0 (2.2)
gh 3.4 (0.5) 4.2 (0.8) 4.6 (0.5)
pb 3 (1.4) 3.2 (1.1) 3.2 (0.4)
TVL 9.2 (0.8) 9.2 (0.4) 9.3 (1.0)
Ap -1.6 (1.5) -2.6 (0.5) -2.6 (0.5)
Bp -1.8 (1.6) -2.6 (0.5) -2.4 (0.9)
D -4.2 (3.6) -5 (2.1) -7.5 (0.6)
Postoperative POP-Q assessment (mean (SD))
Aa -2.2 (1.1) -2.2 (1.1) -1.8 (0.8) 0.724
Ba -3.0 (0) -2.4 (0.9) -2.8 (0.4) 0.291
C -8.4 (0.5) -8.0 (0.7) -8.6 (0.5) 0.330
gh 3.6 (0.5) 3.8 (0.4) 4.0 (0.7) 0.565
pb 3.4 (0.5) 3.2 (0.4) 3.0 (0.7) 0.565
TVL 10.0 (0) 10.0 (0.7) 9.4 (1.1) 0.418
Ap -1.6 (2.6) -2.8 (0.4) -2.8 (0.4) 0.638
Bp -2.8 (0.4) -2.8 (0.4) -2.8 (0.4) 1.000
D -8.6 (0.9) -8.6 (0.9) N.A. 1.000
Numbers were calculated using non-missing data. 
SSHP = vaginal sacrospinous hysteropexy, LSH = laparoscopic sacrohysteropexy, VH = vaginal hysterectomy, 
IQR = interquartile range. POP-Q = pelvic organ prolapse quantification system, SD  = standard deviation
* p value using Chi-square test or Kruskal-Wallis as appropriate
In table 2, the postoperative prolapse complaints (assessed with UDI, DDI and IIQ) and 
health-related quality of life (SF-36) are showed. After LSH, more women reported 
bothersome pain during defecation as compared to SSHP and VH. Women of the 
SSHP group scored significantly higher on the item “embarrassment due to urinary 
incontinence and/or prolapse and/or defecatory problems” of the IIQ. No other 
significant differences between the groups were found regarding prolapse complaints 
6 months after prolapse surgery. Furthermore, health-related quality of life was 
comparable between all groups. 
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FIGURE 4. Mean vertical displacement (mm) in anterior vaginal wall (AV), posterior vaginal wall (PV) and 
cervix/vaginal vault (C/VV) assessed with MRI 6 months after vaginal sacrospinous hysteropexy (SSHP), vaginal 
hysterectomy (VH) and laparoscopic sacrohysteropexy (LSH). 
FIGURE 5. Vaginal axes after POP surgery. LSH = laparoscopic sacrohysteropexy, SSHP = sacrospinous 
hysteropexy, VH  = vaginal hysterectomy, SCIPP = sacro-coccygeal inferior pubic point, PCIS = pelvic 
inclination correction system
DISCUSSION
In the present study, dynamic MRI 6 months after SSHP demonstrated no difference 
in pelvic organ mobility of the anterior vaginal wall, neither in the posterior vaginal 
wall and cervix/vaginal vault as compared to LSH and VH. Furthermore, the angle of 
displacement of the cervix/vaginal vault was comparable between the three groups 
and no significant difference was found in the vaginal axes after SSHP as compared 
to LSH and VH. Based on these data, no explanation for the higher recurrence rate of 
cystocele after SSHP was found.
Table 3. Pelvic organ mobility: displacement per area (mm). Values are medians (interquartile 
range).
Characteristics SSHP (n=5) LSH (n=5) VH (n=5) p-value*
Anterior vaginal wall
25% of max straining 11.1 (10.0 – 21.8) 16.8 (15.4 – 23.7) 22.1 (1.3 – 27.9) 0.566
50% of max straining 21.0 (15.6 – 28.8) 22.6 (17.6 – 29.1) 18.7 (8.5 – 31.0) 0.914
75% of max straining 24.9 (16.5 – 30.7) 23.9 (15.9 – 32.1) 25.5 (9.6 – 34.9) 0.932
100% of max straining 23.9 (19.7 – 33.5) 20.5 (16.8 – 31.6) 20.6 (13.5 – 35.2) 0.677
Posterior vaginal wall 
25% of max straining 14.1 (11.8 – 24.1) 21.1 (19.0 – 25.5) 23.6 (2.0 – 30.8) 0.566
50% of max straining 24.4 (18.1 – 30.2) 27.9 (21.7 – 31.9) 20.5 (10.3 – 34.4) 0.677
75% of max straining 24.7 (18.9 – 35.2) 29.7 (20.3 – 34.5) 26.0 (11.8 – 37.1) 0.878
100% of max straining 22.7 (16.4 – 35.2) 23.6 (21.1 – 33.3) 22.7 (16.4 -  35.2) 0.651
Cervix/vaginal vault
25% of max straining 10.6 (9.5 – 23.5) 17.1 (10.9 – 21.0) 18.2 (1.3 – 30.7) 0.914
50% of max straining 18.5 (13.2 – 28.7) 21.3 (14.2 – 29.0) 17.1 (8.0 – 34.1) 0.852
75% of max straining 18.4 (13.7 – 28.6) 18.9 (13.9 – 31.8) 21.5 (9.0 – 38.7) 0.932
100% of max straining 17.8 (16.1 – 34.8) 18.2 (11.3 – 34.8) 19.5 (11.2 – 38.4) 0.961
Cervix/vaginal vault: angle of displacement (degrees)
25% of max straining 29.5 (22.1 – 36.6) 32.8 (12.5 – 47.2) 16.0 (-26.3 – 45.1) 0.698
50% of max straining 25.3 (22.0 – 28.2) 25.7 (8.7 – 44.9) 33.1 (12.2 – 38.9) 0.878
75% of max straining 26.2 (20.1 – 30.2) 29.2 (7.8 – 47.6) 31.7 (20.1 – 37.8) 0.651
100% of max straining 23.7 (18.8 – 28.5) 30.6 (11.3 – 53.8) 31.1 (17.7 – 36.3) 0.403
Vaginal axes (degrees)
Upper vaginal axis† 36.3 (26.0-50.7) 43.3 (35.2-60.9) 13.7 (11.6-29.9) 0.042
Middle vaginal axis† 102.8 (85.8-123.9) 116.5 (98.8-129.9) 98.6 (87.6-102.7) 0.237
Lower vaginal axis† 116.4 (109-124.9) 106.8 (97.7-113.1) 108.3 (105.8-116.9) 0.151
Upper-middle vaginal axis 120.7 (97-126.4) 110 (89.5-134.2) 115.4 (89.6-126.3) 0.878
Middle-lower vaginal axis 165.7 (152.8-183.4) 197.9 (173.3-207.8) 153.7 (146.7-173) 0.057
* p value using Kruskal-Wallis test
† angle in degrees between the vaginal region and the pelvic inclination system (PCIS) line 
SSHP = vaginal sacrospinous hysteropexy, LSH  = laparoscopic sacrohysteropexy, VH = vaginal hysterectomy
After VH, the vaginal axis of the upper vaginal region was significantly inferior as 
compared to SSHP and LSH (median 13.7 degrees, compared to resp. 36.3 and 43.3, p 
0.042, table 3). After VH, the upper part of the vagina seems to be more posterior as 
compared to LSH and SSHP (figure 5). Regarding middle and lower vaginal region, no 
difference between procedures was found in vaginal axes. 
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are different in these women compared to our study group. All measurements were 
done in the midsagittal plane. The vaginal axis, especially in case of SSHP, might point 
to the right side what is not reflected by midsagittal measurements. Lacking of the 
3D-aspect of the vaginal axis could be considered a weakness of this study. To evaluate 
pelvic organ mobility, patients were instructed to put strain of their pelvic floor by 
performing a Valsalva maneuver. However, the effect of Valsalva on the extent of POP 
(and thus pelvic organ mobility) is dependent on the instructions by the physician and 
the knowledge and the ability of the patients to relax (strain) their pelvic floor muscles 
[29]. In addition, repeating the Valsalva maneuver increases the induced maximal strain. 
Interpreting pelvic organ mobility using this method could be subjective. Literature 
suggests that upright MRI scanning both at rest and maximal straining shows a larger 
extent of the prolapse than that observed during supine straining [30]. At time of this 
study, an upright MRI scanner was not available in our clinic. However, it would be 
interesting to assess pelvic organ mobility using an upright MRI scanner. 
In conclusion, we found no difference in pelvic organ mobility after SSHP as compared 
to other POP operations. Based on these data, we cannot explain the higher recurrence 
risk in the anterior compartment after SSHP. This might be due to the small sample size 
of this pilot study. It will be interesting to evaluate pelvic organ mobility after SSHP 
in a larger sample size and in women who have recurrence or de novo cystocele 
to further assess the relation between pelvic organ mobility and the occurrence of 
anterior vaginal wall prolapse. Furthermore, assessing pelvic organ mobility using an 
upright MRI scanner could provide additional insights.  
Little is known about pelvic organ mobility after prolapse surgery. To the best of our 
knowledge, this is the first study to compare pelvic organ mobility after hysteropexy 
and hysterectomy.  One prospective clinical trial compared preoperative pelvic organ 
mobility to postoperative pelvic organ mobility in women who underwent anterior 
and/or posterior mesh-repair surgery [27]. In this study, pelvic organ mobility improved 
significantly after surgery. 
Vaginal configuration after POP surgery has been described in several studies. After 
attaching the post-hysterectomy vaginal vault to the sacrospinous ligaments, static 
magnetic resonance images demonstrate a distortion of the vaginal anatomy by 
pulling the upper vaginal plane superiorly and at times anteriorly [24,28]. This finding is 
contrary to the common belief that the vagina is pulled posteriorly by a sacrospinous 
fixation. A possible explanation may be that the vaginal vault is normally situated below 
the level of the ischial spines and sacrospinous ligaments, but suspension to these 
ligaments would pull the vagina superiorly resulting in a “straining” effect in the sagittal 
plane [28]. These findings are mainly in line with our study results. After SSHP, we 
found the vagina to be pulled more superior as compared to VH, but vaginal axis 
after SSHP was comparable to LSH. A retrospective cohort study assessed vaginal 
axes using dynamic MRI in women after hysterectomy as compared to women with a 
uterus in place [25]. After hysterectomy, the middle vaginal axis was positioned more 
anteriorly as compared to the middle vaginal axis with a uterus in place. Furthermore, 
the angles between upper-middle vagina and between middle-lower vagina were 
more obtuse in women after hysterectomy, suggesting straightening of the vaginal 
axis. These findings are not in line with our study. After VH, we found a more posterior 
position of the upper vagina as compared to SSHP and LSH, with no differences of the 
middle and lower vaginal region.  A possible explanation for this difference might be 
in the fact that in the latter study hysterectomy was performed for various conditions, 
whereas in our study only women after POP treatment were included. 
This study has several strengths and limitations. The strength of this report is that this 
is the first study to compare anatomical and functional results of SSHP, LSH and VH 
by MRI measurement including dynamic evaluation. Furthermore, MR images were 
analyzed by one experienced researcher, with no risk of inter-observer variability. In 
addition, images were obtained by a standardized protocol. 
A limitation of this study is the small sample size. In this pilot study only 15 women were 
included in total (5 of each group). Furthermore, we did not investigate recurrences of 
POP in this study. It is unclear whether or not angle of displacement and vaginal axes 
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1938, in some school districts in the UK more than half of the children had undergone 
tonsillectomies by age of 18, as compared with fewer than 10% in other districts, even 
though only 7 miles separated [2]. In the last decades, several studies have documented 
wide regional variation in the rates of numerous other surgical procedures, e.g. surgery 
for hip, knee and spine, coronary bypass surgery and prostatectomy [4,5]. Furthermore, 
geographical variation in hysterectomy rates and surgical routes for hysterectomy 
(vaginal/abdominal) for benign diseases was observed in The Netherlands [5]. 
Little is known on practice pattern variation of POP. In the United States, a variation 
in the current practice of colpocleisis was found, likely because of lack of long-term 
prospective studies [6]. Furthermore, a variable surgical policy in case of uterine 
descent was found in the Netherlands and the United Kingdom [7,8].  
Several factors contributing to PPV have been described. First, variation in patient 
characteristics and demand for surgery might contribute to PPV [4]. Some regions 
might have a higher rate of surgical procedures because of greater demand for 
surgery. Second, the preference of the patient can contribute to PPV [4]. For some 
clinical conditions, the decision to intervene should depend as much on patient 
preferences as on scientific evidence. Third, scientific uncertainty contributes to 
PPV [3]. In the evidence of professional consensus and evidence-based guidelines, 
individual or small groups of physicians can hold on their own clinical rules of defining 
which patient needs surgery. This might result in the “surgical signature” of a region: 
rates for specific surgical procedures that are peculiar to a region sometimes differ 
substantially between surrounding regions [3,9]. Last, surgical innovations and new 
technologies can pronounce PPV by increasing the number of therapeutic alternatives 
available to clinicians [4]. 
PPV is considered to be a great problem in controlling medical costs. Furthermore, 
PPV in the ratio between conservative and surgical management of POP might imply 
over- and undertreatment. In case of overtreatment, the patient is exposed to the 
unnecessary risks of surgery. However, in case of undertreatment, the patient might 
not receive adequate treatment. Since a gold standard for treating POP is still a matter 
of debate, the main question arises what the optimal ratio is between conservative 
and surgical management. As a result, it is difficult to conclude whether or not we 
observed over- or undertreatment.
To reduce PPV in POP, studies with respect to conservative versus surgical treatment, 
and randomized controlled trials between different types of surgery are needed to 
This thesis focuses on the surgical management of uterine prolapse with emphasis 
on surgical procedures for hysteropexy. We aimed to answer the following questions: 
do women prefer uterus preservation or hysterectomy in case of uterine prolapse? 
How do Dutch gynaecologists treat pelvic organ prolapse (POP) and which type of 
hysteropexy should be done in case of uterine descent? 
HOW DO DUTCH GYNAECOLOGISTS TREAT POP?
The choice for surgical treatment for POP mainly depends on the prolapse severity, 
symptoms, the general health of the woman, and the preference and capabilities of 
the surgeon [1]. Practice pattern variation (PPV) is defined as the difference in care that 
cannot be explained by the underlying medical condition. We calculated PPV for POP 
and urinary incontinence (UI) in the Netherlands using data of health declaration codes 
(CHAPTER 2). In our small country, we found a high PPV in surgical management of 
POP and UI with respect to choose for surgical treatment and the type of surgery. 
Surgical treatment regarding uterine descent varies per hospital: non-teaching 
hospitals performed significantly more hysterectomies in relation to uterus-preserving 
techniques compared with teaching and university hospitals. Furthermore, the ratio 
between conservative and surgical management of POP and UI varies per hospital. As 
a consequence, a patient’s odds of undergoing surgery for POP or UI seems to depend 
more on where the patient lives and to which hospital she is referred than on clinical 
circumstances. 
In addition to practice pattern variation on POP and UI in general, we have studied 
practice variation on laparoscopic sacrohysteropexy and sacrocolpopexy in specific. 
In the Netherlands, a standardized approach or published guideline for these 
procedures is lacking. We performed a nationwide survey to assess variation among 
Dutch gynaecologist in executing laparoscopic sacrohysteropexy and laparoscopic 
sacrocolpopexy (CHAPTER 3). In the Netherlands these laparoscopic operations are 
performed only by a selected group of gynaecologists. Nevertheless, we found great 
variations in operative technique for these procedures. Variation was found in several 
important aspects of the surgery, such as level of dissection along the anterior and 
posterior vaginal wall, the type of mesh used, the type of sutures used, the tension of 
the implanted mesh, and reperitonealisation of the mesh. 
DISCUSSION ON PRACTICE PATTERN VARIATION OF POP
Regional variation in the use of surgical procedures has long been recognized. In 
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cystoscopy afterwards). However, in some keypoints of the procedure, standardization 
could be realizable and beneficial.  
Regarding laparoscopic sacrohysteropexy and laparoscopic sacrocolpopexy, in our 
opinion these keypoints are: 
- Extent of dissection
- Attachment of the mesh to the cervix or vaginal vault (anterior and/or posterior) 
- Type of sutures to be used for attachment of the mesh
It is unknown to what level these keypoints contribute to the surgical outcome. 
Furthermore, conducting a guideline is complex as there is no evidence in the specific 
parts of the procedure. First, well-designed prospective studies or randomized 
controlled trials with regard to the specific parts of laparoscopic sacrohysteropexy 
and sacrocolpopexy are needed to provide evidence for the best surgical technique. 
WHAT DO WOMEN WANT? 
We studied Dutch women’s attitudes and preferences regarding surgical management 
of uterine prolapse in a cross-sectional study using a questionnaire (CHAPTER 4). In 
case functional and anatomical outcomes after hysterectomy and uterus preserving 
surgery were equal, more women expressed preference for uterus preservation (43%) 
over hysterectomy (27%).  The majority of women expected a similar improvement in 
sexuality and body image after both treatment modalities. Most common reasons to 
choose for hysterectomy were menstrual disorders, the believe that the uterus has 
become unnecessary and to avoid future problems. Reasons for uterus preservation 
were a less invasive procedure, the wish to stay as complete as possible and not 
removing a healthy organ. Treatment success, risk for urinary incontinence after 
surgery and complication risk were the most important factors when choosing a type 
of surgical intervention. The future risk of endometrial cancer was for the majority of 
women not a reason to choose for hysterectomy. 
DISCUSSION ON PATIENT PREFERENCES 
Our study results are in line with two preference studies conducted in the USA, Germany 
and Russia [18-20]. 
Several studies determined patients’ expectations regarding POP surgery. Physical 
improvement and symptom release are thought to be the most important factor to 
establish evidence-based guidelines to prevent over- and undertreatment in the future. 
Furthermore, shared decision making (SDM) might be an important tool in reducing 
PPV. Differences in the extent of which doctors incorporate preferences of the 
individual patient into treatment decisions might be an important factor underlying 
regional variation in surgery rates [4]. The concept of SDM is particularly relevant for 
preference-sensitive decisions, when two or more options are medically appropriate 
and the best choice for the individual patient depends on their own assessment of 
relative importance of different characteristics and outcomes [10]. Therefore, SDM can 
be perfectly applied in POP.
Patient decision aids are frequently used to support SDM. These tools provide patients 
with detailed information of the risks and benefits of different treatments for specific 
conditions. It can be delivered across various media formats, including mobile 
device applications, printed leaflets and interactive computer programs [11]. In the 
Netherlands, to our knowledge, no decision aid regarding treatment of POP has been 
developed so far. No studies have assessed whether decision aids reduce variation in 
procedure rates but several trials have shown significant decreases in overall surgery 
rates following their implementation [12-14]. Randomised controlled trials like the 
LAVA trial could not only help to establish evidence-based guidelines, but also help to 
develop a decision tool for SDM to reduce PPV. 
DISCUSSION ON VARIATION OF SURGICAL TECHNIQUE
Several studies have demonstrated variation among surgeons in surgical technique 
of POP procedures. Considerable variation was found among UK-based surgeons 
in both native and mesh-augmented POP repairs [15]. In the Netherlands a variation 
has been found among Dutch gynaecologists in performing anterior colporrhaphy 
[16]. Furthermore, an international survey among members of the International 
Urogynaecology Association (IUGA) demonstrated variation in anterior and posterior 
vaginal wall repair [17]. 
The great variations in surgical technique may be a consequence of the lack of evidence 
as to what the best practice is. Furthermore, different techniques could affect surgical 
outcomes. To monitor the outcome and long-term complications of (laparoscopic) 
POP repair, consensus on how to perform these procedures seems mandatory. It 
may not be possible to achieve complete standardization of the surgical procedures, 
as some points depend on the preference of the gynaecologists. In addition, it can 
be discussed whether or not complete standardization would be relevant, as some 
variables probably do not contribute to the surgical outcome (e.g. trocar placement, 
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with bothersome symptoms or repeat surgery or pessary use compared to vaginal 
sacrospinous hysteropexy. Furthermore, quality of life did not differ between the 
surgeries. However, more bothersome symptoms of overactive bladder and faecal 
incontinence were reported after laparoscopic sacrohysteropexy. Dyspareunia was 
more frequently reported after vaginal sacrospinous hysteropexy.
DISCUSSION ON THE LAVA TRIAL
The LAVA trial is the first randomized controlled trial comparing two techniques 
for hysteropexy. The study demonstrated non-inferiority to vaginal sacrospinous 
hysteropexy for surgical failure in the apical compartment. Furthermore, no differences 
were found in anatomical and surgical failure in other compartments, neither in sexual 
functioning and quality of life. Our findings are mainly in line with data of several studies 
of vaginal sacrospinous hysteropexy versus vaginal hysterectomy and laparoscopic 
sacrohysteropexy versus vaginal hysterectomy. 
When looking at the vaginal sacrospinous hysteropexy, we observed a higher overall 
surgical failure after this procedure at one-year follow-up as compared to the SAVE U 
trial (62.3% versus 51%) [27]. This might be caused by a higher incidence of prolapse 
of the anterior compartment in our study group (56.9% versus 47%), whereas the rates 
of concomitant anterior colporrhaphy were comparable (98.4% and 97%). This finding 
may be attributed to the large variation in surgical technique of anterior colporrhaphy, 
which might lead to different surgical outcomes [16]. Compared to the randomized 
controlled trial of Dietz et al. we found less anatomical recurrences of the apical 
compartment (3.4% versus 21%) after vaginal sacrospinous hysteropexy [29]. In the 
randomized controlled trial of Dietz et al, which was performed between 2004 and 
2006, vaginal sacrospinous hysteropexy was perhaps a relatively novel technique. The 
differences between anatomical recurrence might be explained by more experience 
nowadays and improvement in surgical skills.
Regarding laparoscopic sacrohysteropexy, our findings are mainly in line with other 
prospective studies and RCTs. In a prospective study by Price et al, one surgical failure 
(2%) of the apical compartment was observed at 10-week follow-up, compared to 
1.9% in our study [31]. In a prospective observational study 3 women (2%) required 
reoperation for apical support for symptomatic prolapse at a mean follow-up of 2.1 
years [32]. In our study, no reoperation of the apical compartment was observed 
at a follow-up of 12 months, probably due to the shorter follow-up. Furthermore, 
our findings are mainly in line with a randomised study comparing laparoscopic 
sacrohysteropexy to vaginal hysterectomy [33]. However, we found lower reoperation 
consider surgery a success, along with restoration of “normality” [21,22]. The majority of 
patients that are scheduled for POP surgery fear de novo symptoms, particularly urinary 
incontinence [22]. In our study, we have stated that hysterectomy might be more often 
associated with urinary incontinence. Unfortunately, no counter-factual statements 
were used providing advantages of hysterectomy over uterine preservation. 
It is generally accepted that the uterus plays a passive role in the development of 
POP [23]. As a result, hysterectomy may not be necessary, to correct the underlying 
defect in the apical vaginal support structures. Incorporating patient preferences and 
expectations of POP surgery when choosing a surgical intervention is of importance to 
choose the best surgical option for the specific patient. Since the majority of women 
prefer uterine preservation, uterine sparing surgical options should be assessed and 
considered in the surgical decision-making process. 
 
HOW SHOULD UTERINE PROLAPSE BE TREATED?
Traditionally, uterine prolapse was treated by vaginal hysterectomy and suspension of 
the vaginal vault. However, the uterus is not the cause but only a passive structure in 
the development of prolapse [23] and more women express a preference for uterus 
preservation [18-20,24]. Several studies have demonstrated that uterine suspension 
is as effective and safe as prolapse surgery including vaginal hysterectomy [25,26]. 
To suspend the uterus laparoscopic, robotic, abdominal and vaginal procedures have 
been described. To date, no randomized controlled trials are available to compare 
these different routes. As a result, whether or not these operations have comparable 
anatomical and functional outcomes remains unclear.
Vaginal sacrospinous hysteropexy is the most studied technique for uterus suspension, 
its efficacy has been demonstrated in several RCT’S [27-29]. Although, laparoscopic 
sacrohysteropexy seems to become increasingly popular [8,30] laparoscopic 
sacrohysteropexy has not been compared directly in a randomized trial against 
vaginal sacrospinous hysteropexy. Therefore, we initiated the LAVA-trial (LAparoscopic 
sacrohysteropexy versus VAginal sacrospinous hysteropexy in treatment of uterine 
prolapse) in 2013 (CHAPTER 5 AND 6). Women with uterine prolapse stage two or 
higher without previous prolapse surgery were randomized between laparoscopic 
sacrohysteropexy and vaginal sacrospinous hysteropexy. Main findings were that after 
a follow-up of 12 months, laparoscopic sacrohysteropexy was non-inferior to vaginal 
sacrospinous hysteropexy regarding anatomical recurrence in the apical compartment 
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PELVIC ORGAN MOBILITY AND VAGINAL AXES AFTER POP SURGERY
The risk of recurrent prolapse of the anterior vaginal wall after vaginal sacrospinous 
hysteropexy is often discussed with incidences ranging from 5.8-21.3% [38,39]. We 
hypothesized that pelvic organ mobility, which is defined as the displacement of pelvic 
organs between rest and maximal straining, after vaginal sacrospinous hysteropexy 
is increased, which might contribute to the high occurrence of postoperative 
cystocele after this surgery. Pelvic organ mobility and the vaginal axes after vaginal 
sacrospinous hysteropexy were assessed by dynamic magnetic resonance imaging 
and compared with vaginal hysterectomy with uterosacral vault suspension and 
laparoscopic sacrohysteropexy (CHAPTER 7).  We found no differences in pelvic organ 
mobility 6 months after vaginal sacrospinous hysteropexy as compared to vaginal 
hysterectomy and laparoscopic sacrohysteropexy. After vaginal hysterectomy, a more 
posterior position of the upper vagina was found as compared to vaginal sacrospinous 
hysteropexy and laparoscopic sacrohysteropexy. Based on our data, the higher 
recurrence risk in the anterior compartment after vaginal sacrospinous hysteropexy 
cannot be explained. This might be due to the small sample size of this pilot study. 
Little is known about pelvic organ mobility after prolapse surgery. To the best of our 
knowledge, this is the first study to compare pelvic organ mobility after hysteropexy 
and hysterectomy.  
It will be interesting to evaluate pelvic organ mobility after vaginal sacrospinous 
hysteropexy in a larger sample size and in women who have recurrence or de novo 
cystocele to further assess the relation between pelvic organ mobility and the 
occurrence of anterior vaginal wall prolapse. Furthermore, assessing pelvic organ 
mobility using an upright MRI scanner could provide additional insights.  
THE ROLE OF LAPAROSCOPIC UTERINE PRESERVATION
Surgery for POP is performed traditionally via abdominal or vaginal approaches. 
Advances in minimal invasive surgery have led to an increase in adoption of 
laparoscopic techniques [40]. The laparoscopic approach has been successfully 
adopted for many procedures previously relied on an abdominal route.  Laparoscopy 
should be considered only as a mode of abdominal access and not a change in 
operative technique [41]. The possible advantages of laparoscopic POP repair include 
improved visualization of anatomy because of laparoscopic magnification, insufflation 
effects and improved haemostasis; shortened hospitalization resulting in potential 
costs reduction; decreased postoperative pain and more rapid recovery and return to 
work; and better cosmetic appearance of smaller incisions [42].  
rates of the apical compartment at one-year follow-up (0% versus 6%). Differences in 
sample size (37 versus 59) and subtle differences in surgical protocol might explain 
this finding.
Although the LAVA trial demonstrated no differences in primary outcome, we found some 
differences in secondary outcomes. First, more bothersome symptoms of overactive 
bladder were reported after laparoscopic hysteropexy. This finding seems mostly due to 
persistence of preoperative overactive bladder symptoms. Therefore, it implicates that 
women with preoperative symptoms of overactive bladder benefit more from vaginal 
sacrospinous hysteropexy. Second, more bothersome faecal incontinence has been 
reported after laparoscopic sacrohysteropexy as compared to vaginal sacrospinous 
hysteropexy. Since treatment options are limited and associated with side-effects, 
faecal incontinence is thought to be a devastating outcome [34,35]. Third, dyspareunia 
was reported almost three times as often after vaginal sacrospinous hysteropexy as 
compared to laparoscopic sacrohysteropexy. These differences in secondary outcomes 
may help in the process of shared decision making and choosing the optimal surgical 
route for the individual patient. One could hypothesize that for example a woman with 
overactive bladder symptoms is better off with a vaginal sacrospinous hysteropexy and 
sexually active women with a laparoscopic sacrohysteropexy. 
The outcomes of the LAVA trial were evaluated at 12 months’ follow-up.  This follow-up 
is short for a treatment that should last a lifetime and recurrences may further develop 
during longer follow-up. As stated in our study protocol, included women will be 
followed until 60 months after surgery. However, a recent cohort study demonstrated 
that the highest risk for undergoing repeat surgery for POP is within the first year [36]. 
 
A major problem in evaluating results after POP surgery is the significant variation 
in how outcomes are reported [37]. It is known that treatment success varies widely 
depending on the definition of surgical success. However, definitions of treatment 
success that require patient reported outcome postoperatively are more clinically 
relevant and meaningful to the patient than those that include anatomical criteria 
only [37]. The absence of vaginal bulge symptoms postoperatively has a significant 
relationship with patient’s assessment of overall improvement, while anatomical 
success has not. In the LAVA trial, we have chosen a composite outcome measure 
including anatomical outcome of the apical compartment, absence of bothersome 
bulge complaints and repeat surgery or pessary use. Furthermore, we reported on 
outcomes of the anterior and posterior compartment and also reported on outcomes 
using the hymen as threshold for success. 
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FUTURE PERSPECTIVES
With respect to future research, we would like to discuss the following topics: 
1. Outcomes after POP treatment
2. Conservative versus surgical management of POP
3. Minimally invasive POP procedures
1. OUTCOMES AFTER POP TREATMENT
One major problem in evaluating effects of POP surgery is the range of outcome 
measures, which are not reported in a consistent manner. Treatment success varied 
widely depending on the definition used [37]. In a recent systematic review on 
reported outcomes in randomized controlled trials on apical prolapse surgery, 76 
outcomes and 66 outcome measures were identified [46]. As a result of heterogenous 
outcomes, meaningful meta-analysis of POP outcome data is impossible [47].  This 
problem is not unique for uterine prolapse, it has been observed in surgery for 
posterior vaginal prolapse, stress urinary incontinence, childbirth perineal trauma 
research and heavy menstrual bleeding [48,51]. The development of a core-outcome 
set to standardize reporting outcomes will enable high-quality meta-analyses to 
be performed in the future. The core-outcomes can be determined by a group of 
selected stakeholders (for instance health care professionals, researchers and patient 
representatives. Core outcome have already established in fetal growth restriction 
and a protocol for developing and implementing core outcomes have been published 
for endometrioses and stress urinary incontinence [52-54]. In 2012, the International 
Urogynaecology Association (IUGA) and International Continence Society (ICS) 
published a terminology report with definitions of surgery and a structure for reporting 
the outcomes of surgical procedures [55]. However, this document does not define 
surgical success and failure. An ideal outcome measure should be valid, reliable, 
responsive, easily assessed, easily interpreted and clinically relevant [37]. Regarding 
POP surgery, any definition of success should include the absence of vaginal bulge 
symptoms in addition to anatomical criteria and the absence of re-treatment [37]. In 
addition, using the hymen as a threshold for anatomical success seems a reasonable 
and defensible approach since 40% of parous women have anatomical prolapse 
POP-Q grade 2 or higher.
However, patient reported outcome measurements (PROM’s) on quality of life, 
functional outcome and sexual functioning are perhaps be the most important 
outcome since severity of the prolapse does not correlate with prolapse symptoms or 
the impact on quality of life [56]. In addition, the goals of POP treatment should always 
With the advantages of laparoscopic POP repair, laparoscopic procedures have mostly 
replaced the open abdominal procedures [43]. The main question is when to treat POP 
vaginally or laparoscopically. Hysteropexy is a relatively novel technique for treating 
uterus prolapse. Traditionally, surgical repair of uterine descent involved vaginal vault 
suspension utilizing native tissue or mesh with concurrent hysterectomy. Nowadays, 
there is a growing interest in uterine conservation and hysteropexy procedures. 
Although these procedures were first described more than a century ago, they have 
gained interest over the past decade [25]. Laparoscopic hysteropexy has never been 
compared to vaginal hysteropexy in a randomized controlled trial. However, abdominal 
sacrocolpopexy of the vaginal vault is well described in the literature. When compared 
with sacrospinous fixation of the vaginal vault, abdominal sacrocolpopexy has been 
shown to have a lower rate of recurrent apical prolapse, less post-operative dyspareunia 
and a lower reoperation rate. However, the open abdominal procedure takes longer to 
perform, has a longer recovery time and is more expensive [1].  Randomized controlled 
trials comparing laparoscopic to open abdominal sacrocolpopexy demonstrated less 
blood loss and shorter hospital stay after the laparoscopic approach, with equivalent 
functional and anatomical outcomes [43,44]. 
When looking at the evidence of laparoscopic sacrocolpopexy, laparoscopic 
hysteropexy in case of uterine descent seems promising. However, randomized 
controlled trials are needed to compare the efficacy of various hysteropexy 
procedures and to develop a decision aid with risks and benefits of both the vaginal 
and laparoscopic surgical route. The LAVA trial is the first randomized controlled trial 
comparing laparoscopic to vaginal hysteropexy demonstrating non-inferiority of the 
primary outcome (surgical failure). 
Complex operative laparoscopy is associated with a steep and lengthy learning curve. 
A linear decrease in operation time was found after the initial procedure. In the first 
30 consecutive cases, operation time declined rapidly reaching a steady state after 
90 cases [45]. When attending a skills lab dedicated to endoscopic suturing and knot 
tying, stable operation time was achieved after 30 cases. However, when looking at 
complications and outcomes of the learning curve, adequate learning (no need for 
conversion to laparotomy, absence of anatomical failure and major complications) 
was showed after 60 cases [45].  Taking the learning curve into account, and assuming 
the gynaecologists needs to perform this procedure at a regular base to maintain 
the experience, it may not be possible to perform laparoscopic POP surgery in each 
hospital in the Netherlands. Therefore, in our opinion, complex laparoscopic POP 
surgery nowadays should be limited to specialized urogynaecology centres. 
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best patient satisfaction and the best functional and anatomical outcome.
Furthermore, apical prolapse can be treated with a laparoscopic sacrocervicopexy. 
This surgical procedure combines laparoscopic assisted supracervical hysterectomy 
(LASH) with the suspension of the cervical stump to the sacral promontory using a 
mesh. Since laparoscopic sacrocervicopexy is not directly compared to laparoscopic 
sacrohysteropexy, it is unknown if concomitant supracervical hysterectomy leads to 
better surgical outcome and higher patient satisfaction. It would be interesting to 
compare these techniques in a RCT. 
Finally, the technique of laparoscopic sacrohysteropexy can be optimized. We found 
practice variation in this surgical technique on several keypoints including extent of 
dissection, attachment of the mesh to cervix (anterior and/or posterior), and the type 
of sutures to be used for attachment of the mesh. 
Well-designed prospective studies or randomized controlled trials are needed to 
provide evidence for the best surgical technique and to assess to what level that specific 
technique contributes to surgical outcome. In these studies, specific techniques of the 
procedure (e.g. extent of dissection, staplers versus tackers to attach the mesh to the 
promontory) can be compared between study groups. Furthermore, large databases 
(big data) can contribute to answer these questions as well. 
GENERAL CONCLUSION
According to this thesis, several conclusions can be made: 
- In case functional and anatomical outcomes after hysterectomy and uterus 
preserving surgery were equal, more women expressed preference for uterus 
preservation (43%) over hysterectomy (27%).  
- In our small country of the Netherlands, we found a high PPV in surgical 
management of POP and UI with respect to the choice for surgical treatment 
and the type of surgery. Furthermore, we found great variations in the practice 
of laparoscopic sacrohysteropexy and sacrocolpopexy, performed by a selected 
group of gynaecologists.
- Laparoscopic sacrohysteropexy is non-inferior to vaginal sacrospinous hysteropexy 
for surgical failure of the apical compartment at 12 months’ follow-up. Following 
laparoscopic sacrohysteropexy, bothersome overactive bladder and faecal 
incontinence were more frequent, yet dyspareunia was less frequent.
be reducing the symptoms and improving quality of life. Therefore, these PROM’s 
should always take into account when evaluating surgical outcomes. 
2. CONSERVATIVE VERSUS SURGICAL MANAGEMENT OF POP
In our study on PPV in the Netherlands, we observed large differences in the ratio 
between surgical and conservative treatment of POP. The absence of clearly defined 
guidelines regarding indications for conservative and surgical management of POP 
might contribute to this finding. Randomized controlled trials comparing conservative 
versus surgical treatment are lacking but are needed to establish guidelines.  In 2015, 
the PEOPLE study, a prospective randomized controlled clinical trial was started in 
the Netherlands with the aim to determine non-inferiority of the endpoint (patient 
improvement) between pessary therapy and surgical treatment of POP. 
We analysed practice pattern variation in the Netherlands based on data of 2010. Five 
years later, the results of the SAVE U trial were published. This study demonstrated 
the vaginal sacrospinous hysteropexy to be non-inferior as compared to vaginal 
hysterectomy in case of uterine descent It [27]. It would be of interest to assess practice 
pattern variation after the publication of this study, to determine the implementation 
of this study in the Netherlands and to assess trends in practice pattern variation. We 
hypothesize that the ratio between hysterectomy and uterus preservation has changed 
in favour of the hysteropexy and that practice pattern variation will be lower due to 
more evidence.
3. LAPAROSCOPIC UTERUS PRESERVING PROCEDURES 
This thesis focuses on laparoscopic sacrohysteropexy whereas the uterus is suspended 
to the sacral promontory using a mesh. While vaginally-placed mesh has decreased 
since the FDA notifications, laparoscopic sacrohysteropexy and sacrocolpopexy 
are considered to be a more durable procedure [25]. The use of abdominal mesh 
appears to result in lower rates of complications compared with transvaginal 
mesh [1]. However, long term data is limited for laparoscopic sacrohysteropexy to 
determine the number of mesh complications. Therefore, it is important to analyse 
other laparoscopic procedures for uterine suspension without mesh. The best-known 
laparoscopic procedure without mesh is the laparoscopic uterosacral hysteropexy [57]. 
This procedure involves placing sutures through the uterosacral ligaments to suspend 
the cervix with permanent sutures. With regard to this procedure, no large randomized 
controlled trials are available comparing its effectiveness to vaginal hysterectomy or 
other hysteropexy procedures. Comparing both laparoscopic hysteropexy techniques 
is of interest to determine which laparoscopic technique for uterus suspension has the 
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Netherlands, a patient’s odds of undergoing surgery for POP and urinary incontinence 
seems to depend more on where the patient lives and to which hospital she is referred 
than on clinical circumstances. The choice of treatment is mainly subjected to the 
preference of the gynaecologists. The absence of clearly defined guidelines regarding 
indications for conservative and surgical management of POP and the availability of 
different surgical techniques might contribute to this high PPV. 
CHAPTER 3 focuses on variation in practice of laparoscopic sacrohysteropexy and 
laparoscopic sacrocolpopexy. A standard approach or published guideline on how 
to perform these procedures is lacking. Different methods have been described in 
literature, and there is no consensus on how to perform these procedures. In this chapter 
we describe the variation in surgical technique of laparoscopic sacrohysteropexy and 
laparoscopic sacrocolpopexy among Dutch gynaecologists. A high practice variation 
was found on several key points, such as level of dissection along the anterior and 
posterior walls of the vagina, the type of mesh, the type of sutures, the tension of 
the implanted mesh and reperitonealisation of the mesh. To monitor the outcome 
and long-term complications of laparoscopic prolapse repair, consensus on how to 
perform these procedures is mandatory. 
CHAPTER 4 presents the results of a prospective study regarding women’s preferences 
towards hysterectomy or uterus preservation. It is believed that uterus preservation 
is becoming more popular because women want to retain their uterus more often. 
However, evidence to support this statement is lacking. In this chapter women’s 
attitudes towards hysterectomy and uterus preservation in surgical management 
of uterine prolapse are described. In case outcomes after hysterectomy and uterus 
preserving surgery were expected to be equal, more women expressed preference 
for uterus preservation (43%, 44/102 women) compared to hysterectomy (27%, 
27/102 women). The majority of women expected that sexuality and body image 
would equally improve after both interventions. Treatment success, risk of urinary 
incontinence after surgery and complication risk were the most important factors for 
choosing a treatment. Taken the future risk of endometrial cancer into account, 18% 
of the women preferred hysterectomy because of this risk. 
CHAPTER 5 provides a study protocol for a randomised clinical trial to investigate 
outcomes after laparoscopic sacrohysteropexy and vaginal sacrospinous hysteropexy 
in women with uterine prolapse stage 2 or higher (LAVA-trial). The study was designed 
to test the hypothesis that laparoscopic sacrohysteropexy was non-inferior to vaginal 
sacrospinous hysteropexy regarding surgical failure at 12 months’ follow-up. Primary 
This thesis focuses on the surgical management of uterine prolapse. Emphasis is 
placed on uterine suspension in general and laparoscopic hysteropexy in specific. It 
comprises the results of the LAVA trial (laparoscopic sacrohysteropexy versus vaginal 
sacrospinous hysteropexy). 
CHAPTER 1 provides a general introduction on pelvic organ prolapse (POP) and the 
management of uterine prolapse. POP is one of the most common gynaecological 
disorders. The lifetime risk of undergoing surgery for POP or stress urinary 
incontinence is estimated to be 20% by the age of 80 years. Although POP is not a 
life-threatening condition, it significantly affects a woman’s quality of life and may 
influence urinary, gastrointestinal, sexual and psychological functioning. Traditionally, 
vaginal hysterectomy was the standard treatment for uterine prolapse but uterine 
suspension (hysteropexy) is becoming more popular. Although hysteropexy has been 
compared with hysterectomy in several randomized controlled trials, no randomized 
controlled trials have been performed comparing different hysteropexy routes so far. 
As a result, it is unclear whether or not these operations have comparable anatomical 
and functional outcomes. 
In this thesis, the following objectives are addressed: 
•	 How do doctors in the Netherlands treat uterine prolapse? And more specific, 
how do Dutch gynaecologists perform laparoscopic sacrohysteropexy and 
sacrocolpopexy? 
•	 What treatment do women in the Netherlands prefer (uterus preservation or 
removal) when surgical management for uterine descent is indicated? 
•	 How should women with uterine prolapse be treated and is there a difference in 
outcomes between laparoscopic and vaginal hysteropexy?
•	 Is there a difference in pelvic mobility after sacrospinous hysteropexy as compared 
to other treatments for uterine prolapse? 
CHAPTER 2 describes practice pattern variation (PPV) in treatment of POP and 
urinary incontinence. The availability of many treatment modalities for POP can 
lead to variation in care between physicians and hospitals, the so-called PPV. PPV is 
defined as the difference in care that cannot be explained by the underlying medical 
condition. In this chapter we describe PPV in Dutch hospitals in treatment of POP 
and urinary incontinence. A high PPV per hospital and per region was found. In some 
hospitals, a hysterectomy was performed in all cases of uterovaginal prolapse, while 
in other hospitals uterus-preserving techniques were mostly performed. Furthermore, 
a high PPV of transvaginal mesh placement was found. In the small country of the 
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to other surgical techniques for uterine descent (laparoscopic sacrohysteropexy and 
vaginal hysterectomy with uterosacral suspension).  No difference in pelvic organ 
mobility was found 6 months after vaginal sacrospinous hysteropexy as compared to 
vaginal hysterectomy and laparoscopic sacrohysteropexy. After vaginal hysterectomy, 
we found a more posterior position of the upper vagina as compared to vaginal 
sacrospinous hysteropexy and laparoscopic sacrohysteropexy. Based on these data, 
the higher recurrence risk in the anterior compartment after vaginal sacrospinous 
hysteropexy cannot be explained. 
CHAPTER 8 discusses the main results of this thesis, its clinical implication and topics 
for future research. According to this thesis, several conclusions can be made: 
- In case functional and anatomical outcomes after hysterectomy and uterus 
preserving surgery were equal, more women expressed preference for uterus 
preservation (43%) over hysterectomy (27%).  
- In our small country of the Netherlands, we found a high PPV in surgical 
management of POP and UI with respect to the choice for surgical treatment 
and the type of surgery. Furthermore, we found great variations in the practice 
of laparoscopic sacrohysteropexy and sacrocolpopexy, performed by a selected 
group of gynecologists.
- Laparoscopic sacrohysteropexy is non-inferior to vaginal sacrospinous hysteropexy 
for surgical failure of the apical compartment at 12 months’ follow-up. Following 
laparoscopic sacrohysteropexy, bothersome overactive bladder and faecal 
incontinence were more frequent, yet dyspareunia was less frequent.
- The higher recurrence risk in the anterior compartment after vaginal sacrospinous 
hysteropexy cannot be explained by differences in pelvic organ mobility or vaginal 
axes on dynamic magnetic resonance imaging.
outcome of this study was surgical failure, defined as either bothersome symptoms 
and/or repeat surgery for prolapse stage 2 or higher at point C by 12 months 
postoperative. Secondary outcomes were overall anatomical recurrences, functional 
outcome, quality of life, complications, hospital stay, post-operative recovery, 
and sexual functioning. All women with uterine prolapse POP-Q stage 2 or higher 
without previous POP surgery are eligible for participation. Exclusion criteria are a 
known malignancy of the cervix or cervical dysplasia, language barriers, a wish to 
preserve fertility, presence of immunological or hematological disorders interfering 
with recovery after surgery, contraindications for laparoscopic surgery (e.g. ileus, risk 
of severe adhesions), abnormal ultrasound findings of uterus or ovaries which cause 
symptoms and/or require treatment, abnormal uterine bleeding that requires surgical 
treatment, postmenopausal bleeding in the past year and women who are unwilling 
to return for follow-up. 
According to the power analysis, a total of 124 women (62 in each arm) were needed 
to prove the hypothesis.
CHAPTER 6 presents the results of the LAVA trial. In total, 126 women with uterine 
prolapse stage two or higher requiring surgery, were randomised between laparoscopic 
sacrohysteropexy (n=64) and vaginal sacrospinous hysteropexy (n=62) in one of the 
six participating hospitals. Laparoscopic sacrohysteropexy was non-inferior to vaginal 
sacrospinous hysteropexy regarding surgical failure after 12 months in the intention to 
treat analysis. The failure rate was 1/64 (1.6%) in the laparoscopic group versus 2/62 (3.3%) 
in the vaginal group (difference -1.7% ; 95% CI for difference -7.1 to 3.7). A per protocol 
analysis also demonstrated non-inferiority of the laparoscopic sacrohysteropexy. 
There were no differences in overall anatomical recurrences and quality of life. More 
bothersome symptoms of overactive bladder and faecal incontinence were reported 
after laparoscopic sacrohysteropexy. Dyspareunia was more frequently reported after 
vaginal sacrospinous hysteropexy. Based on the analysis after 12 months’ follow-
up, we concluded that laparoscopic sacrohysteropexy was non-inferior to vaginal 
sacrospinous hysteropexy for surgical failure of the apical compartment. 
CHAPTER 7 describes the results of a prospective study regarding pelvic organ 
mobility and vaginal axes assesses by dynamic magnetic resonance imaging (MRI) after 
different surgical procedures for uterine descent. In literature, the high risk for recurrent 
prolapse of the anterior vaginal wall after vaginal sacrospinous hysteropexy is often 
discussed. In order to find an explanation, the vaginal axes and pelvic organ mobility 
after vaginal sacrospinous hysteropexy were studied by dynamic MRI and compared 
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NEDERLANDSE SAMENVATTING
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als de variatie in behandeling die niet verklaard kan worden door de onderliggende 
aandoening. We vonden een grote praktijkvariatie per ziekenhuis en per regio. In 
sommige ziekenhuizen werd altijd een hysterectomie verricht in geval van een 
chirurgische behandeling voor uterusprolaps, terwijl in andere ziekenhuizen bijna 
altijd een uterussparende operatie werd uitgevoerd. Een grote praktijkvariatie werd 
ook gezien in het plaatsen van kunststofmaterialen. In een klein land als Nederland 
is de kans voor een patiënt om geopereerd te worden aan een verzakking of urine-
incontinentie meer afhankelijk van waar ze woont en naar welk ziekenhuis ze wordt 
verwezen dan van de klinische omstandigheden. De keuze van de behandeling wordt 
vooral bepaald door de gynaecoloog. De geconstateerde praktijkvariatie zou kunnen 
komen door afwezigheid van een duidelijke richtlijn over de chirurgische behandeling 
van prolaps. 
HOOFDSTUK 3 beschrijft de variatie in operatietechniek van laparoscopische 
sacrohysteropexie en laparoscopische sacrocolpopexie. Een standaard beschrijving, 
protocol of richtlijn hoe deze ingrepen uit te voeren ontbreekt. Verschillende 
methoden zijn beschreven in de literatuur, maar er is tot op heden geen consensus 
over hoe de ingrepen uit te voeren. In dit hoofdstuk beschrijven we de variatie in 
operatietechniek van de laparoscopische sacrohysteropexie en laparoscopische 
sacrocolpopexie tussen Nederlandse gynaecologen. Een grote praktijkvariatie werd 
gevonden op enkele belangrijke punten in de operatie, zoals niveau van dissectie langs 
de anterieure en posterieure vaginawanden, het type kunststofmateriaal (mesh), het 
type hechtingen, de spanning van de mesh en reperitonealisatie van de mesh. Het 
is erg belangrijk om consensus te verkrijgen, hoe de ingrepen uit te voeren, zodat 
uitkomsten en lange-termijn complicaties in beeld kunnen worden gebracht. 
HOOFDSTUK 4 presenteert de resultaten van een prospectieve studie naar de voorkeur 
en houding van Nederlandse vrouwen ten aanzien van uterussparend opereren en 
hysterectomie. In de literatuur wordt vaak beweerd dat behouden van de uterus 
steeds populairder wordt en dat vrouwen steeds vaker hun uterus niet willen laten 
verwijderen als chirurgische behandeling nodig is.  Echter het bewijs voor deze laatste 
bewering is beperkt. In dit hoofdstuk wordt de preferentie van Nederlandse vrouwen 
beschreven. Wanneer de uitkomsten na een hysterectomie en uterussparende 
operatie gelijk zouden zijn, hadden meer vrouwen een voorkeur voor het behouden 
van de uterus (43%, 44/102 vrouwen) vergeleken met een hysterectomie (27%, 27/102 
vrouwen). De meerderheid van de vrouwen verwachtte een gelijke verbetering in 
seksualiteit en lichaamsbeeld na beide behandelmethoden. Behandelsucces, risico op 
urine-incontinentie en het risico op complicaties werden het belangrijkst bevonden. 
Dit proefschrift richt zich op de operatieve behandeling van uterusprolaps 
(baarmoederverzakking) bij vrouwen. De nadruk ligt op uterussparende prolapschirurgie 
(hysteropexie) in het algemeen, en op laparoscopische hysteropexie in het bijzonder. 
Het beschrijft de resultaten van de LAVA-studie (LAparoscopische sacrohysteropexie 
versus VAginale sacrospinale hysteropexie). 
HOOFDSTUK 1 geeft een algemene introductie over (uterus)prolaps en de behandeling 
van uterusprolaps. Een prolaps is een veelvoorkomende aandoening. Het levenslange 
risico om geopereerd te worden vanwege prolaps is 20% op de leeftijd van 80 jaar. 
Alhoewel een prolaps niet levensbedreigend is, heeft het een duidelijk negatieve 
invloed op de kwaliteit van leven van de vrouw, maar ook op seksueel en psychisch 
functioneren. Tevens kunnen er klachten ontstaan op het gebied van mictie en 
defaecatie. 
Van oudsher was het verwijderen van de uterus de standaardbehandeling voor 
uterusprolaps, maar uterussparende chirurgie wordt steeds populairder. Verschillende 
randomized controlled trials hebben hysteropexie vergeleken met vaginale 
hysterectomie, maar er zijn tot op heden nog geen studies uitgevoerd die de 
verschillende technieken voor hysteropexie met elkaar vergelijken. Hierdoor is het 
onbekend hoe de anatomische en functionele uitkomsten van deze verschillende 
operaties ten opzichte van elkaar zijn. 
In dit proefschrift worden de volgende onderwerpen behandeld: 
- Hoe wordt prolaps door Nederlandse gynaecologen behandeld? En specifieker, 
hoe voeren Nederlandse gynaecologen een laparoscopische sacrohysteropexie 
en sacrocolpopexie uit? 
- Welke behandeling heeft de voorkeur voor Nederlandse vrouwen (uterussparende 
chirurgie of hysterectomie) wanneer een chirurgische behandeling voor 
uterusprolaps is geïndiceerd? 
- Hoe moeten vrouwen met uterusprolaps behandeld worden en is er verschil in 
uitkomst tussen vaginale en laparoscopische hysteropexie? 
- Is er een verschil in mobiliteit van de bekkenorganen na sacrospinale hysteropexie 
vergeleken met andere operaties voor uterusprolaps?
In HOOFDSTUK 2 bestudeerden we de praktijkvariatie in Nederlandse ziekenhuizen 
in de behandeling van prolaps en urine-incontinentie. De verschillende 
behandelmogelijkheden voor prolaps kunnen leiden tot variatie in behandeling tussen 
artsen en tussen ziekenhuizen (praktijkvariatie). Praktijkvariatie wordt gedefinieerd 
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vrouwen na een vaginale sacrospinale hysteropexie (verschil -1.7%; 95% BI -7.1 tot 3.7). 
Per protocol analyse liet ook zien dat een laparoscopische sacrohysteropexie non-
inferieur was. Er was geen verschil in het totaal aantal recidieven en in kwaliteit van 
leven. Na een laparoscopische sacrohysteropexie werden meer hinderlijke klachten 
van overactieve blaas en faecale incontinentie gemeld. Dyspareunie werd frequenter 
gerapporteerd na een vaginale sacrospinale hysteropexie. Op basis van de analyse 
na 12 maanden concluderen wij dat een laparoscopische sacrohysteropexie non-
inferieur is aan een vaginale sacrospinale hysteropexie wat betreft recidief prolaps 
van het apicale compartiment met hinderlijke prolapsklachten en/of herbehandeling 
(operatie of pessarium) vanwege prolaps van het middelste compartiment.
HOOFDSTUK 7 beschrijft de resultaten van een prospectieve studie naar de mobiliteit 
van de bekkenorganen en vaginale as na verschillende chirurgische behandelingen 
voor uterusprolaps. In literatuur wordt het hoge risico op een voorwandprolaps 
na vaginale sacrospinale hysteropexie vaak beschreven. Om een oorzaak voor dit 
hoge recidiefaantal te vinden, hebben we vaginale assen en de mobiliteit van de 
bekkenorganen in kaart gebracht met behulp van een dynamische MRI. We hebben 
hiervoor vrouwen na een vaginale sacrospinale hysteropexie vergeleken met vrouwen 
na een laparoscopische sacrohysteropexie of een vaginale hysterectomie met 
uterosacrale suspensie. Zes maanden na de operatie werd geen verschil gevonden 
in mobiliteit van de bekkenbodemorganen na vaginale sacrospinale hysteropexie 
vergeleken met vaginale hysterectomie en laparoscopische sacrohysteropexie. 
Na vaginale hysterectomie is de as van het bovenste deel van de vagina meer naar 
posterior gelegen in vergelijking met de uterussparende ingrepen. Op basis van deze 
data kunnen we geen verklaring geven voor het hoge recidiefrisico van het anterieure 
compartiment na een vaginale sacrospinale hysteropexie. 
HOOFDSTUK 8 bespreekt de resultaten van dit proefschrift, de klinische implicaties en 
de onderwerpen voor toekomstig onderzoek. Aan de hand van dit proefschrift kunnen 
de volgende conclusies getrokken worden:
- Wanneer de functionele en anatomische uitkomsten van hysterectomie en 
uterussparende chirurgie gelijk zijn, hebben meer vrouwen een voorkeur voor 
uterussparende chirurgie (43%) ten opzichte van de hysterectomie (27%). 
- In een klein land als Nederland vonden we een hoge praktijkvariatie in de 
chirurgische behandeling van prolaps en urine-incontinentie met betrekking tot 
chirurgische versus conservatieve behandeling en soort chirurgische behandeling. 
We vonden tevens variaties in de gebruikte techniek van laparoscopische 
sacrohysteropexie en laparoscopische sacrocolpopexie, uitgevoerd door een 
Het toekomstig risico op een endometriumcarcinoom was voor 18% van de vrouwen 
reden om te kiezen voor een hysterectomie. 
In HOOFDSTUK 5 beschrijven we het ontwerp van de LAVA-studie. Dit is een 
gerandomiseerde studie waarin de laparoscopische sacrohysteropexie wordt 
vergeleken met de vaginale sacrospinale hysteropexie bij vrouwen met een 
uterusprolaps stadium 2 of hoger. De studie werd ontworpen om de hypothese te 
testen dat de laparoscopische sacrohysteropexie non-inferieur is aan de vaginale 
sacrospinale hysteropexie na 12 maanden follow-up. De primaire uitkomst was 
chirurgisch falen, gedefinieerd als recidief stadium 2 of hoger van de uterus (het 
apicale compartiment) vastgesteld middels POP-Q onderzoek, met daarbij hinderlijke 
prolapsklachten of een reïnterventie (operatie of pessarium) vanwege recidief prolaps 
van het apicale compartiment. Secundaire uitkomstmaten waren recidief prolaps 
in alle compartimenten, functionele uitkomsten, kwaliteit van leven, complicaties, 
opnameduur, postoperatief herstel en seksueel functioneren. Alle vrouwen met een 
uterusprolaps POP-Q stadium 2 of hoger zonder voorafgaande prolapsbehandeling 
werden gevraagd deel te nemen. 
Exclusie criteria waren bekende maligniteit of dysplasie van de cervix, een taalbarrière, 
wens tot behoud fertiliteit, aanwezigheid van immunologische of hematologische 
aandoeningen die het postoperatieve herstel kunnen beïnvloeden, contra-indicaties 
voor laparoscopie (zoals ileus, verdenking op ernstige adhesies), afwijkende bevindingen 
bij echografisch onderzoek aan uterus en/of ovaria die klachten veroorzaken of 
waarvoor een behandeling nodig is, abnormaal vaginaal bloedverlies wat chirurgische 
behandeling behoeft, postmenopauzaal bloedverlies in het afgelopen jaar en niet 
terug willen komen voor follow-up. 
Volgens de powerberekening moesten er 124 vrouwen (62 per studie arm) geïncludeerd 
worden om de hypothese te kunnen testen. 
In HOOFDSTUK 6 presenteren we de resultaten van de LAVA-studie. In totaal werden 
126 vrouwen met een uterusprolaps stadium 2 of hoger gerandomiseerd tussen 
laparoscopische sacrohysteropexie (n=64) en vaginale sacrospinale hysteropexie 
(n=62) in één van de zes deelnemende ziekenhuizen. De intention to treat analyse 
liet zien dat de laparoscopische sacrohysteropexie non-inferieur was aan de vaginale 
sacrospinale hysteropexie wat betreft chirurgisch falen van het apicale compartiment 
na 12 maanden follow-up. Chirurgisch falen werd gezien bij 1.6% (1/64) van de 
vrouwen na een laparoscopische sacrohysteropexie tegenover 3.3% (2/62) van de 
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selecte groep gynaecologen. 
- Laparoscopische sacrohysteropexie is non-inferieur aan vaginale sacrospinale 
hysteropexie wat betreft chirurgisch falen in het apicale compartiment na 12 
maanden follow-up. Na laparoscopische sacrohysteropexie worden meer 
hinderlijke klachten van overactieve blaas en faecale incontinentie gemeld, maar 
dyspareunie komt minder frequent voor. 
- Het verhoogde risico op een voorwandprolaps na een vaginale sacrospinale 
hysteropexie kan niet worden verklaard door verschillen in mobiliteit van de 
bekkenorganen of vaginale as, bepaald met behulp van dynamische MRI. 
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is still a matter of debate, the main question arises what the optimal ratio is between 
conservative and surgical treatment management. 
To reduce practice pattern variation, well-designed prospective studies are necessary 
to establish evidence based guidelines. 
HYSTEROPEXY
Vaginal sacrospinous hysteropexy is the most studied surgical technique for uterine 
descent in the Netherlands and the procedure is very popular among Dutch 
gynaecologists. However, there are some concerns about this technique. After 
vaginal sacrospinous hysteropexy, the vaginal axis is changed to a more horizontal 
and posterior position. Furthermore, the high risk of anterior vaginal wall prolapse 
after this technique is often discussed. Abdominal or laparoscopic uterine suspension 
might not have these disadvantages. In case of vaginal vault prolapse, abdominal 
sacrocolpopexy has been shown to have a lower rate of recurrent apical prolapse and 
a lower reoperation rate as compared to vaginal sacrospinous fixation of the vaginal 
vault.
In our randomised controlled study (LAVA-trial) we compared laparoscopic 
sacrohysteropexy with vaginal sacrospinous hysteropexy in women with uterine 
descent POP-Q stage 2 or higher. To our knowledge, this is the first randomised 
controlled trial comparing these two techniques for hysteropexy. The study 
demonstrated non-inferiority of laparoscopic sacrohysteropexy as compared to 
vaginal sacrospinous hysteropexy for surgical failure in the apical compartment. 
Furthermore, no differences were found in anatomical and surgical failure in other 
compartments, neither in sexual functioning and quality of life. However, we found 
some differences in secondary outcomes. Following laparoscopic sacrohysteropexy, 
bothersome symptoms of overactive bladder and faecal incontinence were reported 
more frequently, but dyspareunia was reported less frequent. These subtle differences 
in secondary outcomes may help in the process of shared-decision making and 
choose the optimal surgical route for a specific patient.
TARGET GROUPS
The results of this thesis are interesting for physicians, gynaecologists, general 
practitioners, medical industry and most important, women. The study regarding 
practice pattern variation demonstrates great variation in the treatment of POP in a 
small country as the Netherlands, and indicates the importance of developing a clearly 
defined guideline. 
WHY IS THIS THESIS RELEVANT?
Traditionally, uterine prolapse is treated by vaginal hysterectomy and suspension of 
the vaginal vault. However, nowadays more women express a preference for uterus 
preservation and consequently, hysteropexy techniques are gaining interest. Several 
procedures have been described to suspend the uterus, including the vaginal or 
the abdominal (laparoscopic/robotic) route. Although the different techniques for 
hysteropexy have been studied for many years, no randomised controlled trials have 
been performed to compare these techniques. As a result, it is unclear whether or 
not these uterine suspension procedures have comparable anatomical and functional 
outcomes. This thesis focuses on the effectiveness of laparoscopic hysteropexy 
compared to vaginal hysteropexy. Furthermore, variation in treatment of pelvic organ 
prolapse (POP) is assessed. 
RELEVANCE
POP is one of the most common gynaecological conditions. The aetiology of POP 
is multifactorial. Risk factors include higher parity, vaginal childbirth, advancing age, 
obesity and previous hysterectomy. 
Although POP is not a life-threatening condition, it significantly affects a woman’s 
quality of life and may influence urinary, gastrointestinal, sexual and psychological 
functioning. The lifetime risk of undergoing surgery for POP or stress urinary 
incontinence is estimated to be 20% by the age of 80 years. In the Netherlands, about 
13.000 POP surgeries are performed every year, with estimated total costs of 75 
million euro per year. Due to aging of the population, a significant increase in both 
the number of women with POP and those seeking care for POP is expected to occur 
over the next decades. As a result, there will be an enormous extra demand for future 
prolapse treatment. 
PRACTICE PATTERN VARIATION
In the Netherlands, a great variation was found in the treatment of POP. The surgical rate 
of POP and urinary incontinence (UI) varies per hospital and per region. Consequently, 
a woman’s odd of undergoing surgery for POP seems to depend more on where she 
lives than on the clinical circumstances. 
Practice pattern variation in the ratio between conservative and surgical treatment of 
POP might imply over- and undertreatment. In case of undertreatment, the patient 
might not receive adequate treatment. However, in case of overtreatment the patient 
is exposed to the unnecessary risks of surgery. Since a gold standard for treating POP 
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The results of the LAVA-trial will not only help to establish evidence-based guidelines, 
but also help to develop a decision tool for shared-decision making. Hopefully this will 
lead to an increase in patient satisfaction. 
ACTIVITIES AND INNOVATIONS
All study results have been submitted to international scientific research journals. To 
gain more attention on this work, the results of the studies are presented and discussed 
on national and international scientific meetings. 
SCHEDULE AND IMPLEMENTATION
In order to evaluate treatments for POP and to determine the best treatment with 
the highest patient satisfaction, further research is necessary. Studies regarding 
conservative versus surgical treatment of POP are needed, and furthermore the 
technique of laparoscopic sacrohystopexy can be optimized. Other laparoscopic 
uterine suspension techniques need to be evaluated as well. 
One major problem in evaluating effects of POP surgery is the range of outcome 
measures, which are not reported in a consistent manner. As a result of heterogenous 
outcomes, meaningful meta-analysis of POP outcome data is impossible. Regarding 
POP surgery, any definition of success should include the absence of vaginal bulge 
symptoms in addition to anatomical criteria and the absence of re-treatment. 
However, patient reported outcome measurements (PROM’s) on quality of life, 
functional outcome and sexual functioning are perhaps the most important since 
severity of the prolapse does not correlate with prolapse symptoms or the impact on 
quality of life. In addition, the goals of POP treatment are reducing the symptoms and 
improving quality of life. Therefore, these PROM’s should always take into account 
when evaluating surgical outcomes. 
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LIST OF ABBREVIATIONS
BMI  Body Mass Index
CI  Confidence interval
DDI  Defecatory Distress Inventory
EQ5D  Euroqol-5D
FDA  Food and Drug Administration
IIQ  Incontinence Impact Questionnaire
ITT  Intention to treat
ITT-LOCF Intention to treat with last observation carried forward
LSC  Laparoscopic sacrocolpopexy
LSH  Laparoscopic sacrohysteropexy
MRI  Magnetic Resonance Imaging
OAB  Overactive bladder 
PFMT  Pelvic floor muscle training
PISQ  Pelvic organ prolapse/Urinary incontinence Sexual questionnaire
POP  Pelvic organ prolapse
POP-Q  Pelvic organ prolapse quantification system
PP  Per protocol
PPV  Practice pattern variation
PROM  Patient reported outcome measurements 
RCT  Randomised controlled trial
SDM  Shared-decision making
SF-36  Short Form-36
SSHP  Sacrospinous hysteropexy 
UI  Urinary incontinence
VH  Vaginal hysterectomy
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VRAGENLIJST PREFERENTIE STUDIE
STEL DAT U EEN BAARMOEDERVERZAKKING HEBT
1. Stel er is helemaal geen verschil tussen het verwijderen of het sparen van de 
baarmoeder. De herstelperioden zijn even lang, de kans op opnieuw een verzakking 
is even groot en de klachten na de ingreep zijn hetzelfde. Welke behandeling heeft 
dan op dit moment uw voorkeur?
  Baarmoederverwijdering     
  Baarmoedersparende ingreep     
  Geen voorkeur        
 
Indien u een voorkeur aangeeft: waarom kiest u voor deze ingreep?
………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………..
De belangrijkste risico’s van opereren bij een verzakking zijn een nabloeding, infectie 
en een beschadiging van de blaas of de darm. Ook kunnen er tijdelijke problemen zijn 
met uitplassen. Deze risico’s lijken op dit moment bij beide type operaties even groot. 
Sommige vrouwen krijgen na de operatie opnieuw een verzakking. Zowel na een 
baarmoedersparende ingreep als na het verwijderen van de baarmoeder kan er 
opnieuw een verzakking ontstaan. Indien de baarmoeder is verwijderd, is er sprake 
van een verzakking van de top van de schede. Op dit moment is het niet duidelijk 
of het opnieuw optreden van een verzakking vaker voorkomt bij het verwijderen van 
de baarmoeder of bij een baarmoedersparende ingreep, omdat dit nog weinig is 
onderzocht. 
Het is ook mogelijk dat de operatie helpt tegen uw klachten, maar dat u er andere 
klachten voor in de plaats krijgt. Een klein aantal vrouwen krijgt bijvoorbeeld last van 
ongewenst urineverlies (incontinentie) na een operatie voor een verzakking. Mogelijk 
gaat het verwijderen van de baarmoeder iets vaker gepaard met ongewenst urineverlies 
na de operatie in vergelijking met baarmoedersparende operaties, maar ook dit moet 
nog meer onderzocht worden. 
Uit eerder onderzoek blijkt dat sommige baarmoedersparende operaties gepaard gaan 
met een kortere opnameduur in het ziekenhuis na de operatie (ongeveer een dag 
korter) en een iets sneller herstel na de ingreep. 1212
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5. Hieronder staan geschatte percentages van optreden van aandrang urine-
incontinentie na de door uw gekozen procedure. Vanaf welk verschil in risico op 
aandrang urine-incontinentie zou u voor de andere ingreep kiezen ten opzichte 
van uw keuze bij vraag 2? 
 5%  (5 op 100 vrouwen)   
 10%  (10 op de 100 vrouwen)   
 15%  (15 op de 100 vrouwen)   
 20%  (20 op de 100 vrouwen)   
 25%  (25 op de 100 vrouwen)   
 30%  (30 op de 100 vrouwen)   
 35%  (35 op de 100 vrouwen)   
 40%  (40 op de 100 vrouwen)   
 45%  (45 op de 100 vrouwen)   
 50%  (50 op de 100 vrouwen)   
 Meer dan 50%      
 Ik kies niet voor een andere ingreep  
  
6. Hieronder staan geschatte percentages van optreden van stressincontinentie 
(ongewenst urineverlies bij drukverhogende momenten, zoals niezen, persen 
en hoesten) na de door uw gekozen procedure. Vanaf welk verschil in risico op 
stressincontinentie zou u voor de andere ingreep kiezen ten opzichte van uw 
keuze bij vraag 2? 
 5%  (5 op 100 vrouwen)  
 10%  (10 op de 100 vrouwen)   
 15%  (15 op de 100 vrouwen)
 20%  (20 op de 100 vrouwen)
 25%  (25 op de 100 vrouwen)
 30%  (30 op de 100 vrouwen)
 35%  (35 op de 100 vrouwen)
 40%  (40 op de 100 vrouwen)
 45%  (45 op de 100 vrouwen)
 50%  (50 op de 100 vrouwen) 
 Meer dan 50%
 Ik kies niet voor een andere ingreep    
 
2. Na het lezen van de bovenstaande informatie kies ik
  Voor dezelfde ingreep namelijk. de baarmoederverwijdering 
  Voor de andere ingreep namelijk de baarmoederverwijdering  
  Voor dezelfde ingreep namelijk de baarmoedersparende ingreep 
  Voor de andere ingreep namelijk de baarmoedersparende ingreep
  Ik heb nog steeds geen voorkeur      
 
Indien u gekozen hebt voor een andere ingreep: waarop is dit gebaseerd? 
………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………..
3. De gemiddelde opnameduur na een operatie vanwege  een baarmoederverzakking 
is 2-6 dagen. Bij hoeveel dagen verschil in opnameduur zou u toch kiezen voor 
de andere operatie? Dus hoeveel dagen moet de opnameduur korter zijn, wil u 
voor de andere ingreep kiezen?
 1 dag        
 2 dagen       
 3 dagen       
 4 dagen       
 Meer dan 4 dagen     
 Ik verander hierdoor niet van keuze  
  
4. Het gemiddelde herstel na een verzakkingsoperatie (geheel herstel, weer aan het 
werk) duurt ongeveer 6 tot 10 weken. Bij welk verschil in het aantal weken herstel 
zou u voor de andere ingreep kiezen ten opzichte van uw keuze bij vraag 2? Dus 
hoeveel weken moet het herstel korter zijn om toch voor de andere ingreep te 
kiezen?
 minder dan 1 week     
 1 week        
 2 weken        
 4 weken       
 6 weken       
 Ik verander hierdoor niet van keuze    
 
Urine-incontinentie kan optreden na een operatieve ingreep. Hierbij kan onderscheid 
gemaakt worden in aandrangincontinentie (bij aandrang om te plassen ontstaat 
ongewenst urineverlies) en incontinentie bij drukverhogende momenten zoals 
hoesten, niezen en persen (stressincontinentie). 
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10.  Wanneer een baarmoederverwijdering wordt uitgevoerd, kan er geen 
baarmoederslijmvlieskanker ontstaan. Wanneer een baarmoedersparende 
operatie wordt uitgevoerd, is er een kleine kans op het krijgen van 
baarmoederslijmvlieskanker. Deze kans is NIET toegenomen door de ingreep.  In 
Nederland wordt jaarlijks bij ongeveer 1900 vrouwen baarmoederslijmvlieskanker 
gediagnosticeerd. Deze vorm van kanker wordt vaak in een vroege fase ontdekt 
doordat vrouwen abnormaal vaginaalbloedverlies hebben. Bij dit vroege stadium 
bedraagt de globale 5-jaarsoverleving 95%. Dit betekent dat 95% van de vrouwen 
waarbij in dit stadium baarmoederslijmvlieskanker is geconstateerd nog in leven is. 
Beïnvloeden deze gegevens uw keuze voor een ingreep?
 Nee       
 Ja         
 Weet ik niet     
   
11. De meeste vrouwen hebben een verbetering van hun seksleven na een 
verzakkingsoperatie. Sommige vrouwen hebben na een operatie vanwege 
verzakking pijn bij vrijen, wat soms blijvend kan zijn. Vanaf welk verschil in risico 
op pijn tijdens het vrijen zou u voor de andere ingreep kiezen ten opzichte van uw 
keuze bij vraag 2? 
 5%  (5 op 100 vrouwen)    
 10%  (10 op de 100 vrouwen)    
 15%  (15 op de 100 vrouwen)    
 20%  (20 op de 100 vrouwen)    
 25%  (25 op de 100 vrouwen)    
 30%  (30 op de 100 vrouwen)
 35%  (35 op de 100 vrouwen)
 40%  (40 op de 100 vrouwen)
 45%  (45 op de 100 vrouwen)
 50%  (50 op de 100 vrouwen)
 Meer dan 50%
 Ik kies niet voor een andere ingreep    
 
7. Geef hieronder aan op een schaal van 1 tot 5 hoe belangrijk u de onderstaande 
factoren vindt in het maken van een keuze tussen de twee ingrepen 
(baarmoedersparende operatie of baarmoederverwijdering). 
Helemaal niet 
belangrijk 
Niet belangrijk Neutraal Belangrijk Heel erg 
belangrijk 
Verzakking weg □ □ □ □ □
Risico op ongewenst urineverlies na 
de ingreep
□ □ □ □ □
Herstel na de operatie □ □ □ □ □
Kosten □ □ □ □ □
Duur van de opname □ □ □ □ □
Complicaties na de ingreep 
(nabloeding, infectie, problemen met 
uitplassen)
□ □ □ □ □
Seksueel functioneren na de ingreep □ □ □ □ □
8.  Denkt u dat het type operatie van invloed is op de mate van verandering in uw 
lichaamsbeeld / zelfbeeld na de operatie?
 Nee 
 Ja, mijn lichaamsbeeld/zelfbeeld zal meer verbeteren door een 
baarmoederverwijdering
 Ja, mijn lichaambeeld/zelfbeeld zal meer verbeteren door een 
baarmoedersparende operatie     
9.  Denkt u dat het type operatie van invloed is op de mate van verandering in 
seksualiteit na de operatie?
 Nee       
 Ja, mijn seksualiteit zal meer verbeteren door een baarmoederverwijdering
 Ja, mijn seksualiteit zal meer verbeteren door een baarmoedersparende 
operatie 
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VRAGENLIJST LAVA-TRIAL
1. Wat is uw leeftijd? …………………….. jaar
2. Welke opleiding(en) heeft u voltooid? 
 Basisonderwijs / lagere school (of een deel hiervan)
 Lager beroepsonderwijs (lts, lhno, leao, huishoudschool etc.)
 Mavo, (m)ulo etc. 
 Middelbaar beroepsonderwijs (MTS, MEAO, opleiding tot verpleegkundige etc.)
 Havo, VWO, gymnasium, mms etc. 
 Hoger beroepsonderwijs (HTS, HEAO, sociale academie)
 Wetenschappelijk onderwijs (doctoraal examen)
3. a. Wat is uw huidige beroep of zijn uw werkzaamheden? ………………………………………….
b. Rookt u?
 Zo ja, hoeveel rookt u per dag?  ……… sigaretten/shag per dag  
 Nee
c. Drinkt u alcohol?
 Zo ja,  ……… eenheden per dag      
 Nee
d. Gebruikt u medicijnen? (inclusief de anticonceptiepil)?
 Ja         
 Nee
Zo ja, kunt u  omschrijven welke? ………………………………………………………………..
4. a. Heeft u kinderen?
 Ja    Nee (ga door naar vraag 5)
b. Hoeveel kinderen heeft u? …………………….. (aantal)
c. Heeft u een keizersnede gehad? Zo ja, hoe vaak?
 Ja, …………….. keer  Nee
d. Heeft u een tangverlossing gehad? Zo ja, hoe vaak?
 Ja, …………….. keer  Nee
e. Heeft u een vacuümcup verlossing gehad? Zo ja, hoe vaak?
 Ja, …………….. keer  Nee 
f. Heeft u een ‘knip’  gehad bij de bevalling? Zo ja, hoe vaak?
  Ja, …………….. keer  Nee
g. Bent u ‘ingescheurd’  bij de bevalling? Zo ja, hoe vaak?
 Ja, …………….. keer  Nee
12. Sommige vrouwen krijgen in de loop van hun leven vloeistoornissen (ook wel 
abnormaal vaginaal bloedverlies genoemd), bijvoorbeeld zeer hevig bloedverlies 
tijdens de menstruatie of onregelmatig bloedverlies. Soms kan een behandeling 
hiervoor noodzakelijk zijn,  bijvoorbeeld een spiraaltje, een kleine operatie in 
dagbehandeling of het laten verwijderen van de baarmoeder . Vanaf percentage 
van risico op het  optreden van vloeistoornissen zou u kiezen verwijdering 
van de baarmoeder? Dus: hoe hoog moet het risico op vloeistoornissen zijn 
om te kiezen voor een verwijdering van de baarmoeder in het geval van een 
baarmoederverzakking? 
 5%  (5 op 100 vrouwen)
 10%  (10 op de 100 vrouwen) 
 15%  (15 op de 100 vrouwen) 
 20%  (20 op de 100 vrouwen) 
 25%  (25 op de 100 vrouwen)    
 30%  (30 op de 100 vrouwen)    
 35%  (35 op de 100 vrouwen)    
 40%  (40 op de 100 vrouwen)    
 45%  (45 op de 100 vrouwen)   
 50%  (50 op de 100 vrouwen)    
 Meer dan 50%     
 Ik kies bij dit probleem niet voor een baarmoederverwijdering  
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e. Stemming (slechts één antwoord aankruisen)
 Ik ben niet angstig of somber.  
 Ik ben matig angstig of somber.   
 Ik ben erg angstig of somber. 
f. Gezondheidstoestand op meetschaal
Om u te helpen bij het aangeven hoe goed of hoe slecht een gezondheidstoestand 
is, hebben we een meetschaal gemaakt, te vergelijken met een thermometer. 
Op deze schaal betekent ‘100’ de beste gezondheidstoestand die u zich kunt 
voorstellen en ‘0’ de slechtste. Wil u met het zetten van een kruis op de horizontale 
lijn aangeven hoe u uw eigen gezondheidstoestand op dit moment waardeert? 
ALGEHELE GEZONDHEID
‘de slechtste 
gezondheids-
toestand die 
u zich kunt 
voorstellen’
0
‘de beste 
gezondheids-
toestand die 
u zich kunt 
voorstellen’
100
                
 
UDI-12 (UROGENITAL DISTRESS INVENTORY)
Vrouwen met ongewenst urineverlies hebben aangegeven dat ze de volgende klachten 
hadden. Kunt u aangeven welke klachten u op dit moment ook heeft, en hoeveel last 
u daarvan heeft? Ook als u geen klachten denkt te hebben, is het belangrijk dat u alle 
vragen beantwoordt. Kruis het juiste antwoord aan.  
7. a. Vindt u dat u vaak moet plassen?
 Ja  Nee (ga naar vraag 8)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
8. a. Als u moet plassen, voelt u dan altijd een sterke aandrang?
 Ja  Nee (ga naar vraag 9)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
h. Wanneer was u laatste bevalling? …………………………………… (dag/maand/jaar)
i. Hoe oud was u tijdens de eerste bevalling? ……………………… (leeftijd in jaren)
Bij de volgende vraag lopen de antwoordcategorieën op van 1 (erg slecht) tot 6 
(uitstekend). Wilt u het getal omcirkelen dat het meest op u van toepassing is?
5. Hoe zou u uw algehele kwaliteit van leven gedurende de afgelopen week beoordelen?
 1      2     3    4       5      6
        Erg slecht                       Uitstekend
EQ-5D (EURO QOL-5D)
De volgende 5 vragen hebben betrekking op uw huidige gezondheidstoestand. Kruis 
bij elke vraag de  zin aan die het beste past bij uw eigen gezondheidstoestand vandaag. 
6. a. Mobiliteit (slechts één antwoord aankruisen)
 Ik heb geen problemen met lopen.  
 Ik heb enige problemen met lopen. 
 Ik ben bedlegerig. 
b. Zelfzorg (slechts één antwoord aankruisen)
 Ik heb geen problemen om mijzelf te wassen of aan te kleden. 
 Ik heb enige problemen om mijzelf te wassen of aan te kleden.  
 Ik ben niet in staat mijzelf te wassen of aan te kleden. 
c. Dagelijkse activiteiten, bijv. werk, studie, huishouden, gezins- en vrijetijds-
activiteiten (slechts één antwoord aankruisen)
 Ik heb geen problemen met mijn dagelijkse activiteiten. 
 Ik heb enige problemen met mijn dagelijkse activiteiten.   
 Ik ben niet in staat mijn dagelijkse activiteiten uit te voeren.  
d. Pijn / klachten (slechts één antwoord aankruisen)
 Ik heb geen pijn of andere klachten.  
 Ik heb matige pijn of andere klachten.   
 Ik heb zeer ernstige pijn of andere klachten.  
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14. a. Heeft u wel eens pijn onder in de buik of in de schaamstreek?
 Ja  Nee (ga naar vraag 15)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
15. a. Heeft u wel eens het gevoel dat er iets uit de vagina stulpt?
 Ja  Nee (ga naar vraag 16)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
16. a. Heeft u wel eens gezien dat er iets uit de vagina stulpt?
 Ja  Nee (ga naar vraag 17)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
17. Hoe vaak heeft u het afgelopen jaar een blaasontsteking gehad?
 nooit
 1 keer
 tussen de 2 en 4 keer
 meer dan 4 keer
18. a. Moet u ’s nachts meer dan 1 keer plassen?
 Ja  Nee (ga naar vraag 19)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje   Nogal  Heel erg
DDI (DEFECATORY DISTRESS INVENTORY)
De volgende verschijnselen zijn beschreven door vrouwen met klachten van de 
stoelgang. Geeft u aan welke verschijnselen u tegenwoordig herkent en hoeveel last u 
daarvan heeft. Kruis het juiste antwoord aan.  
19. a. Heeft u minder dan driemaal per week ontlasting?
 Ja  Nee (ga naar vraag 20)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
9. a. Heeft u ongewenst urineverlies als u aandrang voelt om te plassen?
 Ja  Nee (ga naar vraag 10)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
c. Zo ja, hoe vaak verliest u ongewild urine?
 dagelijks
 paar keer per week
 1 keer per week
 1 keer per maand
 1 keer per jaar
10. a. Heeft u ongewenst urineverlies bij lichamelijke inspanning, hoesten of niezen? 
 Ja  Nee (ga naar vraag 11)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
c. Zo ja, hoe vaak verliest u ongewild urine?
 dagelijks
 paar keer per week
 1 keer per week
 1 keer per maand
 1 keer per jaar
11. a. Heeft u moeite uw blaas leeg te plassen?
 Ja  Nee (ga naar vraag 12)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
12. a. Heeft u wel eens het gevoel dat uw blaas na het plassen niet helemaal leeg is?
 Ja  Nee (ga naar vraag 13)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
13. a. Heeft u wel eens een drukkend gevoel onder in de buik?
 Ja  Nee (ga naar vraag 14)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
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26. a. Verliest u wel eens vaste ontlasting zonder dat u daar controle over heeft?
 Ja  Nee (ga naar vraag 27)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
c. Hoe vaak komt het voor?
 dagelijks
 paar keer per week
 1 keer per week
 1 keer per maand
 1 keer per jaar
27. a. Verliest u wel eens windjes zonder dat u daar controle over heeft?
 Ja  Nee (ga naar vraag 28) 
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
c. Hoe vaak komt het voor?
 dagelijks
 paar keer per week
 1 keer per week
 1 keer per maand
 1 keer per jaar
28. a. Moet u wel eens via de schede mee drukken om ontlasting te krijgen?
 Ja  Nee (ga naar vraag 29) 
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
29. a. Moet u de ontlasting wel eens met de vingers via de anus verwijderen?
 Ja  Nee (ga naar vraag 30) 
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
20. a. Moet u om ontlasting te krijgen in meer dan een kwart van de keren persen?
 Ja  Nee (ga naar vraag 21)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
21. a. Heeft u wel eens aandrang tot ontlasting terwijl er dan op het toilet geen 
ontlasting komt?
 Ja  Nee (ga naar vraag 22)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
 
22. a. Heeft u wel eens het gevoel dat er iets uit de anus hangt of er iets voor zit?
 Ja  Nee (ga naar vraag 23)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
23. a. Ervaart u pijn tijdens de aandrang tot ontlasting?
 Ja  Nee (ga naar vraag 24)b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
24. a. Ervaart u pijn tijdens of vlak na de ontlasting?
 Ja  Nee (ga naar vraag 25)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
25. a. Verliest u wel eens dunne ontlasting zonder dat u daar controle over heeft?
 Ja  Nee (ga naar vraag 26)
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
c. Hoe vaak komt het voor?
 dagelijks
 paar keer per week
 1 keer per week
 1 keer per maand
 1 keer per jaar
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39. Wordt u in uw activiteiten beperkt door angst dat anderen u ruiken?
 Helemaal niet   Een beetje    Nogal    Heel erg
 
Heeft u als gevolg van uw probleem de volgende gevoelens?
40. Nervositeit of ongerustheid
 Helemaal niet   Een beetje    Nogal    Heel erg
41. Frustratie
 Helemaal niet   Een beetje    Nogal    Heel erg
42. Zich gegeneerd voelen
 Helemaal niet   Een beetje    Nogal    Heel erg
SEKSUELE DYSFUNCTIES
De volgende vragen gaan over de seksualiteit. Het is de bedoeling dat u bij het 
antwoorden denkt aan de situatie van de afgelopen maand. Kruis voor u het meest 
passende antwoord aan. 
43. a. Heeft u wel eens seksueel contact met uw partner? (denk hierbij aan alle vormen 
van seksueel contact en niet alleen aan geslachtsgemeenschap)
 Ja  Nee
b. Zo ja, hoe tevreden bent u daarover?
 Helemaal niet   Een beetje    Nogal    Heel erg
c. Zo nee, hoe vervelend vindt u dit?
 Helemaal niet   Een beetje    Nogal    Heel erg
44. Hoe vaak heeft u geslachtsgemeenschap?
 Nooit
 Minder dan 1 keer per maand
 1 tot 2 keer per maand
 1 keer per week
 Meerdere keren per week
45. a. Verliest u wel eens urine tijdens de geslachtsgemeenschap?
 Ja  Nee    Niet van toepassing, geen seks
b. Zo ja, hoe veel last hebt u hiervan?
 Helemaal niet   Een beetje    Nogal    Heel erg
IIQ (INCONTINENCE IMPACT QUESTIONNAIRE)
Sommige vrouwen vinden dat ongewenst urineverlies hun activiteiten, relaties en 
gevoelens kunnen beïnvloeden. De vragen in onderstaande lijst gaan over aspecten 
van  uw leven die door uw probleem beïnvloed of veranderd kunnen zijn. Geef voor 
iedere vraag het antwoord dat het beste beschrijft hoe zeer uw activiteiten, relaties en 
gevoelens beïnvloed worden door uw urineverlies en/of verzakking en/of problemen 
met de ontlasting. Kruis het juiste antwoord aan.  
Hoeveel invloed heeft ongewenst urineverlies en/of verzakking en/of problemen met 
de ontlasting gehad op:
30. Uw vermogen om huishoudelijk werk te doen (koken, schoonmaken, wassen)
 Helemaal niet   Een beetje    Nogal    Heel erg
31. Uw vermogen om klein onderhoud of reparaties te verrichten in en om het huis
 Helemaal niet   Een beetje    Nogal    Heel erg
32. Boodschappen doen en winkelen
 Helemaal niet   Een beetje    Nogal    Heel erg
33. Reizen met auto en openbaar vervoer over een afstand van minder dan 20 minuten
 Helemaal niet   Een beetje    Nogal    Heel erg
34. Ergens naar toe gaan als u niet helemaal zeker weet of er daar toiletten zijn
 Helemaal niet   Een beetje    Nogal    Heel erg
35. Bezoek krijgen van vrienden en kennissen
 Helemaal niet   Een beetje    Nogal    Heel erg
36. Relaties met vrienden en kennissen
 Helemaal niet   Een beetje    Nogal    Heel erg
37. Vermogen om een seksuele relatie te hebben
 Helemaal niet   Een beetje    Nogal    Heel erg
38. Geestelijke / emotionele gezondheid
 Helemaal niet   Een beetje    Nogal    Heel erg
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50. Voelt u zich seksueel opgewonden als u seksueel actief bent met uw partner?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
51. Bent u tevreden met de variatie van de seksuele activiteiten in uw huidige seksueel 
leven?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
52. Ervaart u pijn tijdens geslachtsgemeenschap?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
53. Bent u incontinent voor urine tijdens seksuele activiteit?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
46. a. Ervaart u pijn tijdens de geslachtsgemeenschap?
 Ja  Nee    Niet van toepassing, geen seks
b. Zo ja, hoe veel last hebt u hiervan?
 Helemaal niet   Een beetje    Nogal    Heel erg
47. a. Is de vagina zo nauw dat geslachtsgemeenschap daardoor niet mogelijk is?
 Ja  Nee    Niet van toepassing, geen seks
b. Zo ja, hoeveel last heeft u hier van?
 Helemaal niet   Een beetje    Nogal    Heel erg
SEKSUEEL FUNCTIONEREN BIJ VERZAKKING EN ONGEWENST URINEVERLIES 
(KORTE VERSIE: PISQ-12)
Voor u ligt een lijst met vragen over het seksueel leven van u en uw partner. Alle 
informatie is strikt vertrouwelijk. Bij het beantwoorden van de vragen gaat u uit van uw 
seksueel leven van de afgelopen 6 maanden. 
48. Hoe vaak voelt u seksueel verlangen? Dit gevoel kan bestaan uit het willen hebben 
van seks, het voelen van frustratie door het gebrek aan seks, enz. 
 Dagelijks
 1 - 3 keer per week
 1 - 3 keer per maand
 Minder dan een keer per maand
 Nooit
49. Ervaart u altijd een orgasme als u geslachtsgemeenschap heeft met uw partner?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
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58. Heeft uw partner een probleem met voortijdig klaarkomen die uw seksuele 
activiteiten beïnvloeden?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
59. Hoe intens waren de orgasmen in de afgelopen 6 maanden in vergelijking met 
orgasmen in het verleden?
 Veel minder intens
 Minder intens
 Dezelfde intensiteit
 Meer intens
 Veel meer intens
 Niet van toepassing, geen seks 
SHORT FORM HEALTH SURVEY (SF-36)
De volgende vragenlijst gaat over uw standpunten ten aanzien van uw gezondheid. 
Met behulp van deze gegevens kan worden bijgehouden hoe u zich voelt en hoe goed 
u in staat bent uw gebruikelijke bezigheden uit te voeren. Als u niet zeker weet hoe u 
een vraag moet beantwoorden, geef dan het best mogelijke antwoord. 
1. Wat vindt u, over het algemeen genomen, van uw gezondheid? (kruis één vakje 
aan)
 Uitstekend
 Zeer goed
 Goed
 Matig
 Slecht
54. Wordt u in uw seksuele activiteit beperkt door angst voor incontinentie (ontlasting 
en/of urine?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
55. Vermijdt u geslachtsgemeenschap vanwege een uitstulping in de vagina 
(verzakking)?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
56. Heeft u, als u seks heeft met uw partner, negatieve emotionele gevoelens, zoals 
angst, afkeer, schaamte of schuldgevoel?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
57. 57.  Heeft uw partner problemen met erecties die uw seksuele activiteiten 
beïnvloeden?
 Altijd
 Meestal
 Soms
 Zelden
 Nooit
 Niet van toepassing, geen seks 
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6. In hoeverre hebben uw lichamelijke gezondheid of emotionele problemen u 
gedurende de afgelopen 4 weken gehinderd in uw normale omgang met familie, 
vrienden of buren, of bij activiteiten in groepsverband? (kruis één vakje aan)
 Helemaal niet
 Enigszins
 Nogal
 Veel
 Heel erg veel
7. Hoeveel lichamelijke pijn heeft u de afgelopen 4 weken gehad (kruis één vakje aan)
 Geen
 Heel licht
 Licht
 Nogal
 Ernstig
 Heel ernstig
8. In welke mate bent u de afgelopen 4 weken door pijn gehinderd in uw normale 
werk (zowel werk buitenshuis als huishoudelijk werk)? (kruis één vakje aan)
 Helemaal niet
 Enigszins
 Nogal
 Veel
 Heel erg veel
9. Deze vragen gaan over hoe zich voelt en hoe het met u ging in de afgelopen 4 
weken. Wilt u a.u.b. bij elke vraag het antwoord geven dat het best benadert hoe 
u zich voelde. (kruis één vakje aan op elke regel)
Voortdurend Meestal Vaak Soms Zelden Nooit
a. voelde u zich levenslustig? ☐ ☐ ☐ ☐ ☐ ☐
b. voelde u zich erg zenuwachtig? ☐ ☐ ☐ ☐ ☐ ☐
c. zat u zo erg in de put dat niet u kon opvrolijken? ☐ ☐ ☐ ☐ ☐ ☐
d. voelde u zich kalm en rustig ☐ ☐ ☐ ☐ ☐ ☐
e. voelde u zich erg energiek? ☐ ☐ ☐ ☐ ☐ ☐
f. voelde u zich neerslachtig en somber? ☐ ☐ ☐ ☐ ☐ ☐
g. voelde  u zich uitgeblust? ☐ ☐ ☐ ☐ ☐ ☐
h. voelde u zich gelukkig? ☐ ☐ ☐ ☐ ☐ ☐
i. voelde u zich moe? ☐ ☐ ☐ ☐ ☐ ☐
2. In vergelijking met een jaar geleden, joe zou u nu uw gezondheid in het algemeen 
beoordelen? (kruis één vakje aan)
 Veel beter nu dan een jaar geleden
 Wat beter nu dan een jaar geleden
 Ongeveer hetzelfde nu als een jaar geleden
 Wat slechter nu dan een jaar geleden
 Veel slechter nu dan een jaar geleden
3. De volgende vragen gaan over bezigheden die u misschien doet op een doorsnee 
dag. Wordt u door uw gezondheid op dit moment beperkt bij deze bezigheden? 
Zo ja, in welke mate? (kruis één vakje aan op elke regel?
Ja, ernstig 
beperkt
Ja, een beetje 
beperkt
Nee, helemaal 
niet beperkt
a. Forse inspanning
Zoals hardlopen, zware voorwerpen tillen
□ □ □
b. Matige inspanning
Zoals het verplaatsen van een tafel,stofzuigen, fietsen
□ □ □
c. Tillen of boodschappen dragen □ □ □
d. Een paar trappen oplopen □ □ □
e. Eén trap oplopen □ □ □
f. Buigen, knielen of bukken □ □ □
g. Meer dan een kilometer lopen □ □ □
h. Een halve kilometer lopen □ □ □
i. Honderd meter lopen □ □ □
j. Uzelf wassen of aankleden □ □ □
4. Heeft in de afgelopen 4 weken, een van de volgende problemen bij uw werk of 
andere dagelijkse bezigheden gehad, ten gevolge van uw lichamelijke gezondheid? 
(kruis één vakje aan op elke regel)
Ja Nee
a. U heeft minder tijd kunnen besteden aan werk of ander bezigheden ☐ ☐
b. U heeft minder bereikt dan  u zou willen ☐ ☐
c. U was beperkt in het soort werk of het soort bezigheden ☐ ☐
d. U had moeite met het extra werk of andere bezigheden (het kostte u bijvoorbeeld extra 
inspanning)
☐ ☐
5. Heeft u in de afgelopen 4 weken, een van de volgende problemen ondervonden bij 
uw werk of andere dagelijkse bezigheden ten gevolge van  emotionele problemen 
(zoals depressieve of angstige gevoelens)? (kruis één vakje aan op elke regel)
Ja Nee
a. U heeft minder tijd kunnen besteden aan werk of ander bezigheden ☐ ☐
b. U heeft minder bereikt dan  u zou willen ☐ ☐
c. U heeft het werk of andere bezigheden niet zo zorgvuldig gedaan als u gewend bent ☐ ☐
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10. Hoe vaak hebben uw lichamelijke gezondheid of emotionele problemen u 
gedurende de afgelopen 4 weken gehinderd bij uw sociale activiteiten (zoals 
vrienden of familie bezoeken etc.)? (kruis één vakje aan)
 Voortdurend
 Meestal
 Soms
 Zelden
 Nooit
11. Hoe JUIST of ONJUIST is elk van de volgende uitspraken voor u? (kruis één vakje 
aan op iedere elke regel)
Volkomen 
juist
Groten-
deels juist
Weet 
ik niet
Groten-
deels onjuist
Volkomen 
onjuist
a. Ik lijk gemakkelijker ziek te worden dan 
andere mensen
☐ ☐ ☐ ☐ ☐
b. Ik ben net zo gezond als andere mensen 
die ik ken
☐ ☐ ☐ ☐ ☐
c. Ik verwacht dat mijn gezondheid achteruit 
zal gaan
☐ ☐ ☐ ☐ ☐
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Hoera, het is af! Omdat het onmogelijk is om te promoveren zonder de hulp en 
begeleiding van collega’s en steun van vrienden en familie, wil ik in het bijzonder de 
volgende mensen bedanken:
Allereerst wil ik graag alle vrouwen bedanken die aan de verschillende studies hebben 
meegedaan. Zonder hun deelname was dit onderzoek niet mogelijk geweest. 
Veel dank ben ik verschuldigd aan mijn co-promotor, dr. H.W.F. van Eijndhoven, en 
promotoren prof. dr. M.Y. Bongers en prof. dr. J. Deprest. 
Mijn co-promotor dr. H.W.F van Eijndhoven, beste Hugo, ik kan me ons allereerste 
gesprek in de koffiekamer in het oude Sophia ziekenhuis nog goed herinneren. Dankzij 
jou ben ik met dit onderzoek gestart. Vanaf het begin ben je erg betrokken geweest 
bij de projecten; de artikelen en stukken werden door jou altijd binnen een zeer korte 
tijd voorzien van commentaar. Ik ben je erg dankbaar voor het vertrouwen dat je in 
me hebt gehad en de mogelijkheid die je me hebt gegeven om me wetenschappelijk 
te verdiepen. Ik heb veel bewondering voor de kennis en operatieve vaardigheden die 
je hebt, en ik kijk er dan ook naar uit om volgend jaar van jou de urogynaecologische 
praktijk te leren. 
Mijn promotor prof. dr. M.Y. Bongers, beste Marlies, in vele opzichten ben je een 
rolmodel voor mij geweest. Je enthousiasme voor onderzoek werkt enorm motiverend, 
en een gesprek met jou zorgde er altijd voor dat ik weer met veel energie aan de slag 
kon gaan. In de laatste fase van het onderzoek hebben we veel contact gehad om de 
laatste puntjes op de “i” te zetten. Naast interesse in de voortgang van het onderzoek 
toonde je ook veel interesse in mij als persoon. Dank je wel voor je fijne begeleiding!
Mijn promotor prof. dr. J. Deprest, beste Jan, jouw kritische wetenschappelijk blik 
en commentaar op de manuscripten zijn zeer waardevol geweest en hebben dit 
proefschrift naar een hoger niveau gebracht. Bedankt hiervoor!
Leden van de leescommissie, prof. dr. Kruitwagen, dr. Blanker, prof. dr. Bouvy en dr. 
Hakvoort, dank voor de bereidheid dit proefschrift te beoordelen op wetenschappelijke 
waarde.
Alle gynaecologen in de deelnemende centra en met name Geerte van de Pol, Celine 
muffin syndroom”. Ned Tijdschr Geneesk. 2013;157(33):A6460
2011 Aukes AM, IJsselmuiden MN van, Wiegman MJ, Postma IR, Veen TR van, 
Roos N, Graaf AM van der, Zeeman GG. Het maternale brein: oorzaken van 
eclampsie en de langetermijngevolgen. NTOG. 2011 April; 124:116-120. 
2011 IJsselmuiden MN van, Wiegman MJ, Zeeman GG, Faas MM. The S100B protein 
in brain tissue and plasma in a preeclampsia rat model. Hypertens Preg. 2011 
Apr; 1(2):143-149. 
2009 IJsselmuiden MN van, Bos AM, Hoek A, Van Beek AP, Kerstens MN. Lichen 
Sclerosus en het syndroom van Turner. Ned Tijdschr Geneeskd. 2010;154:A773
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Het is heel fijn om onderzoeksmaatjes te hebben om af en toe eens te sparren en ideeën 
uit te wisselen. Renée Detollenaere, wat was het fijn om af en toe wat onderzoeks-
issues te bespreken en wat heb ik veel aan al je tips gehad. Je bevlogenheid en 
voortvarendheid heb ik altijd erg bewonderd, en omdat je altijd net een paar stappen 
voor liep op mij (zowel wetenschappelijk als in de opleiding) ben je in veel opzichten 
een voorbeeld voor me geweest. 
Anne-Lotte Coolen, het is tijd om samen te proosten op onze proefschriften. Enkele 
jaren na de start van onze studies, en inmiddels beiden twee kinderen verder, hebben 
we toch maar mooi allebei de eindstreep gehaald. 
Anique van Oudheusden, de combinatie opleiding en promoveren is niet altijd 
gemakkelijk, maar jij slaat je er dapper doorheen! Nog even en dan jij aan de beurt om 
de SALTO-2 te verdedigen. 
Sacha Schulten en Roosje Enklaar, de SAM-studie is al in volle gang. Nog even en 
dan staan jullie op internationale congressen jullie resultaten te presenteren. Roosje, 
samen gaan we ons verder verdiepen in de praktijkvariatie van prolapschirurgie in 
Nederland, dat gaat een leuk onderzoek worden!
Tom en Mirell van de bibliotheek Isala (DISC), bedankt voor de vele fulltexten die jullie 
voor me opgevraagd hebben met als dieptepunt de fulltext van mijn eigen artikel…
Lieve collega A(N)IOS uit Deventer, Groningen en Zwolle, bedankt voor de prettige 
samenwerking en de gezelligheid op de werkvloer. Ik ga iedere dag met plezier naar 
mijn werk, en dat komt ook zeker door de fijne collega’s die ik heb. 
Alle oud-collega’s in het Deventer Ziekenhuis en opleider Paul van der Linden. Mijn 
eerste jaren als AIOS mocht ik bij jullie werken. Ik heb de samenwerking en begeleiding 
als erg prettig ervaren en voelde me als een vis in het water in jullie ziekenhuis. Ik zal 
de telefoontjes van Paul en de bloemen na de geboorte van de kinderen niet snel 
vergeten, zelfs bijna 2 jaar na vertrek uit het DZ. Ik heb deze betrokkenheid ongelooflijk 
gewaardeerd. 
Mijn oud-collega’s in het UMCG en in het bijzonder de opleiders Maaike Oonk en 
Astrid Cantineau, wil ik graag bedanken voor de fijne tijd die ik als AIOS in de academie 
heb gehad. Maaike en Astrid, tijdens mijn periode in het UMCG werden jullie opleider, 
een rol die jullie op het lijf is geschreven. Ik denk met veel plezier terug aan de chips-
overleggen of de korte gesprekken op de gang over opleiding, onderzoek of de 
kinderen. 
Radder, Astrid Vollebregt, Joggem Veen en Susanne Housmans wil ik bedanken voor 
hun inzet om patiënten te includeren in de LAVA trial en terug te zien voor follow-up. 
Ook veel dank voor de betrokken research verpleegkundigen van de deelnemende 
centra: Leen Mortier, Els Heijman, Rita Kantoor, Anja Ommering, Ingrid ’t Hooff en 
Astrid Ritman. De korte lijntjes met jullie zijn erg fijn, bedankt voor de gastvrijheid en 
lekkere kopjes koffie tijdens de monitor bezoeken. 
Alle mede-auteurs en onderzoekers die meegewerkt hebben aan één of meer 
projecten wil ik bedanken voor hun inbreng en inspanning. Jan den Boon, samen met 
Hugo ben jij het brein achter de LAVA-trial. Dank je wel voor je input en begeleiding 
bij het opzetten van de studie. Sander van Kuijk, wat ben ik blij met jouw hulp bij de 
statistiek. Samen naar de LAVA-database kijken was de lange treinreis naar Maastricht 
zeker waard. 
Een grote studie uitvoeren in combinatie met de opleiding tot gynaecoloog is alleen 
mogelijk met een goede research verpleegkundige. Nitolanda van Rijn, ik ben jou veel 
dank verschuldigd. Dank je wel voor het helpen opzetten van de LAVA en voor je hulp 
bij de logistiek van de studie. Je bent een harde werker die alles tot in de puntjes regelt, 
eigenschappen die je goed van pas gaan komen bij je opleiding tot verpleegkundig 
specialist. 
Jody Walraven, ondanks dat we op dezelfde afdeling werken zien we elkaar niet zo 
vaak. Naast je drukke baan heb je ook nog tijd gevonden om mij te ondersteunen bij 
de LAVA trial, waarvoor heel veel dank! En dan heb je in de tussentijd ook nog ons 
gezamenlijk doel volbracht, nu ik nog… 
Jans en Marianne, bedankt voor jullie hulp bij de logistiek van de studie. 
Ik heb tijdens mijn onderzoek ook veel steun mogen ervaren van de Isala Academie en 
in het bijzonder wil ik de “Innovatie & Wetenschapsraad” van de Isala bedanken voor 
de financiële ondersteuning van de studie. Joep Dille, dank je wel voor je goede hulp 
bij het opstellen van een begroting voor de LAVA, maar ook bij het regelen van allerlei 
logistieke uitdagingen waar ik tegenaan liep. Ik ben heel erg blij dat ik enkele maanden 
fulltime promotie-onderzoek heb mogen doen. Dit was niet mogelijk geweest zonder 
jouw hulp en zonder de vouchers van het I&W. Ik ben het I&W dan ook ongelooflijk 
erkentelijk; heel veel dank. David de Jong en Saskia Abbes, dankzij jullie hebben 
wij een goede randomisatiemodule en database kunnen ontwikkelen voor de LAVA 
trial, hier heb ik veel gemak van gehad. Lonneke Buitenhuis, het monitoren van de 
deelnemende centra was een leuke bezigheid om samen te doen. Dank je wel voor je 
punctualiteit en je kritische blik!
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ik heel trots dat je als paranimf naast me staat. 
Lieve Smitjes, ik voelde me vanaf het begin erg welkom in jullie familie. Ik geniet 
enorm van de gezelligheid en drukte als we met z’n allen zijn. De familie zal weer flink 
uitgebreid worden dit jaar, ik kijk er naar uit. Hoe meer zielen, hoe meer vreugd! Killy, 
ik wil jou in het bijzonder bedanken. Door af en toe op de kinderen te passen heb ik 
wat extra kunnen werken aan dit proefschrift en kon ik de vaart erin houden. Dank je 
wel hiervoor!
Jakob en Anneke, als “bonus-familie” ben ik blij jullie in mijn leven te hebben. Na 
het overlijden van papa zijn jullie een grote steun voor mij geweest en jullie zijn een 
fantastische opa en oma voor onze kinderen. Ik geniet enorm van de weekendjes weg 
en de gezellige dagjes uit die we gehad hebben samen. Laten we de agenda’s (vooral 
die van ons geloof ik…) weer naast elkaar leggen om weer eens gezellig samen uit eten 
te gaan. 
Jessica, mijn lieve zusje. Ondanks dat we in veel dingen verschillend zijn, hebben we 
een ijzersterke band. Jouw nuchtere kijk kan soms erg relativerend werken. Ik heb 
bewondering voor hoe jij je door de afgelopen periode heen hebt geslagen, wat ben je 
toch krachtig en positief. Ik ben trots op je! Dank je wel dat je altijd voor me klaar staat, 
en dat je er nu ook voor me bent als paranimf. 
Lieve mama, wat ben ik trots op jou. Jouw positieve instelling heeft ervoor gezorgd dat 
je de draad weer goed op hebt kunnen pakken na het overlijden van papa. Jullie hebben 
altijd tegen me gezegd dat ik mijn dromen moest nastreven en me gestimuleerd om het 
beste uit mezelf naar boven te halen. Mede dankzij jullie ben ik alsnog Geneeskunde 
gaan studeren. Bedankt voor alles!
Mijn mooie lieve kinderen Koen en Fiene, jullie zijn de leukste mensen die ik ken. Ik 
houd onvoorwaardelijk van jullie, en alleen al naar jullie kijken tovert een glimlach op 
mijn gezicht. Jullie laten me zien waar het echt om gaat in het leven en wat ultiem 
geluk is. 
Koen, de liefde voor muziek en dansen heb je niet van een vreemde. Ik vind het 
fantastisch om met jou door de kamer te dansen. Ik hoop dat we dat nog heel 
lang blijven doen samen. Fiene, wat ben je toch een prachtig meisje en wat heb je 
een engelengeduld. Ik vind het heerlijk om met je te puzzelen en om boekjes met 
je te lezen. Jullie zullen een fantastische grote broer en zus zijn. Ik ben apetrots 
op jullie! 
Collega’s in de Isala Zwolle, wat is het fijn om weer terug op het nest te zijn. Van semi-
arts tot ANIOS, onderzoeker en nu de laatste jaren van mijn opleiding: alle stappen 
heb ik bij jullie gezet. Ik voel me enorm thuis in jullie kliniek, en na een aantal jaren 
weg te zijn geweest voelt mijn terugkomst als een warm bad. Bedankt voor jullie 
interesse in mij en in mijn onderzoek. In het bijzonder wil ik de opleiders Ben Cohlen 
en Walter Kuchenbecker noemen, bedankt voor de fijne opleidingsgesprekken en de 
mogelijkheden die ik in de Isala van jullie krijg om mezelf verder te ontwikkelen. 
Reinie en Marijke, jullie zijn toch echt wel de spil van de afdeling en met een kamer 
tegenover het koffiezetapparaat zwaai ik iedere dag even naar jullie (wat meestal 
uitloopt op lang kletsen..). Fijn dat jullie er zijn voor alle logistieke problemen, een 
luisterend oor, en vooral voor een gezellig praatje. 
Lieve familie en vrienden. Hoewel ik niet iedereen persoonlijk kan noemen, wil ik 
jullie allemaal bedanken voor de interesse in mijn onderzoek maar ook voor alle leuke 
momenten daarnaast!
Mijn lieve vriendinnen: Annemarie, Elianne, Loes, Margreet en Marieke. Al bijna 20 jaar 
vormen we een hecht vriendinnengroepje en onze band is, ondanks dat een aantal 
tijdelijk aan de andere kant van de wereld woonden, alleen maar sterker geworden 
met de jaren. We hebben allemaal een druk leven, maar we weten elkaar iedere keer 
weer te vinden. Ik geniet van onze etentjes, weekendjes weg en als hoogtepunt van 
het jaar het vriendendiner (die nodig weer gepland moet worden!).  Jullie vriendschap 
is mij zeer dierbaar!
Leden van de WES: Sanne en Marieke, wat begon als collega’s op de verloskamers is 
uitgegroeid tot een vriendschap. Altijd gezellig om samen koffie te drinken en bij te 
kletsen, of om “on tour” te gaan. Laten we snel weer een etentje plannen!
Thijs & Sanne, Frank-Nico & Lisette, Laurens & Annemiek, Wouter & Jitske-Annie, Jeffrey 
& Lyanne, door alle drukke agenda’s valt het niet altijd mee om een datum te prikken 
waarop we elkaar kunnen zien. Maar wat is het altijd gezellig! Laurens en Annemiek, 
de chocolade kwam op het juiste moment! Lieve Sanne, je bent mijn meest creatieve 
vriendin, bedankt voor het ontwerpen van de prachtige omslag van dit proefschrift. 
Lieve Annemarie, mijn allerbeste vriendinnetje. Onze vriendschap gaat terug tot de 
basisschool. We hebben dezelfde kijk op het leven en humor die alleen wij begrijpen. 
Het is een fantastisch gevoel om te weten een vriendin zoals jij te hebben. Daarom ben 
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Robbert,  mijn allerliefste en mijn grote liefde. In jou heb ik mijn gelijke gevonden.  Wat 
ben ik blij dat ik jou aan mijn zijde heb. Bedankt voor je steun bij het tot stand komen 
van dit proefschrift, maar vooral voor je steun bij het najagen van mijn droom om 
gynaecoloog te worden. Ik kan niet in woorden uitbrengen hoe fantastisch ik je vind, 
de laatste woorden in dit proefschrift worden dan ook terecht aan jou opgedragen. Ik 
geniet iedere dag weer van jouw aanwezigheid en van ons mooie gezin. Ik hou van je!
CURRICULUM VITAE
Mèlanie Nathalie van IJsselmuiden werd op 30 juni 1984 geboren in Havelte. In 
2002 behaalde zij haar Atheneum diploma aan de Christelijke Scholengemeenschap 
Dingstede te Meppel. Na het voltooien van de opleiding “Medische Beeldvormende 
en Radiotherapeutische Technieken” (HBO-MBRT) heeft zij een half jaar gewerkt 
als radiodiagnostisch laborant in de Isala Zwolle. In 2007 werd zij toegelaten tot de 
zij-instroom Geneeskunde aan de Rijksuniversiteit Groningen. Na het behalen van 
haar artsenbul ging zij in 2012 werken als arts-assistent niet in opleiding (ANIOS) in 
de Isala Zwolle. Onder leiding van dr. H.W.F. van Eijndhoven werd in de zomer van 
2012 een start gemaakt met de LAVA-trial en dit leidde tot een promotie-onderzoek 
in samenwerking met het Maastricht Universitair Medisch Centrum (begeleiders prof. 
dr. M.Y. Bongers, prof. dr. J. Deprest en dr. H.W.F. van Eijndhoven). In januari 2015 
startte zij met de opleiding tot gynaecoloog in het Deventer Ziekenhuis (opleider dr. 
P.J.Q. van der Linden). Van oktober 2016 tot september 2018 was zij werkzaam in het 
Universitair Medisch Centrum Groningen (opleider prof. S.S. Scherjon, dr. M.M. Oonk/
dr. A.E. Cantineau). Sinds september 2019 werkt zij in de Isala Zwolle (opleider dr. B.J. 
Cohlen), waar zij de laatste jaren van haar opleiding zal besteden aan differentiaties in 
de voortplantingsgeneeskunde, minimaal-invasieve gynaecologie en urogynaecologie. 
Mèlanie woont samen met Robbert Smit in Zwolle. Ze zijn de trotse ouders van hun 
zoon Koen (2016) en dochter Fiene (2018). 
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